Clinical Trials

• D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00257361 - Recruiting
  Obsessive Compulsive Disorder
  
• D-Cycloserine for Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00408031 - Recruiting
  Major Depressive Disorder
  
• D-Cycloserine in the Management of Chronic Low Back Pain
  ClinicalTrials.gov Identifier: NCT00125528 - Not yet recruiting
  Low Back Pain; Pain
  
• D-Cycloserine in Treating Cancer Patients With Peripheral Neuropathy Caused by Chemotherapy
  ClinicalTrials.gov Identifier: NCT00301080 - Suspended
  Neurotoxicity; Pain; Unspecified Adult Solid Tumor, Protocol Specific
  
• D-Dimer and IPG for Recurrent Thrombosis (DIRECT)
  ClinicalTrials.gov Identifier: NCT00182247 - Terminated
  Deep Vein Thrombosis; Pulmonary Embolism
  
• D-Dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence
  ClinicalTrials.gov Identifier: NCT00266045 - Recruiting
  Deep Vein Thrombosis; Pulmonary Embolism
  
• D-Dimer to Establish Duration of Anticoagulation After Venous Thromboembolism
  ClinicalTrials.gov Identifier: NCT00264277 - Completed
  Deep Vein Thrombosis; Pulmonary Embolism
  
• D-Dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism
  ClinicalTrials.gov Identifier: NCT00428441 - Not yet recruiting
  Venous Thromboembolism
  
• D-Dimer Vs Serial Compression Ultrasound Study
  ClinicalTrials.gov Identifier: NCT00182351 - Completed
  Deep Vein Thrombosis
  
• D-MPH in the treatment of fatigue and neurobehavioral function related to chemotherapy in adult cancer patients
  ClinicalTrials.gov Identifier: NCT00047476 - Completed
  Fatigue; Neoplasms
  
• D-Serine Adjuvant Treatment for Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00215904 - Recruiting
  Parkinson's Disease
  
• D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00237848 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• D-Serine for Posttraumatic Stress Disorder Treatment
  ClinicalTrials.gov Identifier: NCT00215878 - Recruiting
  Posttraumatic Stress Disorder
  
• D-Serine Monotherapy for Schizophrenia
  ClinicalTrials.gov Identifier: NCT00215917 - Recruiting
  Schizophrenia
  
• D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00237809 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• D.O.S.E. Registry
  ClinicalTrials.gov Identifier: NCT00212862 - Active, not recruiting
  Cancer; Anemia; Epoetin Alfa; Darbepoetin Alfa
  
• D.T. PACE versus High Dose Melphalan and Autologous Transplant in Patients with Previously Treated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00083876 - Completed
  Multiple Myeloma
  
• D2 Dopamine Receptor on Human Aldosterone-Producing Adenoma and Its Role in Aldosterone Secretion and Cell Proliferation
  ClinicalTrials.gov Identifier: NCT00173446 - Recruiting
  Hypertension; Adrenal Aldosterone-Producing Adenoma
  
• D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management
  ClinicalTrials.gov Identifier: NCT00328705 - Active, not recruiting
  Heart Diseases
  
• D2E7-Early AS
  ClinicalTrials.gov Identifier: NCT00235105 - Active, not recruiting
  Ankylosing Spondylitis
  
• D3-Growth Hormone Receptor Polymorphism and Total Effect of Recombinant Human Growth Hormone on Growth in Girls With Turner Syndrome
  ClinicalTrials.gov Identifier: NCT00443144 - Completed
  Turner Syndrome; Growth
  
• D4T or Abacavir Plus Vitamin Enhancement (DAVE)
  ClinicalTrials.gov Identifier: NCT00143702 - Recruiting
  Elevated Lactic Acid
  
• Dabigatran Etexilate in Extended VTE Prevention After Hip Replacement Surgery
  ClinicalTrials.gov Identifier: NCT00168818 - Completed
  Thromboembolism; Arthroplasty, Replacement, Hip
  
• DAC With or Without VPA in MDS and AML
  ClinicalTrials.gov Identifier: NCT00414310 - Active, not recruiting
  Myelodysplastic Syndrome; Acute Myelogenous Leukemia
  
• Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma
  ClinicalTrials.gov Identifier: NCT00324155 - Recruiting
  Melanoma
  
• Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00072124 - Completed
  Melanoma (Skin)
  
• Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00016263 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Daclizumab and Sirolimus to Treat Uveitis
  ClinicalTrials.gov Identifier: NCT00078689 - Active, not recruiting
  Uveitis
  
• Daclizumab Compared With Antithymocyte Globulin in Treating Cytopenia in Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00075530 - Suspended
  Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; previously treated myelodysplastic syndromes; ...
  
• Daclizumab Experience in Pediatric Heart Transplant
  ClinicalTrials.gov Identifier: NCT00486057 - Active, not recruiting
  Congenital Disorders
  
• Daclizumab in Treating Patients With Adult T-Cell Leukemia/Lymphoma
  ClinicalTrials.gov Identifier: NCT00020020 - Recruiting
  Lymphoma
  
• Daclizumab Injections to Treat Non-infectious Sight-threatening Uveitis
  ClinicalTrials.gov Identifier: NCT00043667 - Completed
  Uveitis
  
• Daclizumab to Treat Chronic Immune Thrombocytopenia
  ClinicalTrials.gov Identifier: NCT00049725 - Completed
  Thrombocytopenia
  
• Daclizumab to Treat HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00080431 - Active, not recruiting
  HIV Infections
  
• Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis
  ClinicalTrials.gov Identifier: NCT00070759 - Completed
  Uveitis
  
• Daclizumab to Treat Wegener's Granulomatosis
  ClinicalTrials.gov Identifier: NCT00040248 - Completed
  Wegener's Granulomatosis
  
• Dacron vs Dardik for Fem-Pop Bypass
  ClinicalTrials.gov Identifier: NCT00523263 - Completed
  Intermittent Claudication; Arterial Occlusive Diseases; Atheroslerosis
  
• Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia
  ClinicalTrials.gov Identifier: NCT00003688 - Completed
  recurrent gestational trophoblastic tumor; nonmetastatic gestational trophoblastic tumor; good prognosis metastatic gestational trophoblastic tumor
  
• DAHANCA 19: The Importance of the EGFr-Inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for HNSCC
  ClinicalTrials.gov Identifier: NCT00496652 - Recruiting
  Cancer of the Head and Neck
  
• DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00400426 - Not yet recruiting
  Head and Neck Neoplasms; Recurrence; Neoplasms, Second Primary
  
• Daily dosing of Interferon Alfacon-1 plus Ribavirin for treatment of Hepatitis C Infected Patients (nonresponders)
  ClinicalTrials.gov Identifier: NCT00086541 - Completed
  Chronic Hepatitis C
  
• Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers with HIV
  ClinicalTrials.gov Identifier: NCT00080119 - Recruiting
  HIV Infections; Tuberculosis; Pneumocystis carinii Pneumonia
  
• Daily Nevirapine to Prevent Mother to Infant Transmission of HIV
  ClinicalTrials.gov Identifier: NCT00061321 - Active, not recruiting
  HIV Infections
  
• Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00003746 - Active, not recruiting
  untreated hairy cell leukemia; progressive hairy cell leukemia, initial treatment; Prolymphocytic Leukemia
  
• Daily Patching Plus Daily Atropine for Residual Amblyopia in Children 3 to <8 Years Old
  ClinicalTrials.gov Identifier: NCT00506675 - Recruiting
  Amblyopia
  
• Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol
  ClinicalTrials.gov Identifier: NCT00298493 - Completed
  Critical Illness; Mechanical Ventilation
  
• Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia
  ClinicalTrials.gov Identifier: NCT00078182 - Terminated
  HIV Infections; HIV Seronegativity
  
• Daily Vitamin K in Patients on Warfarin With Unstable INRs
  ClinicalTrials.gov Identifier: NCT00287313 - Recruiting
  Anticoagulants; Warfarin
  
• Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy
  ClinicalTrials.gov Identifier: NCT00162734 - Active, not recruiting
  Chronic Hepatitis C
  
• Dairy Foods and Blood Pressure in Multi-Ethnic Children
  ClinicalTrials.gov Identifier: NCT00495105 - Not yet recruiting
  Blood Pressure, High
  
• Dairy Products and Metabolic Effects (Norwegian Part)
  ClinicalTrials.gov Identifier: NCT00140816 - Recruiting
  Metabolic Syndrome; Heart Disease
  
• Dalacin-T Gel Post Approval Study
  ClinicalTrials.gov Identifier: NCT00219570 - Completed
  Acne Vulgaris
  
• Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort
  ClinicalTrials.gov Identifier: NCT00344903 - Recruiting
  Atherosclerosis; Congestive Heart Failure; Left Ventricular Hypertrophy; Diabetes Mellitus; Hypertension; Obesity; Metabolic Syndrome X; Myocardial Infarction
  
• Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00028678 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Dalteparin in Preventing Blood Clots in Patients With Lung Cancer
  ClinicalTrials.gov Identifier: NCT00519805 - Recruiting
  Lung Cancer; Thromboembolism
  
• Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients
  ClinicalTrials.gov Identifier: NCT00135876 - Completed
  Venous Thromboembolism; Brain Tumors
  
• Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
  ClinicalTrials.gov Identifier: NCT00006083 - Active, not recruiting
  Leukemia; Lymphoma; Cervical Cancer; Multiple Myeloma
  
• Dalteparin Vs Unfractionated Heparin For The Prevention Of VTE In Hospitalized Acutely Ill Medical Patients
  ClinicalTrials.gov Identifier: NCT00445328 - Recruiting
  Heart Failure, Congestive; Respiratory Insufficiency; Infection; Inflammatory Bowel Diseases; Sciatica
  
• Dalteparin vs Unfractionated Heparin In Patients With Acute Coronary Syndrome
  ClinicalTrials.gov Identifier: NCT00435487 - Recruiting
  Angina, Unstable; Myocardial Infarction
  
• Dalteparin''s Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)
  ClinicalTrials.gov Identifier: NCT00138099 - Completed
  Critically Ill; Renal Insufficiency
  
• DAME: Induction of Labor or Waiting for Suspicion Fetal Macrosomia
  ClinicalTrials.gov Identifier: NCT00190320 - Recruiting
  Fetal Macrosomia
  
• Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00003946 - Completed
  stage IV endometrial cancer; recurrent endometrial cancer
  
• Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema
  ClinicalTrials.gov Identifier: NCT00442091 - Not yet recruiting
  Vesicular Palmoplantar Eczema; Pompholyx
  
• Dane County Safety Assessment (SAFE) Research Study
  ClinicalTrials.gov Identifier: NCT00140322 - Completed
  Falls
  
• Dane County Safety Assessment for Elders (SAFE) Research Study
  ClinicalTrials.gov Identifier: NCT00205114 - Recruiting
  Falls
  
• Danish Aspirin Resistance Trial - Pilot Study
  ClinicalTrials.gov Identifier: NCT00389129 - Completed
  Drug Resistance
  
• Danish Carvedilol Study in Portal Hypertension
  ClinicalTrials.gov Identifier: NCT00493480 - Recruiting
  Cirrhosis; Portal Hypertension
  
• Danish Hypertension Prevention Project - DHYPP
  ClinicalTrials.gov Identifier: NCT00150631 - Active, not recruiting
  Prevent or delay development of hypertension
  
• Danish ICD Study in Patients With Dilated Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00542945 - Not yet recruiting
  Heart Failure; Dilated Cardiomyopathy; Reduced LVEF
  
• Danish Lung Cancer Screening Trial (DLCST)
  ClinicalTrials.gov Identifier: NCT00496977 - Active, not recruiting
  Lung Cancer
  
• DANish Multicenter STENT Trial
  ClinicalTrials.gov Identifier: NCT00139802 - Completed
  Ischemic Heart Disease; Stable angina; Unstable Angina
  
• Danish Multicenter Study of Adalimumab in Spondyloarthritis
  ClinicalTrials.gov Identifier: NCT00477893 - Recruiting
  Spondyloarthritis
  
• Danish Osteoporosis Prevention Study
  ClinicalTrials.gov Identifier: NCT00252408 - Completed
  Osteoporosis
  
• Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics
  ClinicalTrials.gov Identifier: NCT00268866 - Recruiting
  COPD
  
• DAPHNE (Duodopa in Advanced Parkinson''s: Health Outcomes & Net Economic Impact).
  ClinicalTrials.gov Identifier: NCT00141518 - Active, not recruiting
  advanced idiopathic Parkinson''s disease
  
• Dapsone 100 mg Versus 50 as Primary Prophylaxis for Pneumocystis carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)
  ClinicalTrials.gov Identifier: NCT00002043 - Completed
  Pneumonia, Pneumocystis carinii; HIV Infections
  
• Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.
  ClinicalTrials.gov Identifier: NCT00401960 - Recruiting
  Endocarditis, Bacterial
  
• Daptomycin for the Treatment of Infections Due to Gram-positive Bacteria
  ClinicalTrials.gov Identifier: NCT00055198 - Completed
  Gram-Positive Bacterial Infections
  
• Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections.
  ClinicalTrials.gov Identifier: NCT00261807 - Recruiting
  Severe Necrotizing Fasciitis; Severe Necrotizing Skin and Soft Tissue Infections; Fournier's Gangrene
  
• Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus
  ClinicalTrials.gov Identifier: NCT00507247 - Active, not recruiting
  Staphylococcus Aureus
  
• Daptomycin in the Treatment of Patients with Renal Insufficiency and Complicated Skin and Skin Structure Infections
  ClinicalTrials.gov Identifier: NCT00102947 - Terminated
  Soft Tissue Infections
  
• Daptomycin in the Treatment of Subjects with Infective Endocarditis or Bacteremia due to S. aureus
  ClinicalTrials.gov Identifier: NCT00093067 - Completed
  Bacterial Endocarditis; Bacteremia
  
• Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00335478 - Active, not recruiting
  Fever, Sweats, and Hot Flashes; Infection; Neutropenia; Unspecified Adult Solid Tumor, Protocol Specific
  
• Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy
  ClinicalTrials.gov Identifier: NCT00296049 - Completed
  Infection; Neutropenia; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Daptomycin Study - Collection of Pharmacokinetic Samples in Patients With Renal Failure
  ClinicalTrials.gov Identifier: NCT00573898 - Not yet recruiting
  Renal Failure
  
• Darbepoetin Administration to Preterm Infants
  ClinicalTrials.gov Identifier: NCT00334737 - Recruiting
  Infant, Newborn
  
• Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00355407 - Completed
  Hematologic Malignancies
  
• Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects with Anemia of Cancer
  ClinicalTrials.gov Identifier: NCT00095277 - Completed
  Anemia
  
• Darbepoetin Alfa Compared With Epoetin alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
  ClinicalTrials.gov Identifier: NCT00046982 - Active, not recruiting
  Fatigue; Anemia; unspecified adult solid tumor, protocol specific
  
• Darbepoetin alfa Compared With Epoetin alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
  ClinicalTrials.gov Identifier: NCT00070382 - Active, not recruiting
  adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
  
• Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)
  ClinicalTrials.gov Identifier: NCT00204633 - Recruiting
  Dysgerminoma
  
• Darbepoetin alfa in Treating Anemia in Patients With Cancer Who Are Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00039247 - Active, not recruiting
  Anemia; unspecified adult solid tumor, protocol specific
  
• Darbepoetin alfa in Treating Anemia in Patients With Non-Myeloid Cancer Who Are Not Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00098696 - Recruiting
  adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
  
• Darbepoetin alfa in Treating Anemic Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00093691 - Recruiting
  Anemia; Fatigue; Myelodysplastic Syndromes
  
• Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects
  ClinicalTrials.gov Identifier: NCT00119587 - Completed
  Anemia
  
• Darbepoetin Alfa With or Without IV Iron
  ClinicalTrials.gov Identifier: NCT00401544 - Not yet recruiting
  Anemia; Non-Myeloid Malignancies
  
• Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)
  ClinicalTrials.gov Identifier: NCT00443339 - Recruiting
  Myelodysplastic Syndromes
  
• Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure
  ClinicalTrials.gov Identifier: NCT00213291 - Recruiting
  Kidney Failure, Chronic
  
• DART II - Study of 3 Antiretroviral Medicines in Combination, in HIV Patients who Have Not Been Previously Treated with Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00116116 - Completed
  HIV Infections; AIDS
  
• DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in C-IBS
  ClinicalTrials.gov Identifier: NCT00220090 - Recruiting
  Irritable Bowel Syndrome
  
• Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
  ClinicalTrials.gov Identifier: NCT00568750 - Recruiting
  Gastrointestinal Stromal Tumor
  
• Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
  ClinicalTrials.gov Identifier: NCT00255346 - Active, not recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndromes; Agnogenic Myeloid Metaplasia; Myelofibrosis; Hypereosinophilic Syndrome; Polycythemia Vera; Mastocytosis; Leukemia, Myelomonocytic, Chronic
  
• Dasatinib in Combination With Revlimid (and Dexamethasone)
  ClinicalTrials.gov Identifier: NCT00560391 - Not yet recruiting
  Multiple Myeloma
  
• Dasatinib in Patients With Head and Neck Squamous Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00507767 - Recruiting
  Head and Neck Cancer; Squamous Cell Carcinoma
  
• Dasatinib in Relapsed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00438854 - Recruiting
  Chornic Lymphocytic Leukemia
  
• Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00550615 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00459108 - Recruiting
  Liver Cancer
  
• Dasatinib in Treating Patients With Advanced Non-Small Cell Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib
  ClinicalTrials.gov Identifier: NCT00570401 - Recruiting
  Lung Cancer
  
• Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00345826 - Completed
  Leukemia
  
• Dasatinib in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00474812 - Recruiting
  Pancreatic Cancer
  
• Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00509041 - Recruiting
  Malignant Mesothelioma
  
• Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00504153 - Recruiting
  Colorectal Cancer
  
• Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
  ClinicalTrials.gov Identifier: NCT00423735 - Suspended
  Brain and Central Nervous System Tumors
  
• Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00513227 - Recruiting
  Head and Neck Cancer
  
• Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00470054 - Recruiting
  Lung Cancer
  
• Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00436605 - Recruiting
  Melanoma (Skin)
  
• Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00459342 - Recruiting
  Lung Cancer
  
• Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
  ClinicalTrials.gov Identifier: NCT00410813 - Recruiting
  Breast Cancer; Metastatic Cancer
  
• Dasatinib in Treating Patients With Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00544908 - Recruiting
  Pancreatic Cancer
  
• Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer
  ClinicalTrials.gov Identifier: NCT00563290 - Recruiting
  Non-Melanomatous Skin Cancer
  
• Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00316953 - Recruiting
  Leukemia; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Dastinib in Polycythemia Vera
  ClinicalTrials.gov Identifier: NCT00538980 - Recruiting
  Polycythemia Vera
  
• Data Bank for Eosinophilic Disorders
  ClinicalTrials.gov Identifier: NCT00267475 - Recruiting
  Eosinophilic Esophagitis; Gastritis; Enteritis; Eosinophilic Colitis; Eosinophilic Gastroenteritis
  
• Data Collection During CT for Axial Flow VADs
  ClinicalTrials.gov Identifier: NCT00427739 - Recruiting
  Heart Failure
  
• Data Collection for Patients With Low Grade Ovarian Carcinoma
  ClinicalTrials.gov Identifier: NCT00488878 - Recruiting
  Ovarian Cancer; Peritoneum Tumors
  
• Data Collection in Women with Fabry Disease
  ClinicalTrials.gov Identifier: NCT00030134 - Completed
  Fabry Disease
  
• Data Collection of Demographics and Care of Patients Undergoing Laparoscopic Surgery
  ClinicalTrials.gov Identifier: NCT00490126 - Recruiting
  Laparascopic Surgery
  
• Data Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders
  ClinicalTrials.gov Identifier: NCT00267501 - Recruiting
  Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease; Food Allergy
  
• Data Distribution Procedures for NHLBI Data Repository
  ClinicalTrials.gov Identifier: NCT00006506 - Active, not recruiting
  Healthy
  
• Database and Registry for Renal Diverticulum
  ClinicalTrials.gov Identifier: NCT00169715 - Completed
  Kidney Stones; Renal Calculi; Tic
  
• Database for Stroke in Infants and Children
  ClinicalTrials.gov Identifier: NCT00084292 - Recruiting
  Cerebrovascular Accident
  
• Database of Interstitial Lung Diseases
  ClinicalTrials.gov Identifier: NCT00267800 - Recruiting
  Interstitial Lung Diseases
  
• Database Registry of the Intermountain Heart Collaborative Study
  ClinicalTrials.gov Identifier: NCT00406185 - Recruiting
  Coronary Artery Disease; Electrophysiology; Cardiovascular Disease
  
• DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study
  ClinicalTrials.gov Identifier: NCT00157820 - Active, not recruiting
  Defibrillators, Implantable; Tachycardia, Ventricular; Ventricular Fibrillation
  
• Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00085124 - Active, not recruiting
  adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Daunorubicin and Cytarabine With or Without Zosuquidar Trihydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
  ClinicalTrials.gov Identifier: NCT00046930 - Active, not recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; Myelodysplastic Syndromes; secondary acute myeloid leukemia
  
• Davallia Divaricata BL
  ClinicalTrials.gov Identifier: NCT00154609 - Recruiting
  Osteoporosis
  
• DAVANAT Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00110721 - Active, not recruiting
  Colorectal Cancer
  
• DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)
  ClinicalTrials.gov Identifier: NCT00187187 - Active, not recruiting
  Ventricular Tachycardia; Ventricular Fibrillation; Sudden Cardiac Death; Congestive Heart Failure
  
• DaVinci
  ClinicalTrials.gov Identifier: NCT00243438 - Completed
  Coronary Disease
  
• DÉCISION+, a Continuous Professional Development Program to Improve Optimal Drug Prescription : a Feasibility Study
  ClinicalTrials.gov Identifier: NCT00354315 - Recruiting
  Choice Behavior
  
• DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)
  ClinicalTrials.gov Identifier: NCT00302341 - Recruiting
  Pneumonia, Interstitial Plasma Cell; Pneumocystis Carinii Pneumonia; Pneumonia, Pneumocystis Carinii; HIV Infections
  
• DBS for Early Stage Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00282152 - Recruiting
  Parkinson's Disease
  
• DBT and Escitalopram in Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00255554 - Recruiting
  Borderline Personality Disorder
  
• DBT in Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00252031 - Recruiting
  Borderline Personality Disorder
  
• DCE-MRI Study (Dynamic Contrast-Enhanced Magnetic Resonance Imaging)
  ClinicalTrials.gov Identifier: NCT00361634 - Recruiting
  Rheumatoid Arthritis
  
• DCEP in Combination with Thalidomide as Salvage Therapy for Post Transplantation Relapse
  ClinicalTrials.gov Identifier: NCT00083681 - Completed
  Multiple Myeloma
  
• DCIS Lapatinib Trial
  ClinicalTrials.gov Identifier: NCT00570453 - Recruiting
  Breast Cancer
  
• DDI HV (ATV - Merck)
  ClinicalTrials.gov Identifier: NCT00518297 - Completed
  HIV Infections
  
• De-Medicalizing Mifepristone Medical Abortion
  ClinicalTrials.gov Identifier: NCT00120224 - Completed
  Medical Abortion
  
• Death Following Congenital Heart Surgery
  ClinicalTrials.gov Identifier: NCT00215072 - Terminated
  Congenital Heart Surgery; Congenital Heart Defects
  
• DEBlue Stent vs Cypher Stent in the Treatment of Advanced Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00473772 - Recruiting
  Coronary Artery Disease
  
• Debulking Effect of Curretage on BCC's - a Histological Assessment.
  ClinicalTrials.gov Identifier: NCT00237107 - Completed
  Carcinoma, Basal Cell
  
• DECARD
  ClinicalTrials.gov Identifier: NCT00140257 - Recruiting
  Myocardial Infarction [C14.907.553.470.500]
  
• DECIPHER STICH - Ancillary to STICH
  ClinicalTrials.gov Identifier: NCT00074724 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Heart Failure; Heart Failure, Congestive; Heart Diseases
  
• Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials
  ClinicalTrials.gov Identifier: NCT00394004 - Recruiting
  HIV Infections; Acquired Immunodeficiency Syndrome
  
• Decision-Making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Counseling and Testing for BRCA1/2 Mutations
  ClinicalTrials.gov Identifier: NCT00579007 - Recruiting
  Breast Cancer; Ovarian Cancer
  
• Decitabine and Carboplatin in Relapsed Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00514124 - Recruiting
  Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer
  
• Decitabine and FR901228 in Treating Patients With Advanced Lung Cancer, Esophageal Cancer, Pleural Mesothelioma, or Lung Metastases
  ClinicalTrials.gov Identifier: NCT00041158 - Recruiting
  Esophageal Cancer; Lung Cancer; Malignant Mesothelioma; Metastatic Cancer
  
• Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disease
  ClinicalTrials.gov Identifier: NCT00114257 - Completed
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; chronic myeloproliferative disorders; Leukemia; ...
  
• Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia
  ClinicalTrials.gov Identifier: NCT00002832 - Active, not recruiting
  Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid; Leukemia, Lymphocytic
  
• Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00382200 - Recruiting
  Myelodysplastic Syndromes
  
• Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00084981 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00079378 - Recruiting
  adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma
  
• Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00416598 - Recruiting
  Leukemia
  
• Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00042796 - Completed
  recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; ...
  
• Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00089089 - Recruiting
  adult solid tumor; Leukemia; Lymphoma; small intestine cancer
  
• Decitabine in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00030615 - Active, not recruiting
  adult solid tumor; Bladder Cancer; Breast Cancer; Male Breast Cancer; Melanoma
  
• Decitabine in Treating Patients With Melanoma or Other Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002980 - Completed
  Cancer
  
• Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
  ClinicalTrials.gov Identifier: NCT00085293 - Suspended
  recurrent thyroid cancer; stage IV follicular thyroid cancer; stage IV papillary thyroid cancer
  
• Decitabine in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003361 - Active, not recruiting
  de novo myelodysplastic syndrome; refractory anemia with excess blasts in transformation; refractory anemia with excess blasts; Refractory Anemia; ...
  
• Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00049582 - Completed
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes; ...
  
• Decitabine in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00095784 - Recruiting
  chronic idiopathic myelofibrosis
  
• Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00492401 - Recruiting
  Leukemia
  
• Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura
  ClinicalTrials.gov Identifier: NCT00019825 - Completed
  Esophageal Cancer; Lung Cancer; Malignant Mesothelioma; Metastatic Cancer
  
• Decitabine versus Supportive Care in Adults with Advanced-stage MDS
  ClinicalTrials.gov Identifier: NCT00043381 - Completed
  Myelodysplastic Syndrome
  
• Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00109824 - Recruiting
  recurrent adult Burkitt's lymphoma; recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma
  
• Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00075634 - Completed
  unspecified childhood solid tumor, protocol specific; recurrent neuroblastoma
  
• Decline in Cardiovascular Mortality: Framingham 1950-1984
  ClinicalTrials.gov Identifier: NCT00005222 - Completed
  Cardiovascular Diseases; Coronary Disease; Hypertension; Heart Diseases
  
• Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00006130 - Active, not recruiting
  Bone Avascular Necrosis; Sickle Cell Anemia
  
• Decompression Intervention of Variceal Rebleeding Trial (DIVERT)
  ClinicalTrials.gov Identifier: NCT00006161 - Completed
  Esophageal and Gastric Varices; Liver Cirrhosis
  
• Decompressive Craniectomy In Malignant Middle Cerebral Artery Infarcts
  ClinicalTrials.gov Identifier: NCT00190203 - Terminated
  Malignant Middle Cerebral Artery Infarction
  
• Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold
  ClinicalTrials.gov Identifier: NCT00452270 - Completed
  Common Cold
  
• Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)
  ClinicalTrials.gov Identifier: NCT00172666 - Recruiting
  Rheumatoid Arthritis; Systemic Lupus Erythematosus
  
• Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group
  ClinicalTrials.gov Identifier: NCT00135148 - Completed
  Transsexualism
  
• Decrease of Recurrent Pancreatitis
  ClinicalTrials.gov Identifier: NCT00534534 - Completed
  Pancreatitis
  
• DECREASE-HF
  ClinicalTrials.gov Identifier: NCT00158951 - Completed
  Congestive Heart Failure
  
• Decreased Testosterone Levels in Men over 65
  ClinicalTrials.gov Identifier: NCT00104572 - Recruiting
  Aging; Hypogonadism; Andropause
  
• Decreasing Rates of Illness in Kids (DRINK)
  ClinicalTrials.gov Identifier: NCT00356382 - Active, not recruiting
  Healthy
  
• Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial
  ClinicalTrials.gov Identifier: NCT00056563 - Active, not recruiting
  Parkinson's Disease
  
• Deep Brain Stimulation for Depression
  ClinicalTrials.gov Identifier: NCT00555698 - Enrolling by invitation
  Depression
  
• Deep Brain Stimulation for Parkinson's Disease Trial
  ClinicalTrials.gov Identifier: NCT00053625 - Recruiting
  Parkinson's Disease; Parkinsonism
  
• Deep Brain Stimulation for Refractory Major Depression
  ClinicalTrials.gov Identifier: NCT00296920 - Recruiting
  Major Depressive Disorder
  
• Deep Brain Stimulation for Treatment of Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00101556 - Recruiting
  Idiopathic Parkinson's Disease
  
• Deep Brain Stimulation for Treatment Resistant Depression
  ClinicalTrials.gov Identifier: NCT00367003 - Recruiting
  Major Depressive Disorder
  
• Deep Brain Stimulation for Treatment-Refractory Major Depression
  ClinicalTrials.gov Identifier: NCT00122031 - Recruiting
  Depression
  
• Deep Brain Stimulation for Treatment-Resistant Obsessive Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00057603 - Active, not recruiting
  Obsessive-Compulsive Disorder
  
• Deep Brain Stimulation in Treating Patients With Dystonia
  ClinicalTrials.gov Identifier: NCT00004421 - Recruiting
  Dystonia
  
• Deep Brain Stimulation of the Globus Pallidus Interna or the Subthalamic Nucleus for Treatment of Generalized Primary Dystonia.
  ClinicalTrials.gov Identifier: NCT00105430 - Completed
  
  
• Deep Brain Stimulation of the Globus Pallidus Interna or the Subthalamic Nucleus for Treatment of Primary Cervical Dystonia.
  ClinicalTrials.gov Identifier: NCT00132340 - Completed
  
  
• Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00552474 - Recruiting
  Parkinson Disease; Movement Disorders
  
• Deep Lamellar Endothelial Keratoplasty: Small Incision Technique
  ClinicalTrials.gov Identifier: NCT00345020 - Terminated
  Corneal Transplantation
  
• Deep Transcranial Magnetic Stimulation (TMS)- Treatment for Post Traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00517400 - Not yet recruiting
  Post Traumatic Stress Disorder
  
• Deep Vein Thrombosis (DVT) Prevention in Total Hip Replacement: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)
  ClinicalTrials.gov Identifier: NCT00358735 - Recruiting
  Venous Thrombosis; Pulmonary Embolism
  
• Deferment of Imaging for Pulmonary Embolism
  ClinicalTrials.gov Identifier: NCT00381511 - Completed
  Pulmonary Embolism
  
• Deferoxamine for the Treatment of Hemochromatosis
  ClinicalTrials.gov Identifier: NCT00001203 - Active, not recruiting
  Diabetes Mellitus; Heart Disease; Hemochromatosis; Thalassemia
  
• DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
  ClinicalTrials.gov Identifier: NCT00487279 - Recruiting
  Coronary Artery Disease; Left Ventricular Dysfunction; Sudden Cardiac Death
  
• Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver
  ClinicalTrials.gov Identifier: NCT00263978 - Recruiting
  Liver Diseases
  
• Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients
  ClinicalTrials.gov Identifier: NCT00358501 - Recruiting
  Severe Hepatic Veno Occlusive Disease
  
• Defibrotide in Treating Hepatic Veno-Occlusive Disease in Patients Who Have Undergone a Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00410917 - Recruiting
  Cancer
  
• Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003966 - Active, not recruiting
  veno-occlusive disease
  
• Defibrotide Use for Veno-Occlusive Disease
  ClinicalTrials.gov Identifier: NCT00143546 - Recruiting
  Hepatic Veno-Occlusive Disease
  
• Defining an Obesity QTL on Chromosome 3q
  ClinicalTrials.gov Identifier: NCT00087919 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Defining Central Circuits of Pain
  ClinicalTrials.gov Identifier: NCT00112333 - Recruiting
  Dyspepsia
  
• Defining the Best Approach to Block the Pain After Knee Surgery
  ClinicalTrials.gov Identifier: NCT00294073 - Recruiting
  Pain, Postoperative
  
• Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families
  ClinicalTrials.gov Identifier: NCT00393224 - Recruiting
  Nasopharyngeal Carcinoma
  
• Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI
  ClinicalTrials.gov Identifier: NCT00242112 - Recruiting
  Prostate Cancer
  
• Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
  ClinicalTrials.gov Identifier: NCT00001452 - Recruiting
  Cushing's Syndrome; Hereditary Neoplastic Syndrome; Lentigo; Neoplasm; Testicular Neoplasm
  
• Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome
  ClinicalTrials.gov Identifier: NCT00134745 - Recruiting
  Turner Syndrome
  
• Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
  ClinicalTrials.gov Identifier: NCT00242164 - Not yet recruiting
  Hemodialysis; Chronic Kidney Disease; Arrhythmia
  
• Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00466713 - Recruiting
  Dilated Cardiomyopathy
  
• Deflazacort in Dysferlinopathies
  ClinicalTrials.gov Identifier: NCT00527228 - Recruiting
  LGMD2B; MM; Miyoshi Myopathy; Dysferlinopathy
  
• Deforolimus (AP23573) in Treatment of Sarcoma - SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Deforolimus) Study
  ClinicalTrials.gov Identifier: NCT00538239 - Recruiting
  Metastatic Soft-Tissue Sarcomas; Metastatic Bone Sarcomas
  
• Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00516542 - Recruiting
  Breast Cancer
  
• Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
  ClinicalTrials.gov Identifier: NCT00189124 - Recruiting
  Systemic Lupus Erythematosus
  
• Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome
  ClinicalTrials.gov Identifier: NCT00391924 - Completed
  Lupus Erythematosus, Systemic; Sjogren's Syndrome
  
• Dehydroepiandrosterone Effects on HIV-1 Replication
  ClinicalTrials.gov Identifier: NCT00065104 - Completed
  HIV Infections
  
• Dehydroepiandrosterone Substitution in Adolescent and Young Women With Central Adrenal Insufficiency
  ClinicalTrials.gov Identifier: NCT00575341 - Completed
  Adrenal Insufficiency
  
• Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)
  ClinicalTrials.gov Identifier: NCT00157586 - Completed
  Type 2 Diabetes
  
• Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00427427 - Terminated
  Breast Cancer
  
• Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00285233 - Completed
  Type 1 Diabetes; Hypoglycemia
  
• Delayed Umbilical Cord Clamping in Infants Less Than 32 Weeks
  ClinicalTrials.gov Identifier: NCT00562536 - Not yet recruiting
  Premature Birth
  
• Delayed-Immediate Breast Reconstruction
  ClinicalTrials.gov Identifier: NCT00473122 - Recruiting
  Breast Cancer
  
• Delaying Alzheimer Disease Symptoms with Anti-Inflammatory Drugs
  ClinicalTrials.gov Identifier: NCT00065169 - Completed
  Alzheimer Disease; Dementia
  
• Delaying Sexual Activity in African American Adolescent Girls
  ClinicalTrials.gov Identifier: NCT00058760 - Recruiting
  Adolescent behavior; Sex Behavior
  
• Delaying the Progression of Diabetic Nephropathy in Pima Indians
  ClinicalTrials.gov Identifier: NCT00353600 - Active, not recruiting
  Diabetic Nephropathy
  
• Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00476008 - Recruiting
  Alzheimer's Disease
  
• Delirium Recall in Advanced Cancer Patients
  ClinicalTrials.gov Identifier: NCT00493714 - Active, not recruiting
  Advanced Cancer; Delirium
  
• Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes
  ClinicalTrials.gov Identifier: NCT00470158 - Recruiting
  Anemia; Diarrhea; Iron
  
• Delivery of Preventive Services in Primary Care
  ClinicalTrials.gov Identifier: NCT00115557 - Recruiting
  Delivery of preventive services; Healthy; Health Personnel
  
• Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome
  ClinicalTrials.gov Identifier: NCT00244101 - Recruiting
  Respiratory Distress Syndrome, Newborn
  
• Delta Hepatitis and Liver Disease in Hemophiliacs
  ClinicalTrials.gov Identifier: NCT00005304 - Completed
  Blood Disease; Hepatitis, Viral, Human; Hemophilia A; Liver Diseases
  
• Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia
  ClinicalTrials.gov Identifier: NCT00383318 - Recruiting
  Hyperbilirubinemia; Jaundice
  
• Demographics and Findings of Upper Endoscopy Patients
  ClinicalTrials.gov Identifier: NCT00576992 - Recruiting
  Barrett Esophagus; Gastroesophageal Reflux
  
• Demonstrate Exubera® Works As Well As Avandia® When Added To Sulfonylurea + Metformin In Controlling Glucose
  ClinicalTrials.gov Identifier: NCT00150410 - Completed
  Diabetes Mellitus
  
• Demonstrate That MPR is an Effective Evaluation Tool for Musculoskeletal Neck or Back Pain
  ClinicalTrials.gov Identifier: NCT00134225 - Recruiting
  Neck Pain; Low Back Pain
  
• Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult Population
  ClinicalTrials.gov Identifier: NCT00377585 - Active, not recruiting
  Influenza
  
• Dendritic Cell Based Therapy of Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00197912 - Recruiting
  Advanced Melanoma
  
• Dendritic Cell Based Therapy of Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00197925 - Recruiting
  Metastatic Breast Cancer
  
• Dendritic Cell Based Therapy of Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00197860 - Recruiting
  Advanced Renal Cell Carcinoma
  
• Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection
  ClinicalTrials.gov Identifier: NCT00243594 - Recruiting
  Melanoma Stage III or IV
  
• Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00311272 - Recruiting
  Colorectal Neoplasms
  
• Dendritic Cell Vaccine for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00492947 - Recruiting
  Squamous Cell Carcinoma of Head and Neck
  
• Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients
  ClinicalTrials.gov Identifier: NCT00478452 - Recruiting
  Ovarian Cancer
  
• Dendritic Cell Vaccine in HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00402142 - Recruiting
  HIV Infections
  
• Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00345293 - Recruiting
  Prostate Cancer
  
• Dendritic Cell-Based Immunotherapy in Mesothelioma
  ClinicalTrials.gov Identifier: NCT00280982 - Recruiting
  Malignant Pleural Mesothelioma
  
• Dendritic Cells in Lung Cancer
  ClinicalTrials.gov Identifier: NCT00442754 - Recruiting
  Non Small Cell Lung Cancer
  
• Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00450268 - Recruiting
  Graft Versus Host Disease
  
• Denileukin Diftitox and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00278369 - Recruiting
  Kidney Cancer
  
• Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00128622 - Recruiting
  adult solid tumor; Breast Cancer; Colorectal Cancer; Lung Cancer; Male Breast Cancer; Pancreatic Cancer
  
• Denileukin Diftitox in Patients With T-Cell Leukemia/Lymphoma
  ClinicalTrials.gov Identifier: NCT00138190 - Recruiting
  recurrent adult T-cell leukemia/lymphoma; stage I adult T-cell leukemia/lymphoma; stage II adult T-cell leukemia/lymphoma; ...
  
• Denileukin Diftitox in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00425672 - Recruiting
  Breast Cancer
  
• Denileukin Diftitox in Treating Patients With Advanced Refractory Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00357448 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00082940 - Completed
  B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia
  
• Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00082914 - Completed
  Kidney Cancer; Melanoma (Skin)
  
• Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00026429 - Active, not recruiting
  Leukemia; Lymphoma
  
• Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00138164 - Recruiting
  recurrent adult diffuse large cell lymphoma; recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; ...
  
• Denileukin Diftitox in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00238186 - Recruiting
  Ovarian Cancer; Peritoneal Cavity Cancer
  
• Denileukin Diftitox to Treat Advanced Melanoma or Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00078702 - Recruiting
  Melanoma; Kidney Neoplasms
  
• Denosumab Adherence Preference Satisfaction Study
  ClinicalTrials.gov Identifier: NCT00518531 - Recruiting
  Osteoporosis
  
• Dental Anesthesia in Pregnant Women With Rheumatic Heart Disease
  ClinicalTrials.gov Identifier: NCT00482573 - Completed
  Rheumatic Heart Disease; Pregnancy; Dental Caries
  
• Dental Pain (Following Third Molar Tooth Extraction) Study
  ClinicalTrials.gov Identifier: NCT00114049 - Completed
  Pain; Postoperative Pain
  
• Dental Pain 3rd Molar Tooth Extraction GW842166
  ClinicalTrials.gov Identifier: NCT00444769 - Completed
  Pain
  
• Dental PBRN Study 1: Assessment of Caries Diagnosis & Caries Treatment
  ClinicalTrials.gov Identifier: NCT00526422 - Completed
  Dental Caries
  
• Dental Safety Profile of High-Dose Radioiodine Therapy
  ClinicalTrials.gov Identifier: NCT00439478 - Completed
  Thyroid Cancer
  
• Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00006341 - Active, not recruiting
  oral complications of cancer and cancer therapy; stage III lip and oral cavity cancer; stage II lip and oral cavity cancer; Quality of Life; ...
  
• Depakote ER in Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00186186 - Active, not recruiting
  Depression, Bipolar
  
• Depakote ER in Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00222482 - Completed
  Borderline Personality Disorder
  
• Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia
  ClinicalTrials.gov Identifier: NCT00073164 - Completed
  Schizophrenia
  
• Depakote ER Therapy for Mania Comorbid With Substance Abuse
  ClinicalTrials.gov Identifier: NCT00208195 - Completed
  Bipolar Disorder; Mania; Substance Abuse; Substance Dependence
  
• Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
  ClinicalTrials.gov Identifier: NCT00315900 - Recruiting
  Agitation; Dementia
  
• Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects during the Maintenance Phase of Bipolar Illness
  ClinicalTrials.gov Identifier: NCT00071253 - Terminated
  Bipolar Disorder
  
• Depakote-ER for Depressive and Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00226343 - Active, not recruiting
  Bipolar Disorder
  
• DEPENAS: Efficacy of a Psychosocial Intervention for Patients with Medically Unexplained Symptoms
  ClinicalTrials.gov Identifier: NCT00130988 - Active, not recruiting
  Somatoform Disorders
  
• Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00310544 - Completed
  Myocardial Infarction
  
• Depletion of Latent HIV in CD4 Cells
  ClinicalTrials.gov Identifier: NCT00576290 - Not yet recruiting
  HIV Infections
  
• Deployment of Functional Optical Brain Monitor [fNIR] in Clinical Anesthesia
  ClinicalTrials.gov Identifier: NCT00448877 - Recruiting
  Surgical Procedures, Operative
  
• Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use with Certain Anti-HIV Drugs in HIV-Infected Women
  ClinicalTrials.gov Identifier: NCT00016601 - Completed
  HIV Infections
  
• Depo-Provera: Evaluation of BMDensity and Total Body Ca Adolescent DP150CI Users and Non-Hormonal Contraception
  ClinicalTrials.gov Identifier: NCT00139685 - Active, not recruiting
  Contraception; Bone Density
  
• DEPOCYLAN in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma
  ClinicalTrials.gov Identifier: NCT00388531 - Recruiting
  Lymphoblastic Leukemia; Lymphoma
  
• DepoCyt for Active Lymphomatous or Leukemic Meningitis
  ClinicalTrials.gov Identifier: NCT00523939 - Recruiting
  Neoplastic Meningitis; Lymphoma, B Cell
  
• DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis
  ClinicalTrials.gov Identifier: NCT00515788 - Recruiting
  Neoplastic Meningitis
  
• DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor
  ClinicalTrials.gov Identifier: NCT00029523 - Completed
  Meningeal Neoplasms
  
• Deposition of Inhaled Prolastin in Cystic Fibrosis Patients
  ClinicalTrials.gov Identifier: NCT00486837 - Completed
  Cystic Fibrosis
  
• Depot Disulfiram for AIDS and ARC
  ClinicalTrials.gov Identifier: NCT00002065 - Completed
  HIV Infections
  
• Depression and Adherence in Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00498875 - Recruiting
  Oropharyngeal Cancer; Head and Neck Cancer
  
• Depression And Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00274677 - Completed
  Bipolar Disorder
  
• Depression And Bipolar Disorder Drug Trial
  ClinicalTrials.gov Identifier: NCT00076882 - Recruiting
  Bipolar Disorder
  
• Depression and Congestive Heart Failure (CHF) in Outpatients
  ClinicalTrials.gov Identifier: NCT00321269 - Recruiting
  Heart Failure; Depression
  
• Depression and Health Outcomes in Refractory Epilepsy
  ClinicalTrials.gov Identifier: NCT00026637 - Active, not recruiting
  Depression; Epilepsy
  
• Depression and Increased Health Services Utilization Among Elderly Primary Care Patients
  ClinicalTrials.gov Identifier: NCT00279526 - Completed
  Depression
  
• Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00460200 - Suspended
  Depression; Fatigue; Ovarian Cancer; Psychosocial Effects/Treatment; Sleep Disorders
  
• Depression and Transcranial Direct Current Stimulation (tDCS)
  ClinicalTrials.gov Identifier: NCT00256438 - Recruiting
  Depression
  
• Depression and Traumatic Brain Injury
  ClinicalTrials.gov Identifier: NCT00254007 - Active, not recruiting
  Depression; Traumatic Brain Injury
  
• Depression in Alzheimer's Disease (DIADS-2)
  ClinicalTrials.gov Identifier: NCT00086138 - Recruiting
  Alzheimer's Disease; Depression
  
• Depression In Juvenile Diabetics
  ClinicalTrials.gov Identifier: NCT00005116 - Completed
  Depression; Diabetes Mellitus, Insulin-Dependent
  
• Depression Prevention Program for Adolescents
  ClinicalTrials.gov Identifier: NCT00183417 - Active, not recruiting
  Depression
  
• Depression Prevention Program for American Indian Adolescents During and After Pregnancy
  ClinicalTrials.gov Identifier: NCT00183547 - Active, not recruiting
  Depression; Pregnancy
  
• Depression Screening in Patients With Lung Cancer
  ClinicalTrials.gov Identifier: NCT00404365 - Recruiting
  Depression; Lung Cancer
  
• Depression Study
  ClinicalTrials.gov Identifier: NCT00048204 - Completed
  Major Depressive Disorder
  
• Depression Study In Adults
  ClinicalTrials.gov Identifier: NCT00057239 - Completed
  Major Depressive Disorder
  
• Depression Study in Elderly Patients
  ClinicalTrials.gov Identifier: NCT00067444 - Completed
  Major Depressive Disorder
  
• Depression Treatment and Screening in Ovarian Cancer Patients
  ClinicalTrials.gov Identifier: NCT00515372 - Recruiting
  Ovarian Cancer; Peritoneal Cancer
  
• Depression, Cytokines and Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00582699 - Recruiting
  Pancreatic Cancer
  
• Depression, Epinephrine, and Platelet Function
  ClinicalTrials.gov Identifier: NCT00166114 - Recruiting
  Major Depressive Disorder
  
• Depression- Diabetes Mechanisms: Urban African Americans
  ClinicalTrials.gov Identifier: NCT00209170 - Recruiting
  Diabetes; Depression
  
• Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study
  ClinicalTrials.gov Identifier: NCT00222820 - Completed
  Major Depression
  
• Depsipeptide in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00019318 - Completed
  stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; ...
  
• Depsipeptide to Treat Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005656 - Completed
  Lung cancer; Lung Neoplasm
  
• Depsipeptide to Treat Recurrent Brain Tumors
  ClinicalTrials.gov Identifier: NCT00103909 - Recruiting
  
  
• Depsipeptide to Treat T-Cell Lymphomas
  ClinicalTrials.gov Identifier: NCT00007345 - Recruiting
  Cutaneous T Cell Lymphoma; Peripheral T Cell Lymphoma
  
• Depsipeptide to Treat Thyroid and Other Advanced Cancers
  ClinicalTrials.gov Identifier: NCT00048334 - Recruiting
  Neoplasms
  
• Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, or Pleura
  ClinicalTrials.gov Identifier: NCT00094978 - Recruiting
  Carcinoma, Small Cell; Carcinoma, Non-small-cell Lung; Esophageal Neoplasms; Mesothelioma
  
• DePuy Trochanteric (ATN) Nailing Clinical Outcomes Trial
  ClinicalTrials.gov Identifier: NCT00546429 - Recruiting
  Femoral Fracture (Proximal)
  
• Derivation of New Human Embryonic Stem Cell Lines Lines for Clinical Use
  ClinicalTrials.gov Identifier: NCT00353197 - Recruiting
  Infertility
  
• Derivation of Primary Donor Cell Lines for Human Somatic Cell Nuclear Transfer
  ClinicalTrials.gov Identifier: NCT00553826 - Recruiting
  Parkinson Disease; Amyotrophic Lateral Sclerosis; Diabetes, Type I
  
• Dermabond Protape Versus Sutures for Full-Thickness Surgical Incisions
  ClinicalTrials.gov Identifier: NCT00557947 - Recruiting
  Surgical Incisions
  
• Dermabond Skin Adhesives vs Skin Staples for Closure of Repeat Cesarean Section Skin Incisions
  ClinicalTrials.gov Identifier: NCT00505856 - Not yet recruiting
  Pregnancy
  
• Dermal Substitute and Topical Negative Pressure in Burns
  ClinicalTrials.gov Identifier: NCT00548314 - Recruiting
  Burns
  
• Dermal Thermometry and Self-Care of High Risk Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00105755 - Completed
  Diabetes Mellitus; Diabetic Foot
  
• Derris Scandens Benth Extract VS Naproxen in Knee OA
  ClinicalTrials.gov Identifier: NCT00503828 - Recruiting
  Knee Osteoarthritis
  
• Descemet Membrane Endothelial Keratoplasty (DMEK)
  ClinicalTrials.gov Identifier: NCT00521898 - Recruiting
  Corneal Dystrophies, Hereditary
  
• Descemet Stripping (Automated) Endothelial Keratoplasty (DSEK or DSAEK)
  ClinicalTrials.gov Identifier: NCT00543660 - Recruiting
  Corneal Dystrophies, Hereditary
  
• Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00188084 - Recruiting
  Adult Acute Lymphoblastic Leukemia
  
• Descriptive Study of a French Sample of “at Risk” and Pathological Gamblers Followed in a French Structure Specialised in Addictive Disorders.
  ClinicalTrials.gov Identifier: NCT00360321 - Not yet recruiting
  Pathological Gambling
  
• Descriptive Study of Pain, Anxiety and Depression
  ClinicalTrials.gov Identifier: NCT00378274 - Completed
  Pain
  
• Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome
  ClinicalTrials.gov Identifier: NCT00004815 - Completed
  Werner's Syndrome
  
• Descriptive, Open-Label, Multicenter Study of the Safety of Redosing With ADACEL Vaccine
  ClinicalTrials.gov Identifier: NCT00347958 - Active, not recruiting
  Tetanus; Diphtheria; Pertussis
  
• Descriptive, Post-Marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine
  ClinicalTrials.gov Identifier: NCT00258882 - Active, not recruiting
  Pertussis
  
• Descriptive, Post-Marketing, Passive Surveillance Safety Study of Menactra Vaccine
  ClinicalTrials.gov Identifier: NCT00254995 - Active, not recruiting
  Meningitis
  
• Desensitization of Renal Transplant Candidates
  ClinicalTrials.gov Identifier: NCT00298883 - Recruiting
  End Stage Renal Disease; Kidney Transplantation
  
• Desflurane vs. Propofol Anesthesia for Off-Pump CABG
  ClinicalTrials.gov Identifier: NCT00528515 - Recruiting
  Coronary Artery Disease
  
• Design and Evaluate 12 Week Group Therapy Intervention for HIV+ Methamphetamine Users and Deliver It Within an HIV/AIDS Primary Care Setting. - 1
  ClinicalTrials.gov Identifier: NCT00249678 - Not yet recruiting
  Behavior Therapy; Methamphetamine
  
• Desipramine for Improving Cellular Signaling and Decreasing Symptoms of Major Depression
  ClinicalTrials.gov Identifier: NCT00320632 - Completed
  Depression
  
• Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
  ClinicalTrials.gov Identifier: NCT00080756 - Recruiting
  Breast Cancer
  
• Desmopressin in Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00337766 - Recruiting
  Hemorrhage; Blood Loss, Surgical; Postoperative Hemorrhage
  
• Desmopressin Response in the Young
  ClinicalTrials.gov Identifier: NCT00230594 - Active, not recruiting
  Primary Nocturnal Enuresis
  
• DESOLO – SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults
  ClinicalTrials.gov Identifier: NCT00252863 - Active, not recruiting
  Asthma
  
• DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril
  ClinicalTrials.gov Identifier: NCT00274118 - Completed
  Hypertension; Diabetes Mellitus, Type 2
  
• Detecting a Reward Signal in the Motor Cortex
  ClinicalTrials.gov Identifier: NCT00422071 - Recruiting
  Healthy
  
• Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
  ClinicalTrials.gov Identifier: NCT00001148 - Completed
  Astrocytoma; Glioblastoma; Glioma
  
• Detecting Urinary Retention After Child Birth With a Ultrasound Scanner
  ClinicalTrials.gov Identifier: NCT00418223 - Recruiting
  Urinary Retention
  
• Detection and Characterisation of Varicella Zoster Virus from Dermal Lesions of Chickenpox-Infected Patients
  ClinicalTrials.gov Identifier: NCT00127608 - Active, not recruiting
  Chickenpox
  
• Detection and Characterization of Host Defense Defects
  ClinicalTrials.gov Identifier: NCT00001355 - Recruiting
  Immunologic Deficiency Syndrome; Infection
  
• Detection and Characterization of Infections and Infection Susceptibility
  ClinicalTrials.gov Identifier: NCT00404560 - Recruiting
  Immune Disorders; Chronic Granulomatous Disease; Genetic Immunological Deficiencies; Hyperimmunoglobulin-E Recurrent Infection Syndrome; Recurrent Infections
  
• Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant
  ClinicalTrials.gov Identifier: NCT00063648 - Active, not recruiting
  Liver Disease; Lymphoproliferative Disorders
  
• Detection and Treatment of Depression in Patients Admitted to the General Hospital
  ClinicalTrials.gov Identifier: NCT00521911 - Recruiting
  Depressive Disorder; Depression
  
• Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00504218 - Recruiting
  Hypopituitarism; Hypogonadism; Thyroid Dysfunction; Bone Diseases, Metabolic
  
• Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results
  ClinicalTrials.gov Identifier: NCT00004091 - Active, not recruiting
  screening for cervical cancer; Cervical Cancer
  
• Detection of Bladder Cancer Microsatellite Analysis (MSA) of Urinary Sediment
  ClinicalTrials.gov Identifier: NCT00185627 - Active, not recruiting
  Bladder Cancer
  
• Detection of Coronary Artery Calcification: Comparison of Volumetric and Electron Beam Computed Tomography
  ClinicalTrials.gov Identifier: NCT00001836 - Completed
  Coronary Disease
  
• Detection of Coronary Stenosis With Intravenous Microbubbles
  ClinicalTrials.gov Identifier: NCT00580580 - Recruiting
  Coronary Stenosis; Carotid Stenosis; Myocardial Reperfusion
  
• Detection of Early Lung Cancer by Serum Protein Expression Profiling
  ClinicalTrials.gov Identifier: NCT00175578 - Recruiting
  Non-Small Cell Lung Cancer
  
• Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003006 - Active, not recruiting
  stage I non-small cell lung cancer
  
• Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophobstic Disease
  ClinicalTrials.gov Identifier: NCT00166790 - Recruiting
  Trophoblastic Neoplasms
  
• Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation with Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections
  ClinicalTrials.gov Identifier: NCT00000858 - Completed
  HIV Infections
  
• Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter
  ClinicalTrials.gov Identifier: NCT00481221 - Recruiting
  Thalassemia; Iron Deficiency
  
• Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00004153 - Active, not recruiting
  stage I melanoma; stage II melanoma; stage III melanoma; Stage IV Melanoma
  
• Detection of Neural Loss in Patients With Permanent Temporal Visual Field Defect From Chiasmal Compression
  ClinicalTrials.gov Identifier: NCT00553761 - Recruiting
  Band Atrophy
  
• Detection of Peritoneal Micrometastasis in Gastric and Pancreatic Cancer in Peritoneal Wash Samples
  ClinicalTrials.gov Identifier: NCT00582062 - Recruiting
  Gastric and Pancreatic Cancer
  
• Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation
  ClinicalTrials.gov Identifier: NCT00114504 - Recruiting
  Atherosclerosis
  
• Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
  ClinicalTrials.gov Identifier: NCT00213798 - Recruiting
  Non-Small Cell Lung Carcinoma; Small Cell Lung Cancer
  
• Detection of Pulmonary Embolism With CECT
  ClinicalTrials.gov Identifier: NCT00351754 - Completed
  Pulmonary Embolism
  
• Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003790 - Active, not recruiting
  Previously Treated Myelodysplastic Syndrome; untreated childhood acute myeloid leukemia; secondary myelodysplastic syndrome; ...
  
• Detection of Topographic Residual Acuity in Patients With Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00329277 - Recruiting
  Age-Related Macular Degeneration
  
• Detection of Ultrasound Contrast Signals in the Cerebral Circulation
  ClinicalTrials.gov Identifier: NCT00579241 - Recruiting
  Brain Vascular Disorders; Coronary Artery Disease
  
• Detemir versus Glargine in Type 2 Diabetes - Treat to Target
  ClinicalTrials.gov Identifier: NCT00106366 - Completed
  Diabetes Mellitus, Type 2
  
• Detemir: Role in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00564395 - Recruiting
  Type 1 Diabetes Mellitus
  
• Determinants in Antidepressant Outcomes
  ClinicalTrials.gov Identifier: NCT00108316 - Terminated
  Depression
  
• Determinants of Cardiac Risk Factor Modification in Latinos With Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00248859 - Recruiting
  Coronary Artery Disease
  
• Determinants of Compliance With Glaucoma Therapy
  ClinicalTrials.gov Identifier: NCT00362622 - Recruiting
  Open Angle Glaucoma
  
• Determinants of Coronary Disease in High Risk Families
  ClinicalTrials.gov Identifier: NCT00005508 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases
  
• Determinants of Corticosteroid Insensitivity in Smokers With Asthma
  ClinicalTrials.gov Identifier: NCT00411320 - Recruiting
  Asthma; Smoking; Steroid Resistance; Corticosteroid Insensitivity
  
• Determinants of Disease Severity in Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00004457 - Active, not recruiting
  Amyotrophic Lateral Sclerosis
  
• Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease
  ClinicalTrials.gov Identifier: NCT00498082 - Recruiting
  Gastroesophageal Reflux Disease
  
• Determinants of Respiratory Health in Young Adults
  ClinicalTrials.gov Identifier: NCT00005361 - Completed
  Lung Diseases
  
• Determinants of Vitamin K Metabolism
  ClinicalTrials.gov Identifier: NCT00336232 - Recruiting
  Aging; Osteoporosis
  
• Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)
  ClinicalTrials.gov Identifier: NCT00261339 - Completed
  Gastroesophageal Reflux; GERD; GORD
  
• Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00186953 - Suspended
  Abdominal Neoplasms; Pelvic Neoplasms
  
• Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women
  ClinicalTrials.gov Identifier: NCT00443716 - Completed
  Osteoporosis; Postmenopausal
  
• Determination of Carboplatin''s Optimal Plasmatic Exposure
  ClinicalTrials.gov Identifier: NCT00145028 - Recruiting
  Neoplasms
  
• Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine
  ClinicalTrials.gov Identifier: NCT00520104 - Recruiting
  Pharmacokinetics
  
• Determination of Fraction Size Equivalent Dose (FED) Dose Levels for Intracranial Conformal Avoidance Radiotherapy
  ClinicalTrials.gov Identifier: NCT00214175 - Recruiting
  Low Grade Gliomas and Benign CNS Lesions
  
• Determination of Genetic Relatedness of Linezolid-Resistant VRE Surveillance Cultures
  ClinicalTrials.gov Identifier: NCT00475891 - Recruiting
  Isolate; Linezolid
  
• Determination of Gentamicin Dosing in Neonatal Patients
  ClinicalTrials.gov Identifier: NCT00198601 - Active, not recruiting
  Infection
  
• Determination of HIV-1 Production by the Prostate
  ClinicalTrials.gov Identifier: NCT00001584 - Completed
  
  
• Determination of Kidney Function
  ClinicalTrials.gov Identifier: NCT00001978 - Recruiting
  Kidney Disease
  
• Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris
  ClinicalTrials.gov Identifier: NCT00365625 - Recruiting
  Psoriasis; Psoriasis Vulgaris
  
• Determination of Safe and Effective Dose of AMG 531 in Subjects With MDS Receiving Hypomethylating Agents
  ClinicalTrials.gov Identifier: NCT00321711 - Recruiting
  MDS; Myelodysplastic Syndromes; Refractory Cytopenias; Thrombocytopenia
  
• Determination of Safe Dose of AMG 531 in Subjects With MDS
  ClinicalTrials.gov Identifier: NCT00303472 - Recruiting
  MDS; Myelodysplastic Syndromes; Refractory Cytopenias; Thrombocytopenia
  
• Determination of Safety and Efficacy of a Laser With Cooling for Treatment of Skin
  ClinicalTrials.gov Identifier: NCT00323921 - Active, not recruiting
  Aged Skin
  
• Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)
  ClinicalTrials.gov Identifier: NCT00246909 - Completed
  Gastroesophageal Reflux
  
• Determination of the Optimal Prophylactic Platelet Dose Strategy to Prevent Bleeding in Thrombocytopenic Patients ( A TMH CTN Study)
  ClinicalTrials.gov Identifier: NCT00128713 - Recruiting
  Blood transfusion; Blood Platelets
  
• Determination of the Prevalence and Prognostic Importance of Unrecognized Non-Q-Wave Myocardial Infarction by MRI
  ClinicalTrials.gov Identifier: NCT00493168 - Completed
  Coronary Arteriosclerosis; Myocardial Infarction
  
• Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer
  ClinicalTrials.gov Identifier: NCT00220077 - Recruiting
  Oesophageal Cancer
  
• Determination of Variances in Exhaled Nitric Oxide Output in Normal Healthy Male Volunteers Consuming High and Low Nitrate/Nitrite Diets
  ClinicalTrials.gov Identifier: NCT00027157 - Completed
  Healthy
  
• Determination of Voiding Patterns of Children With Vesicoureteral Reflux
  ClinicalTrials.gov Identifier: NCT00186199 - Recruiting
  Vesicoureteral Reflux
  
• Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.
  ClinicalTrials.gov Identifier: NCT00245713 - Active, not recruiting
  Epilepsy, Partial
  
• Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women with Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00156273 - Recruiting
  Metastatic breast cancer
  
• Determine if Either of 2 Doses of Study Drug Given With a Low-Dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-Based Second-Line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Comp
  ClinicalTrials.gov Identifier: NCT00408967 - Terminated
  Ovarian Cancer
  
• Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects
  ClinicalTrials.gov Identifier: NCT00547599 - Completed
  Impotence
  
• Determine Long-Term Safety and Tolerability of Pregabalin in Patients with Anxiety Disorders.
  ClinicalTrials.gov Identifier: NCT00150449 - Completed
  Anxiety Neuroses
  
• Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection
  ClinicalTrials.gov Identifier: NCT00547573 - Completed
  Impotence
  
• Determine Safety and Efficacy of Long-Term Oral Lacosamide in Patients With Partial Seizures
  ClinicalTrials.gov Identifier: NCT00522275 - Active, not recruiting
  Partial Epilepsies
  
• Determine the association between the level of SCI with chronic respiratory symptoms, measures of pulmonary function, and respiratory illness.
  ClinicalTrials.gov Identifier: NCT00011336 - Completed
  Spinal Cord Injuries
  
• Determine the Effect of Administering Periostat(R) Twice Daily on Patients with Acne Rosacea
  ClinicalTrials.gov Identifier: NCT00041977 - Completed
  Acne Rosacea
  
• Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB.
  ClinicalTrials.gov Identifier: NCT00143377 - Completed
  Urinary Incontinence
  
• Determine the efficacy of topical tretinoin cream for the prevention of nonmelanoma skin cancer
  ClinicalTrials.gov Identifier: NCT00007631 - Active, not recruiting
  nonmelanoma skin cancer
  
• Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects with COPD
  ClinicalTrials.gov Identifier: NCT00064402 - Completed
  Chronic Obstructive Pulmonary Disease; Chronic Bronchitis; Emphysema
  
• Determine the safety of a sublingual tablet formulation of buprenorphine and naloxone by extending the combination tablet availability to physicians in office-based practice
  ClinicalTrials.gov Identifier: NCT00007527 - Completed
  Opiate Dependence
  
• Determine whether glycemic control is different between Lantus & a 3rd oral agent when failure with other treatment
  ClinicalTrials.gov Identifier: NCT00046462 - Completed
  Diabetes Mellitus
  
• Determining an Effective Site (Groin versus Arm) for Giving HIV Vaccines
  ClinicalTrials.gov Identifier: NCT00056745 - Completed
  HIV Infections
  
• Determining Changes in Brain Structure Associated With Symptoms of Late-Life Depression
  ClinicalTrials.gov Identifier: NCT00178087 - Recruiting
  Late-Life Depression
  
• Determining Depression Treatment Preferences of Low-Income Latinos in Primary Care Settings
  ClinicalTrials.gov Identifier: NCT00260169 - Enrolling by invitation
  Depression
  
• Determining Disease Activity Biomarkers in Individuals With Churg-Strauss Syndrome
  ClinicalTrials.gov Identifier: NCT00315380 - Recruiting
  Churg-Strauss Syndrome
  
• Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
  ClinicalTrials.gov Identifier: NCT00315497 - Recruiting
  Temporal Arteritis
  
• Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa
  ClinicalTrials.gov Identifier: NCT00315406 - Recruiting
  Polyarteritis Nodosa
  
• Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis
  ClinicalTrials.gov Identifier: NCT00315471 - Recruiting
  Takayasu's Arteritis
  
• Determining Disease Activity Biomarkers in Individuals With Wegener's Granulomatosis and Microscopic Polyangiitis
  ClinicalTrials.gov Identifier: NCT00315393 - Recruiting
  Wegener's Granulomatosis; Microscopic Polyangiitis
  
• Determining How the Nervous System Processes Pain in Adults With Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00496886 - Recruiting
  Fibromyalgia; Rheumatoid Arthritis
  
• Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
  ClinicalTrials.gov Identifier: NCT00412516 - Active, not recruiting
  Encephalitis, Japanese B
  
• Determining Metabolic Effects of Valproate and Antipsychotic Therapy
  ClinicalTrials.gov Identifier: NCT00167934 - Recruiting
  Schizophrenia
  
• Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00332787 - Completed
  Depression
  
• Determining Optimal Halo Pin Management Practises to Decrease Pin Complications
  ClinicalTrials.gov Identifier: NCT00480727 - Not yet recruiting
  Unstable Cervical Injury
  
• Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program
  ClinicalTrials.gov Identifier: NCT00498147 - Recruiting
  Disease Management; Diabetes Complications; Diabetic Vascular Complications; Diabetic Neuropathies
  
• Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals
  ClinicalTrials.gov Identifier: NCT00393276 - Recruiting
  HIV Infections; Hepatitis C
  
• Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
  ClinicalTrials.gov Identifier: NCT00249769 - Completed
  Encephalitis, Japanese B
  
• Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
  ClinicalTrials.gov Identifier: NCT00346619 - Completed
  Immune Response
  
• Determining the Effect on Patients of Internet-Based Diabetes Disease Management
  ClinicalTrials.gov Identifier: NCT00220207 - Completed
  Diabetes Mellitus, Type 2
  
• Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence
  ClinicalTrials.gov Identifier: NCT00215579 - Active, not recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Determining the Prevalence of HIV-Related Neurological Disorders in the Asia Pacific
  ClinicalTrials.gov Identifier: NCT00168246 - Active, not recruiting
  HIV Infections; HIV Related Neurological Diseases
  
• Determining the Response to Sipping Beverages Without Swallowing in People With Eating Disorders
  ClinicalTrials.gov Identifier: NCT00353548 - Recruiting
  Eating Disorders
  
• Determining the Responsiveness of Intestinal Lipoprotein Production to an Elevation of Plasma Free Fatty Acids
  ClinicalTrials.gov Identifier: NCT00152945 - Recruiting
  Intestinal lipoprotein production; Insulin Resistance
  
• Determining the Risk Factors such as Smoking, Alcohol, and Caffeine and their Association with Osteoporosis in Men
  ClinicalTrials.gov Identifier: NCT00011323 - Completed
  Osteoporosis
  
• Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00183612 - Active, not recruiting
  Bipolar Disorder; Psychotic Disorders
  
• Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
  ClinicalTrials.gov Identifier: NCT00367224 - Recruiting
  Vitiligo
  
• Determining Women's Preferences for Medical Abortion Using Willingness to Pay
  ClinicalTrials.gov Identifier: NCT00472394 - Completed
  Medical Abortion
  
• Detoxification and Treatment of Subjects With Medication Overuse Headache
  ClinicalTrials.gov Identifier: NCT00432549 - Recruiting
  Analgesic Rebound Headache
  
• Detrol LA In Men With Overactive Bladder.
  ClinicalTrials.gov Identifier: NCT00282932 - Completed
  Overactive Bladder (OAB)
  
• Detrol LA vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms
  ClinicalTrials.gov Identifier: NCT00465894 - Recruiting
  Overactive Bladder; Postmenopausal
  
• Develop and Implement Asthma Controlling Strategies
  ClinicalTrials.gov Identifier: NCT00005731 - Completed
  Asthma; Lung Diseases
  
• Develop and Implement Asthma Controlling Strategies (1)
  ClinicalTrials.gov Identifier: NCT00005732 - Completed
  Asthma; Lung Diseases
  
• Develop and Implement Asthma Controlling Strategies (2)
  ClinicalTrials.gov Identifier: NCT00005733 - Completed
  Asthma; Lung Diseases
  
• Develop Biomarkers for Assessing RA Joint Erosion
  ClinicalTrials.gov Identifier: NCT00154947 - Active, not recruiting
  Rheumatoid Arthritis
  
• Develop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With Diabetes
  ClinicalTrials.gov Identifier: NCT00465881 - Completed
  Diabetes; Glucose Variability; CGM
  
• Developement of Questionnaire to Evaluate a Regularity of Lifestyle in Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00455988 - Recruiting
  Type 2 Diabetes
  
• Developing a Cognitive Behavioral Therapy Manual for People with Body Dysmorphic Disorder
  ClinicalTrials.gov Identifier: NCT00106223 - Active, not recruiting
  Body Dysmorphic Disorder; Somatoform Disorders
  
• Developing a Questionnaire for Assessing Quality of Life Related to Facial Appearance in Patients Who Have Undergone or Are Planning to Undergo Surgery and Reconstruction for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00530049 - Recruiting
  Head and Neck Cancer; Psychosocial Effects/Treatment
  
• Developing a Self-Management Program for People With Depression and Chronic Medical Illness
  ClinicalTrials.gov Identifier: NCT00523029 - Recruiting
  Depression
  
• Developing an Instrument to Measure Personal Keyboarding Style
  ClinicalTrials.gov Identifier: NCT00167336 - Completed
  Cumulative Trauma Disorders
  
• Developing and Assessing Competencies for Caregivers and Patients with Ventricular Assist Devices
  ClinicalTrials.gov Identifier: NCT00178009 - Recruiting
  Congestive Heart Failure
  
• Developing and Implementing a Quality Measure for Glycemic Control
  ClinicalTrials.gov Identifier: NCT00012675 - Completed
  Diabetes
  
• Developing Criteria for Cortical Resections
  ClinicalTrials.gov Identifier: NCT00152659 - Recruiting
  Epilepsy; Tumor
  
• Developing Interview Questions to Estimate Workplace Exposure to Electric and Magnetic Fields
  ClinicalTrials.gov Identifier: NCT00340054 - Active, not recruiting
  Health Status Unknown
  
• Developing Medication For Tobacco Addiction - 1
  ClinicalTrials.gov Identifier: NCT00136747 - Recruiting
  Tobacco Use Disorder
  
• Developing Newborn Screening for Infants with Primary Immunodeficiency
  ClinicalTrials.gov Identifier: NCT00113464 - Completed
  
  
• Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)
  ClinicalTrials.gov Identifier: NCT00467597 - Recruiting
  Parkinson Disease; Dyskinesia; Movement Disorders
  
• Developing Violence Prevention Therapy for Substance Abusers
  ClinicalTrials.gov Identifier: NCT00551863 - Active, not recruiting
  Substance Use Disorders; Violence
  
• Developing World Study for RotaTeq(TM)
  ClinicalTrials.gov Identifier: NCT00362648 - Active, not recruiting
  Vomiting; Diarrhea; Fever
  
• Development and Evaluation of a Cancer-Related Fatigue Patient Education Program
  ClinicalTrials.gov Identifier: NCT00552552 - Not yet recruiting
  Cancer-Related Fatigue
  
• Development and Evaluation of a Hormone Replacement Therapy Decision-Aid
  ClinicalTrials.gov Identifier: NCT00012909 - Completed
  Menopause
  
• Development and Evaluation of A Mailed Arthritis Self-Management Program
  ClinicalTrials.gov Identifier: NCT00448474 - Completed
  Osteoarthritis; Rheumatoid Arthritis
  
• Development and Evaluation of a Medical Intervention for Early Childhood Caries
  ClinicalTrials.gov Identifier: NCT00464009 - Completed
  Early Childhood Dental Caries
  
• Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS)
  ClinicalTrials.gov Identifier: NCT00364936 - Completed
  Multiple Sclerosis
  
• Development and Evaluation of an HIV, STD, and Pregnancy Prevention Program for Middle School Students
  ClinicalTrials.gov Identifier: NCT00161382 - Active, not recruiting
  HIV Infections; Sexually Transmitted Diseases; Pregnancy
  
• Development and Evaluation of Community Asthma Program
  ClinicalTrials.gov Identifier: NCT00005714 - Completed
  Asthma; Lung Diseases
  
• Development and Optimization of a GBS Diagnostic Test
  ClinicalTrials.gov Identifier: NCT00322829 - Recruiting
  Streptococcus Group B
  
• Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis
  ClinicalTrials.gov Identifier: NCT00465920 - Recruiting
  Psychotic Disorders; Schizophrenia; Schizoaffective Disorder; Delusional Disorder; Schizophreniform Disorder
  
• Development and Validation of a Mindfulness Intervention for Problem Gambling: An Exploratory Study
  ClinicalTrials.gov Identifier: NCT00495261 - Recruiting
  Gambling
  
• Development and Validation of the Food Acceptability Questionnaire
  ClinicalTrials.gov Identifier: NCT00412724 - Active, not recruiting
  Healthy
  
• Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China
  ClinicalTrials.gov Identifier: NCT00340405 - Active, not recruiting
  Lung Cancer
  
• Development of a Breath Analyzer for Asthma Screening
  ClinicalTrials.gov Identifier: NCT00386737 - Recruiting
  Asthma
  
• Development of a Breath Test for Monitoring Patients With Liver Disease
  ClinicalTrials.gov Identifier: NCT00244569 - Completed
  Fatty Liver; Cirrhosis
  
• Development of a Collapsible Folding Manual Wheelchair
  ClinicalTrials.gov Identifier: NCT00283296 - Not yet recruiting
  Wheelchair Users
  
• Development of a Comprehensive ADL Scale for Stroke Patients
  ClinicalTrials.gov Identifier: NCT00173771 - Recruiting
  Cerebrovascular Accidents
  
• Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer
  ClinicalTrials.gov Identifier: NCT00579293 - Active, not recruiting
  Childhood Cancer
  
• Development of a Cue Reactivity Model as a Pharmacological Intervention for Marijuana Dependent Individuals - 1
  ClinicalTrials.gov Identifier: NCT00218478 - Recruiting
  Marijuana Abuse
  
• Development of a Hospital Service That Uses Critical Pathway (Protocolized) Care Plans to Provide High-Quality, High-Reliability, Evidence-Based Medical Care
  ClinicalTrials.gov Identifier: NCT00275587 - Recruiting
  Critical Pathways
  
• Development of a Hospital-Based Home Program for the Use of Inhaled Nitric Oxide in the Chronic Management of Severe Cardiopulmonary Diseases
  ClinicalTrials.gov Identifier: NCT00041574 - Terminated
  Pulmonary Hypertension; Lung Disease; Sickle Cell Disease; Cardiac transplant; Lung transplant
  
• Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their Caregivers
  ClinicalTrials.gov Identifier: NCT00224900 - Terminated
  HIV Infection
  
• Development of a New HIV Vaccine
  ClinicalTrials.gov Identifier: NCT00051922 - Active, not recruiting
  HIV Infections
  
• Development of a New Method for Steady-State Measurement of NO Lung Diffusing Capacity in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00315965 - Recruiting
  Pulmonary Diffusing Capacity
  
• Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)
  ClinicalTrials.gov Identifier: NCT00332033 - Completed
  Uterine Leiomyoma; Fibroids
  
• Development of a Noninvasive Method of Evaluation of Pulmonary Inflammation in the Condensates of Exhaled Air
  ClinicalTrials.gov Identifier: NCT00356629 - Recruiting
  Bronchopulmonary Ignition; Condensate of Exhaled Air; Mucoviscidosis; Asthma
  
• Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population
  ClinicalTrials.gov Identifier: NCT00165022 - Recruiting
  GERD
  
• Development of a Predictive Model for Post-Discharge Nausea and Vomiting (PDNV)
  ClinicalTrials.gov Identifier: NCT00514878 - Not yet recruiting
  Nausea; Postoperative Nausea and Vomiting; Postdischarge Nausea and Vomiting; Postoperative Pain
  
• Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions
  ClinicalTrials.gov Identifier: NCT00471601 - Recruiting
  Breast Cancer
  
• Development of a Refined Version of the Stroke Rehabilitation Assessment of Movement Scale for Stroke Patients
  ClinicalTrials.gov Identifier: NCT00173810 - Recruiting
  Cerebrovascular Accidents
  
• Development of a Web-Based Course to Maintain Skills in Nurses Trained to Screen for Dysphagia
  ClinicalTrials.gov Identifier: NCT00570557 - Recruiting
  Deglutition Disorders; Dysphagia; Stroke
  
• Development of a Web-Based Interactive Patient Decision Aid for the Treatment of Acute Low Back Pain and Depression
  ClinicalTrials.gov Identifier: NCT00525811 - Recruiting
  Acute Low Back Pain; Depression
  
• Development of Active Safety Surveillance System for Traditional Chinese Medicine
  ClinicalTrials.gov Identifier: NCT00275964 - Completed
  Climacteric Symptoms; Hot Flushes and/or Sweats
  
• Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans
  ClinicalTrials.gov Identifier: NCT00581204 - Enrolling by invitation
  Hemorrhagic Shock
  
• Development of an Algorithm to Better Predict Clinical Responsiveness to Peanut
  ClinicalTrials.gov Identifier: NCT00243555 - Recruiting
  Peanut Hypersensitivity
  
• Development of an Ergonomic Wheelchair Pushrim
  ClinicalTrials.gov Identifier: NCT00392860 - Not yet recruiting
  Spinal Cord Injury
  
• Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
  ClinicalTrials.gov Identifier: NCT00210249 - Completed
  Lymphoma; Digestive System Diseases; Ovarian Diseases; Pulmonary Disease; Prostatic Disease; Bladder Disease
  
• Development of an Instrumental Activities of Daily Living Scale
  ClinicalTrials.gov Identifier: NCT00173784 - Recruiting
  Spinal Cord Injury
  
• Development of Cognitive Assessment Tools in Parkinson Disease
  ClinicalTrials.gov Identifier: NCT00556764 - Recruiting
  Parkinson Disease
  
• Development of Gourmet Healthy Cooking Workshop for Cancer Patients
  ClinicalTrials.gov Identifier: NCT00364975 - Not yet recruiting
  Breast Cancer
  
• Development of Gourmet Medical Cooking Workshop for Lifestyle Changing and Its Affect on Perimenopausal Women
  ClinicalTrials.gov Identifier: NCT00364338 - Not yet recruiting
  Perimenopausal
  
• Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
  ClinicalTrials.gov Identifier: NCT00094315 - Active, not recruiting
  Cocaine-Related Disorders
  
• Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
  ClinicalTrials.gov Identifier: NCT00040066 - Active, not recruiting
  Cocaine-Related Disorders
  
• Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson’s Disease
  ClinicalTrials.gov Identifier: NCT00315250 - Recruiting
  Parkinson's Disease; Parkinsonian Syndrome
  
• Development of Immune Globulin Treatment for Avian Flu
  ClinicalTrials.gov Identifier: NCT00383071 - Recruiting
  Infectious Diseases; Influenza; Avian Flu
  
• Development of Limited Contact CBT Treatment for IBS
  ClinicalTrials.gov Identifier: NCT00248586 - Completed
  IBS
  
• Development of Magnetic Resonance (MR) Simulation for Treatment Planning
  ClinicalTrials.gov Identifier: NCT00314496 - Recruiting
  Healthy
  
• Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
  ClinicalTrials.gov Identifier: NCT00397111 - Recruiting
  Depressive Disorder, Major; Bipolar Disorder; Panic Disorder; Stress Disorders, Post-Traumatic
  
• Development of New Prenatal Diagnostic Tests From Maternal Blood
  ClinicalTrials.gov Identifier: NCT00314691 - Terminated
  Hereditary Diseases
  
• Development of NIC5-15 in the Treatment of Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00470418 - Recruiting
  Alzheimer Disease; Dementia
  
• Development of Normative Ultrasound Databases of Tongue Surface Configuration
  ClinicalTrials.gov Identifier: NCT00001218 - Completed
  Healthy; Speech Disorders
  
• Development of Resistance Mutations in Pregnant HIV-Positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
  ClinicalTrials.gov Identifier: NCT00197366 - Recruiting
  HIV Infections
  
• Development of Serologic Assays for Human Herpes Virus-8
  ClinicalTrials.gov Identifier: NCT00395278 - Recruiting
  Human Herpes Virus-8
  
• Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
  ClinicalTrials.gov Identifier: NCT00002485 - Completed
  childhood solid tumor; childhood acute lymphoblastic leukemia; psychosocial effects/treatment; childhood acute myeloid leukemia
  
• Development of Techniques for Use in MRI with a Magnetic Field of 7 Tesla
  ClinicalTrials.gov Identifier: NCT00056914 - Recruiting
  Healthy; Magnetic Resonance Imaging
  
• Development of the Eye Motor System During the First 7 Months of Life in Infants With and Without a Family History of Cross-Eye
  ClinicalTrials.gov Identifier: NCT00001143 - Completed
  Healthy; Strabismus
  
• Development of the GameCycle Exercise System: Phase II
  ClinicalTrials.gov Identifier: NCT00232609 - Recruiting
  Wheelchair Users
  
• Development of the MDASI-Spine Tumor Module
  ClinicalTrials.gov Identifier: NCT00430872 - Recruiting
  Spinal Cord Tumor
  
• Development of Treatments Aiming at Improvement of Function in Patients With Chronic Widespread Pain
  ClinicalTrials.gov Identifier: NCT00545649 - Completed
  Fibromyalgia
  
• Development of Treatments Aiming at Improvement of Function in Patients With Chronic Widespread Pain
  ClinicalTrials.gov Identifier: NCT00569218 - Completed
  Fibromyalgia
  
• Development of Tuberculosis Diagnostic Kit
  ClinicalTrials.gov Identifier: NCT00311207 - Recruiting
  Tuberculosis; Lung Cancer; Pneumonia
  
• Development of Workshop for Lifestyle Changing for Crohn's Disease Patients and Its Affect on the Disease's Indexes
  ClinicalTrials.gov Identifier: NCT00376649 - Not yet recruiting
  Crohn's Disease
  
• Development Training in Babies Born Preterm
  ClinicalTrials.gov Identifier: NCT00268931 - Not yet recruiting
  Premature Birth
  
• Development, Testing, and Validation of A Protocol To Assess Cardiovascular Reactivity in Human Populations
  ClinicalTrials.gov Identifier: NCT00005231 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Developmental Dyslexia and Functional Maturation of Auditory Cortex
  ClinicalTrials.gov Identifier: NCT00245804 - Active, not recruiting
  Developmental Reading Disorder; Dyslexia
  
• Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy
  ClinicalTrials.gov Identifier: NCT00021866 - Active, not recruiting
  Epilepsy; Seizure; Cognition Disorders
  
• Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00004324 - Completed
  Tourette Syndrome; Obsessive Compulsive Disorder
  
• Developmental Regulation of Proteins Responsible for Transforming Drugs in the Body
  ClinicalTrials.gov Identifier: NCT00117715 - Active, not recruiting
  Healthy
  
• Developmental Sequelae of Severe Chronic Lung Disorders
  ClinicalTrials.gov Identifier: NCT00005294 - Completed
  Bronchopulmonary Dysplasia; Lung Diseases
  
• Developmental Study on Fatigue in Cancer
  ClinicalTrials.gov Identifier: NCT00034450 - Completed
  Neoplasms
  
• Devitalized Non-Valved Pulmonary Artery Allograft Implant for the Repair of Congenital Cardiac Abnormalities
  ClinicalTrials.gov Identifier: NCT00411658 - Not yet recruiting
  Congenital Cardiac Abnormality
  
• Deworming and Enhanced Vitamin A Every 6 Month in Rural Indian Children Aged 1-6
  ClinicalTrials.gov Identifier: NCT00222547 - Completed
  Village Children
  
• Deworming and Vitamin A (DEVTA) Prepilot Study
  ClinicalTrials.gov Identifier: NCT00396500 - Completed
  Malnutrition; Worm Infestation; Under-Fives
  
• Dexamethasone 0.01% Solution for the Treatment of Oral Lichen Planus
  ClinicalTrials.gov Identifier: NCT00111072 - Completed
  
  
• Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure
  ClinicalTrials.gov Identifier: NCT00416897 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm; Renal Failure
  
• Dexamethasone and Ondansetron or Palonosetron in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy for Early-Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00343863 - Suspended
  Breast Cancer; Nausea and Vomiting
  
• Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00403065 - Recruiting
  Brain and Central Nervous System Tumors; Lung Cancer
  
• Dexamethasone and the Prevention of Post-Extubation Airway Obstruction in Adults
  ClinicalTrials.gov Identifier: NCT00452062 - Recruiting
  Airway Obstruction
  
• Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00075725 - Recruiting
  untreated childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; ...
  
• Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00006345 - Completed
  Drug Toxicity; recurrent cutaneous T-cell lymphoma; recurrent mycosis fungoides/Sezary syndrome
  
• Dexamethasone for Cardiac Surgery Trial
  ClinicalTrials.gov Identifier: NCT00293592 - Recruiting
  Systemic Inflammatory Response Syndrome; Cardiac Diseases; Postoperative Complications
  
• Dexamethasone for Paediatric Adeno-Tonsillectomy - A Dose-Finding Study
  ClinicalTrials.gov Identifier: NCT00403806 - Recruiting
  Postoperative Nausea and Vomiting; Postoperative Pain
  
• Dexamethasone for Palliation - Brain Metastases
  ClinicalTrials.gov Identifier: NCT00188864 - Recruiting
  Neoplasm Metastasis
  
• Dexamethasone for Symptom Burden in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00489307 - Recruiting
  Solid Tumors
  
• Dexamethasone in Cryptococcal Meningitis
  ClinicalTrials.gov Identifier: NCT00000776 - Completed
  Meningitis, Cryptococcal; HIV Infections
  
• Dexamethasone Infusion in Community-Acquired Pneumonia
  ClinicalTrials.gov Identifier: NCT00471640 - Not yet recruiting
  Pneumonia
  
• Dexamethasone or Dexamethasone in Combination with Thalidomide as Salvage Therapy
  ClinicalTrials.gov Identifier: NCT00083902 - Completed
  Multiple Myeloma
  
• Dexamethasone Pain Flare Study
  ClinicalTrials.gov Identifier: NCT00438828 - Not yet recruiting
  Cancer
  
• Dexamethasone Plus Interferon alfa in Treating Patients With Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00002849 - Active, not recruiting
  primary systemic amyloidosis
  
• Dexamethasone Study
  ClinicalTrials.gov Identifier: NCT00152867 - Recruiting
  Cancer; Quality of Life; Emesis
  
• Dexamethasone to Prevent Oral Chronic Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00391170 - Recruiting
  Graft vs Host Disease
  
• Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00530270 - Recruiting
  Anemia, Sickle Cell
  
• Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns with Lupus
  ClinicalTrials.gov Identifier: NCT00007358 - Recruiting
  Congenital heart block; Neonatal lupus; Atrioventricular nodal dysfunction; Myocardial injury
  
• Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease
  ClinicalTrials.gov Identifier: NCT00152620 - Terminated
  Inflammatory Bowel Disease (IBD)
  
• Dexamethasone With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00064038 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00017602 - Active, not recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00033332 - Completed
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00316927 - Completed
  Prostate Cancer
  
• Dexamethasone-Eluting Stent in Acute Coronary Syndrome to Prevent Restenosis
  ClinicalTrials.gov Identifier: NCT00190099 - Completed
  Vessel Restenosis
  
• Dexmed/Buspirone Synergism on Shivering
  ClinicalTrials.gov Identifier: NCT00334360 - Completed
  Hypothermia; Therapeutic
  
• Dexmedetomidine for Continuous Sedation
  ClinicalTrials.gov Identifier: NCT00226785 - Terminated
  Sedation
  
• Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms
  ClinicalTrials.gov Identifier: NCT00409344 - Not yet recruiting
  Sedation; Respiration, Artificial; Length of Stay
  
• Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients
  ClinicalTrials.gov Identifier: NCT00345384 - Recruiting
  Post-Operative Pain; Post-Operative Respiratory Depression; Sedation
  
• Dexmedetomidine Versus Chloral Hydrate for Pediatric Sedation During EEG
  ClinicalTrials.gov Identifier: NCT00464451 - Not yet recruiting
  Procedural Sedation
  
• Dexmedetomidine Versus Midazolam for Continuous Sedation in the Intensive Care Unit (ICU)
  ClinicalTrials.gov Identifier: NCT00481312 - Recruiting
  Continuous Sedation in Initially Sedated Adults in ICU
  
• Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU)
  ClinicalTrials.gov Identifier: NCT00479661 - Recruiting
  Continuous Sedation in Initially Sedated Adults in ICU
  
• Dexmedetomidine vs. Remifentanil for Sedation During AFI
  ClinicalTrials.gov Identifier: NCT00349245 - Recruiting
  Intubation, Endotracheal
  
• Dexmethylphenidate in Treating Patients With Fatigue and Behavior Change After Chemotherapy
  ClinicalTrials.gov Identifier: NCT00052533 - Completed
  Fatigue; cognitive/functional effects; unspecified adult solid tumor, protocol specific
  
• Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00550901 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Dextro-Amphetamine Versus Caffeine in Treatment-Resistant OCD
  ClinicalTrials.gov Identifier: NCT00363298 - Recruiting
  Obsessive-Compulsive Disorder
  
• Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
  ClinicalTrials.gov Identifier: NCT00000306 - Completed
  Cocaine-Related Disorders; Opioid-Related Disorders
  
• Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
  ClinicalTrials.gov Identifier: NCT00000304 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Dextroamphetamine-Amphetamine Compared With Methylphenidate in Treating Children With Depression and Problems With Memory, Attention, and Thinking Caused By Cancer Treatment
  ClinicalTrials.gov Identifier: NCT00069927 - Completed
  unspecified childhood solid tumor, protocol specific; Depression; neurotoxicity
  
• Dextroamphetamine-Cocaine Behavioral Intervention - 5
  ClinicalTrials.gov Identifier: NCT00000308 - Completed
  Cocaine-Related Disorders
  
• Dextroethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System
  ClinicalTrials.gov Identifier: NCT00001365 - Completed
  Neurodegenerative Disease; Parkinson's Disease
  
• Dextromethorphan in Treating Patients With Fatigue Caused by Cancer
  ClinicalTrials.gov Identifier: NCT00176540 - Completed
  Fatigue; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Dextromethorphan to Treat Patients with Voice Spasms
  ClinicalTrials.gov Identifier: NCT00055549 - Recruiting
  Voice Disorders
  
• Dextromethorphan Versus Placebo for Neuropathic Pain
  ClinicalTrials.gov Identifier: NCT00001344 - Completed
  Diabetic Neuropathies; Herpes Zoster; Neuralgia
  
• Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia
  ClinicalTrials.gov Identifier: NCT00218374 - Recruiting
  Hyperalgesia; Opioid-Related Disorders
  
• DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00440050 - Active, not recruiting
  Alzheimer's Disease
  
• DHA and X-Linked Retinitis Pigmentosa
  ClinicalTrials.gov Identifier: NCT00100230 - Recruiting
  Retinitis Pigmentosa; X-linked Genetic Diseases
  
• DHA Supplement and Pregnancy Outcome
  ClinicalTrials.gov Identifier: NCT00266825 - Recruiting
  Pregnancy
  
• DHA Supplementation in Patients With STGD3
  ClinicalTrials.gov Identifier: NCT00420602 - Active, not recruiting
  Dominantly Inherited Stargardt's Disease (STGD3)
  
• DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00024401 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00024375 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00024414 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• DHEA and Testosterone Replacement in Elderly
  ClinicalTrials.gov Identifier: NCT00254371 - Completed
  Aging; Low DHEA for Women; Low Testosterone and DHEA for Men
  
• DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy
  ClinicalTrials.gov Identifier: NCT00429806 - Active, not recruiting
  Vaginal Atrophy
  
• DHEA Replacement in Adrenalectomized/Hypoadrenal Patients
  ClinicalTrials.gov Identifier: NCT00279929 - Completed
  Aging; Dehydroepiandosterone Replacement; DHEA Replacement
  
• DHEA Supplementation for Low Ovarian Response IVF Patients
  ClinicalTrials.gov Identifier: NCT00549081 - Not yet recruiting
  Infertility, Female; In-Vitro Fertilization
  
• DHEA Treatment for Sjogren's Syndrome
  ClinicalTrials.gov Identifier: NCT00001598 - Completed
  Lacrimal Apparatus Disease; Salivary Gland Disease; Sjogren's Syndrome; Xerostomia
  
• DHPLC Determination of TPMT Polymorphisms.
  ClinicalTrials.gov Identifier: NCT00402090 - Recruiting
  Acute Lymphoblastic Leukemia
  
• DHT-3-Effect of Dihydrotestosterone (DHT) on Prostate Tissue
  ClinicalTrials.gov Identifier: NCT00490022 - Recruiting
  Healthy
  
• Diabetes Aerobic and Resistance Exercise (DARE) Study
  ClinicalTrials.gov Identifier: NCT00195884 - Active, not recruiting
  Diabetes Mellitus, Type 2; Diabetes Mellitus
  
• Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)
  ClinicalTrials.gov Identifier: NCT00005146 - Completed
  Cardiovascular Diseases; Heart Diseases; Diabetes Mellitus, non-insulin dependent; Diabetes Mellitus
  
• Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
  ClinicalTrials.gov Identifier: NCT00309712 - Active, not recruiting
  Type II Diabetes Mellitus; Mixed Dyslipidemia
  
• Diabetes Control and Complications Trial (DCCT)
  ClinicalTrials.gov Identifier: NCT00360815 - Completed
  Type 1 Diabetes Mellitus
  
• Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial (The Dessert Study)
  ClinicalTrials.gov Identifier: NCT00497172 - Active, not recruiting
  Coronary Artery Disease
  
• Diabetes Genome Project (DGP)
  ClinicalTrials.gov Identifier: NCT00428961 - Recruiting
  Diabetes Mellitus; Insulin Resistance; Atherosclerosis
  
• Diabetes Health Enhancement Program to Improve Health of People With Diabetes
  ClinicalTrials.gov Identifier: NCT00291590 - Completed
  Diabetes
  
• Diabetes in Neuropsychiatric Disorders
  ClinicalTrials.gov Identifier: NCT00446992 - Recruiting
  Schizophrenia
  
• Diabetes IN-CHARGE: Trial of Diabetes Intervention in the Community to Help Achieve Reduced Glucose Elevation
  ClinicalTrials.gov Identifier: NCT00182026 - Recruiting
  Diabetes Mellitus, Type 2
  
• Diabetes Knowledge Assessment
  ClinicalTrials.gov Identifier: NCT00198900 - Completed
  Type 2 Diabetes Mellitus
  
• Diabetes Management Personal Trainer
  ClinicalTrials.gov Identifier: NCT00340093 - Completed
  Diabetes
  
• Diabetes Medication Choice
  ClinicalTrials.gov Identifier: NCT00388050 - Recruiting
  Type 2 Diabetes
  
• Diabetes Mellitus and Vulvovaginal Candidiasis
  ClinicalTrials.gov Identifier: NCT00353561 - Completed
  Diabetes Mellitus; Vulvovaginal Candidiasis
  
• Diabetes Mellitus Type II and Tissue Oxygenation
  ClinicalTrials.gov Identifier: NCT00554697 - Active, not recruiting
  Diabetes Mellitus, Type II
  
• Diabetes Prevention Program
  ClinicalTrials.gov Identifier: NCT00004992 - Completed
  Diabetes Mellitus, Non-Insulin-Dependent; Glucose Intolerance
  
• Diabetes Prevention Program in Schizophrenia [DPPS]
  ClinicalTrials.gov Identifier: NCT00182494 - Recruiting
  Diabetes Mellitus; Schizophrenia
  
• Diabetes Prevention Program Outcomes Study
  ClinicalTrials.gov Identifier: NCT00353314 - Active, not recruiting
  Diabetes
  
• Diabetes Quality Improvement Program on Diabetes Case Management Program 2001
  ClinicalTrials.gov Identifier: NCT00471926 - Recruiting
  Diabetes Mellitus
  
• Diabetes Risk Evaluation and Management Tele-Monitoring Study (DREAM-Tel)
  ClinicalTrials.gov Identifier: NCT00325624 - Recruiting
  Hypertension; Diabetes Mellitus
  
• Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population
  ClinicalTrials.gov Identifier: NCT00253240 - Completed
  Diabetes Mellitus; Schizophrenia; Psychotic Disorders
  
• Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II
  ClinicalTrials.gov Identifier: NCT00377117 - Completed
  Diabetes Mellitus; Schizophrenia; Psychotic Disorders
  
• Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
  ClinicalTrials.gov Identifier: NCT00279045 - Completed
  Non-Insulin-Dependent Diabetes Mellitus
  
• Diabetes Technology Study of Real-Time Glucose Alerts in the Team Management of Diabetes
  ClinicalTrials.gov Identifier: NCT00322478 - Recruiting
  Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus, Gestational
  
• Diabetes Telemedicine Consultation: a Systems Improvement Intervention
  ClinicalTrials.gov Identifier: NCT00119041 - Recruiting
  Diabetes Mellitus Type 2; Diabetes Mellitus Type 1
  
• Diabetes Therapy to Improve BMI and Lung Function in CF
  ClinicalTrials.gov Identifier: NCT00072904 - Completed
  Cystic Fibrosis; Diabetes Mellitus
  
• Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy
  ClinicalTrials.gov Identifier: NCT00328302 - Active, not recruiting
  Diabetes, Type I
  
• Diabetes Virtual Trek: Obesity and Diabetes Prevention Through Science Enrichment
  ClinicalTrials.gov Identifier: NCT00542113 - Recruiting
  Type 2 Diabetes; Obesity
  
• Diabetes, Lipoproteins and Accelerated Vascular Disease
  ClinicalTrials.gov Identifier: NCT00005479 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Atherosclerosis; Carotid Artery Diseases; Diabetes Mellitus, non-insulin dependent; ...
  
• Diabetic Educational Eating Plan
  ClinicalTrials.gov Identifier: NCT00473811 - Active, not recruiting
  Low-GI Dietary Education; ADA Dietary Education
  
• Diabetic Foot Infection Study
  ClinicalTrials.gov Identifier: NCT00044746 - Completed
  Ulcer, Diabetic Foot
  
• Diabetic Patients With End-Stage Renal Disease
  ClinicalTrials.gov Identifier: NCT00435786 - Completed
  Diabetes; End-Stage Renal Disease; Cardiovascular Diseases
  
• Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited Training
  ClinicalTrials.gov Identifier: NCT00500097 - Completed
  Diabetic Retinopathy
  
• Diabetic Retinopathy and Visual Function Study
  ClinicalTrials.gov Identifier: NCT00001346 - Completed
  Diabetic Retinopathy; Macular Degeneration; Vision, Subnormal
  
• DIabetic Retinopathy Candesartan Trials
  ClinicalTrials.gov Identifier: NCT00252694 - Active, not recruiting
  Type 2 Diabetes
  
• Diabetic Retinopathy Candesartan Trials
  ClinicalTrials.gov Identifier: NCT00252733 - Active, not recruiting
  Type 1 Diabetes
  
• DIabetic Retinopathy Candesartan Trials.
  ClinicalTrials.gov Identifier: NCT00252720 - Active, not recruiting
  Type 1 Diabetes
  
• Diabetic Retinopathy Study (DRS)
  ClinicalTrials.gov Identifier: NCT00000160 - Completed
  Diabetic Retinopathy; Blindness
  
• Diabetic Retinopathy Vitrectomy Study (DRVS)
  ClinicalTrials.gov Identifier: NCT00000154 - Completed
  Diabetic Retinopathy; Retinal Detachment; Vitreous Hemorrhage
  
• Diabetic Under 70 (Diabetics Below 70)
  ClinicalTrials.gov Identifier: NCT00516204 - Recruiting
  Diabetes; Hyperlipidemia; Atherosclerosis
  
• DIAFAX III-Effects of Inhalative Anesthetics on Left Ventricular Diastolic Function
  ClinicalTrials.gov Identifier: NCT00244517 - Recruiting
  Young Healthy Adults; Ventricular Dysfunction
  
• Diagnosing and Treating Low Blood Sugar Levels
  ClinicalTrials.gov Identifier: NCT00001276 - Recruiting
  Hypoglycemia; Insulinoma
  
• Diagnosing Extremity Fractures and/or Dislocations Using Ultrasound Presenting to the Emergency Department
  ClinicalTrials.gov Identifier: NCT00356837 - Recruiting
  Fractures; Dislocations
  
• Diagnosing Tuberculosis in HIV Infected Children in Peru
  ClinicalTrials.gov Identifier: NCT00054769 - Active, not recruiting
  Tuberculosis; Tuberculosis, Pulmonary; HIV Infections
  
• Diagnosis and Characterization of Coronary Artery Stenosis by Doppler Ultrasound
  ClinicalTrials.gov Identifier: NCT00521326 - Not yet recruiting
  Coronary Stenosis
  
• Diagnosis and Evaluation of Patients Needing Third Molar (Wisdom Tooth) Extraction and Patients with Chronic Facial Pain
  ClinicalTrials.gov Identifier: NCT00001600 - Completed
  Facial Pain; Temporomandibular Joint Disorder
  
• Diagnosis and Follow-up of Patients With Subclinical Hypothyroidism
  ClinicalTrials.gov Identifier: NCT00497575 - Completed
  Congenital Hypothyroidism; L-Thyroxine; Follow-Up
  
• Diagnosis and History Study of Patients with Different Neurological Conditions
  ClinicalTrials.gov Identifier: NCT00001367 - Recruiting
  Nervous System Disease
  
• Diagnosis and Management of Inflammatory and Infectious Diseases
  ClinicalTrials.gov Identifier: NCT00557726 - Recruiting
  Infectious Disease
  
• Diagnosis and Natural History Study of Patients with Neurological Conditions
  ClinicalTrials.gov Identifier: NCT00001549 - Completed
  Alzheimer's Disease; Dementia; Movement Disorder; Multiple System Atrophy; Parkinson's Disease
  
• Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes
  ClinicalTrials.gov Identifier: NCT00222352 - Active, not recruiting
  Angina, Unstable
  
• Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Rapid Bedside cTnl on Outcome.
  ClinicalTrials.gov Identifier: NCT00276432 - Recruiting
  Unstable Angina; Non-ST-Elevation Myocardial Infarction
  
• Diagnosis and Treatment of Leishmanial Infections
  ClinicalTrials.gov Identifier: NCT00344188 - Recruiting
  Leishmaniasis
  
• Diagnosis and Treatment of Patients With Inborn Errors of Metabolism
  ClinicalTrials.gov Identifier: NCT00369421 - Recruiting
  Metabolism
  
• Diagnosis and Treatment of Pheochromocytoma
  ClinicalTrials.gov Identifier: NCT00001229 - Completed
  Pheochromocytoma
  
• Diagnosis and Treatment of Sleep-Disordered Breathing in the Homes of Patients With Transient Ischemic Attack
  ClinicalTrials.gov Identifier: NCT00251290 - Recruiting
  Transient Ischemic Attack; Sleep Apnea
  
• Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005071 - Active, not recruiting
  childhood thorax/respiratory cancer; limited stage small cell lung cancer; stage II non-small cell lung cancer; Quality of Life; ...
  
• Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children
  ClinicalTrials.gov Identifier: NCT00456469 - Not yet recruiting
  Tuberculosis
  
• Diagnosis of Active Tuberculosis by ELISPOT
  ClinicalTrials.gov Identifier: NCT00174083 - Recruiting
  Tuberculosis
  
• Diagnosis of Coronary Artery Disease in High Risk Diabetic Patients: Comparison Between Stress Echocardiography and Stress Scintigraphy in the Detection of Silent Myocardial Ischemia
  ClinicalTrials.gov Identifier: NCT00202670 - Recruiting
  Diabetes Mellitus
  
• Diagnosis of Depression Among Adolescents
  ClinicalTrials.gov Identifier: NCT00443742 - Not yet recruiting
  Depression
  
• Diagnosis of Functional Defecation Disorders in Childhood
  ClinicalTrials.gov Identifier: NCT00230360 - Completed
  Constipation; Fecal Incontinence
  
• Diagnosis of Hemangiomas and Vascular Malformations
  ClinicalTrials.gov Identifier: NCT00577213 - Enrolling by invitation
  Hemangiomas; Vascular Malformations; Venular Malformations; Venous Malformations; Lymphatic Malformations; Arteriovenous Malformations
  
• Diagnosis of Insulin Resistance: 13C-Glucose Breath Test Vs HOMA Index.
  ClinicalTrials.gov Identifier: NCT00264940 - Not yet recruiting
  Glucose Intolerance; Insulin Resistance; Diabetes Mellitus, Type 2
  
• Diagnosis of Occult Hip Fractures With Ultrasound
  ClinicalTrials.gov Identifier: NCT00461864 - Not yet recruiting
  Hip Fractures; Occult Fractures
  
• Diagnosis of Oral Precancers and Cancers Using Optic Coherence Tomography
  ClinicalTrials.gov Identifier: NCT00172965 - Recruiting
  Oral Cancers
  
• Diagnosis of Pheochromocytoma
  ClinicalTrials.gov Identifier: NCT00004847 - Recruiting
  Pheochromocytoma
  
• Diagnosis of Tuberculosis Infection in HIV co-Infected Children
  ClinicalTrials.gov Identifier: NCT00541294 - Not yet recruiting
  Latent Tuberculosis Infection; Tuberculosis; HIV Infections
  
• Diagnosis of Variceal Bleeding and Its Control in Cirrhosis
  ClinicalTrials.gov Identifier: NCT00188097 - Terminated
  Cirrhosis
  
• Diagnosis of Ventilator- Associated Pneumonia in Children: A Comparative Study of Bronchoscopic and Non-Bronchoscopic Methods
  ClinicalTrials.gov Identifier: NCT00495963 - Completed
  Ventilator Associated Pneumonia
  
• Diagnosis, Evaluation and Treatment of Patients in Need of Third Molar Removal
  ClinicalTrials.gov Identifier: NCT00316485 - Recruiting
  Wisdom Teeth
  
• Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism Hypertension
  ClinicalTrials.gov Identifier: NCT00005394 - Completed
  Cardiovascular Diseases; Hypertension; Heart Diseases
  
• Diagnostic Accuracy of Fine Needle Aspiration in Parotid Tumors
  ClinicalTrials.gov Identifier: NCT00534612 - Recruiting
  Parotid Gland Neoplasms
  
• Diagnostic Algorithm in Patients With Minor Head Injury
  ClinicalTrials.gov Identifier: NCT00452036 - Active, not recruiting
  Minor Head Injury; Traumatic Brain Injury
  
• Diagnostic and Genetic Study to Identify Pancreatic Lesions in Patients With Von Hippel-Lindau Syndrome
  ClinicalTrials.gov Identifier: NCT00062166 - Recruiting
  Neuroendocrine Carcinoma; Pancreatic Cancer; von Hippel-Lindau Syndrome
  
• Diagnostic and Prognostic Value of p16INK4a Expression in Low Grade Squamous Intraepithelial Lesions of the Cervix.
  ClinicalTrials.gov Identifier: NCT00343213 - Recruiting
  Cervical Intraepithelial Neoplasia Grade 1 (CIN 1)
  
• Diagnostic and Screening Study of Genetic Disorders
  ClinicalTrials.gov Identifier: NCT00006057 - Completed
  Tay-Sachs Disease; Porphyria, Erythropoietic; Leukodystrophy, Globoid Cell; Metabolism, Inborn Errors
  
• Diagnostic Effectiveness of Virtual Bronchoscopy
  ClinicalTrials.gov Identifier: NCT00001515 - Completed
  Bronchogenic Carcinoma; Chronic Granulomatous Disease; Job's Syndrome; Mycobacterium Infection; Wegener's Granulomatosis
  
• Diagnostic Evaluation of Patients with Neuromuscular Disease
  ClinicalTrials.gov Identifier: NCT00015470 - Completed
  Neuromuscular Disease
  
• Diagnostic Imaging in Children With Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00019292 - Active, not recruiting
  Brain and Central Nervous System Tumors
  
• Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology
  ClinicalTrials.gov Identifier: NCT00288821 - Recruiting
  Cervix Neoplasms; Ovarian Neoplasms; Endometrial Neoplasms; Vulvar Neoplasms; Lymphatic Metastasis
  
• Diagnostic Innovations in Glaucoma Study
  ClinicalTrials.gov Identifier: NCT00221897 - Recruiting
  Primary Open Angle Glaucoma; Persons at Risk for Glaucoma
  
• Diagnostic Investigation of Sudden Cardiac Event Risk
  ClinicalTrials.gov Identifier: NCT00500708 - Recruiting
  Arrhythmia
  
• Diagnostic Outcome Trial in Heart Failure (DOT-HF Trial)
  ClinicalTrials.gov Identifier: NCT00480077 - Recruiting
  Heart Failure
  
• Diagnostic Performance of Screening Tests for Cushing's Syndrome
  ClinicalTrials.gov Identifier: NCT00361777 - Recruiting
  Cushing's Syndrome
  
• Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia Major
  ClinicalTrials.gov Identifier: NCT00006138 - Completed
  Osteoporosis; Thalassemia Major; Osteopenia
  
• Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003186 - Completed
  stage III rectal cancer; Stage IV rectal cancer; stage I rectal cancer; stage I colon cancer; stage II colon cancer; liver metastases; ...
  
• Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Women Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00089323 - Recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery
  ClinicalTrials.gov Identifier: NCT00033397 - Recruiting
  stage II breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
  
• Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.
  ClinicalTrials.gov Identifier: NCT00407784 - Recruiting
  Hyperaldosteronism; Hypertension
  
• Diagnostic Rentability of Screening for Associated Conditions in Calcium Pyrophosphate Deposition Disease Patients
  ClinicalTrials.gov Identifier: NCT00453128 - Completed
  Chondrocalcinosis
  
• Diagnostic Study In Patients Receiving Treatment For Brain Tumors
  ClinicalTrials.gov Identifier: NCT00020293 - Active, not recruiting
  Brain and Central Nervous System Tumors; Long-Term Effects Secondary to Cancer Therapy in Children; Neurotoxicity; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock
  ClinicalTrials.gov Identifier: NCT00005890 - Completed
  Septic Shock
  
• Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003933 - Completed
  recurrent childhood acute lymphoblastic leukemia
  
• Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003931 - Completed
  Leukemia
  
• Diagnostic Study of Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00003861 - Recruiting
  untreated adult acute lymphoblastic leukemia
  
• Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003863 - Completed
  adult non-Hodgkin's lymphoma
  
• Diagnostic Study of Patients With Stage I Testicular Cancer
  ClinicalTrials.gov Identifier: NCT00003800 - Active, not recruiting
  Testicular Cancer
  
• Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00006060 - Suspended
  Multiple Sclerosis
  
• Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma
  ClinicalTrials.gov Identifier: NCT00048984 - Recruiting
  localized tumors of the Ewing's family; metastatic tumors of the Ewing's family; recurrent tumors of the Ewing's family
  
• Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003654 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
  ClinicalTrials.gov Identifier: NCT00049010 - Active, not recruiting
  stage I melanoma; stage II melanoma
  
• Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00042926 - Active, not recruiting
  stage I squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity
  
• Diagnostic Usefulness of Fluorine–18-α–Methyltyrosine PET in Combination With 18F-FDG in Sarcoidosis Patient
  ClinicalTrials.gov Identifier: NCT00369980 - Completed
  Sarcoidosis
  
• Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00539045 - Recruiting
  Thrombus; Myocardial Infarction
  
• Diagnostic Utility of MRI in Intracerebral Hemorrhage
  ClinicalTrials.gov Identifier: NCT00363662 - Recruiting
  Cerebral Hemorrhage
  
• Diagnostics and Therapy of Disease-Related Quality of Life of Patients with Breast Cancer
  ClinicalTrials.gov Identifier: NCT00145743 - Completed
  Breast Neoplasms
  
• Diagnostics for the Reperfusion Injury Following MI
  ClinicalTrials.gov Identifier: NCT00529607 - Recruiting
  Reperfusion Injury
  
• Dialectical Behavior Therapy Compared to Standard Drug Counseling for the Treatment of Opiate Addiction in Emotionally Dysregulated Patients. - 1
  ClinicalTrials.gov Identifier: NCT00218595 - Recruiting
  Dialectical Behavior Therapy; Drug Counseling; Opioid Dependence
  
• Dialectical Cognitive Traumatherapy (DCT) on Patients With Severe PTSD Following Sexual Abuse
  ClinicalTrials.gov Identifier: NCT00481000 - Recruiting
  Posttraumatic Stress Disorder
  
• DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines
  ClinicalTrials.gov Identifier: NCT00233649 - Completed
  Diabetes Mellitus Type 2; Crestor, Rosuvastatin; LDL Cholesterol; Observational
  
• Dialysate Sodium Individualization in Hemodialysis
  ClinicalTrials.gov Identifier: NCT00259714 - Recruiting
  Hypertension in Hemodialysis Patients
  
• Dialysis Catheter Comparative Clinical Trial
  ClinicalTrials.gov Identifier: NCT00526123 - Recruiting
  End Stage Renal Disease
  
• Dialysis Clinical Outcomes Revisited (DCOR) Trial
  ClinicalTrials.gov Identifier: NCT00324571 - Completed
  Chronic Kidney Disease
  
• DIAMANTE - Diseases Infectious Analysis Microflora Antibiotic Effect.
  ClinicalTrials.gov Identifier: NCT00424905 - Recruiting
  Gastrointestinal Diseases
  
• Diamond Blackfan Anemia Registry (DBAR)
  ClinicalTrials.gov Identifier: NCT00106015 - Active, not recruiting
  Anemia; Blood Disease
  
• Diarrhea Brazil
  ClinicalTrials.gov Identifier: NCT00133406 - Active, not recruiting
  Diarrheal diseases
  
• Diarrhea Prodominant Irritable Bowel Syndrome in Females
  ClinicalTrials.gov Identifier: NCT00461526 - Recruiting
  Irritable Bowel Syndrome
  
• Diastolic Dysfunction and Atrial Fibrillation in CABG Surgery
  ClinicalTrials.gov Identifier: NCT00188903 - Recruiting
  Heart Disease; Atrial Fibrillation
  
• Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men
  ClinicalTrials.gov Identifier: NCT00151684 - Recruiting
  Obesity; Hyperinsulinism
  
• Dichloroacetate Kinetics, Metabolism and Toxicology
  ClinicalTrials.gov Identifier: NCT00015015 - Completed
  Lactic Acidosis
  
• Dichotic Listening as a Predictor of Medication Response in Depression
  ClinicalTrials.gov Identifier: NCT00404755 - Recruiting
  Major Depressive Disorder; Dysthymia
  
• Dichotic Listening as a Predictor of Medication Response in Depression
  ClinicalTrials.gov Identifier: NCT00296725 - Active, not recruiting
  Major Depression; Dysthymia; Depressive Disorder NOS
  
• Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients
  ClinicalTrials.gov Identifier: NCT00428025 - Recruiting
  Pancreatitis
  
• Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.
  ClinicalTrials.gov Identifier: NCT00000678 - Completed
  HIV Infections
  
• Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients with AIDS or Advanced ARC who Cannot be Maintained on Zidovudine ( AZT ) Therapy.
  ClinicalTrials.gov Identifier: NCT00002256 - Completed
  HIV Infections
  
• Diet and Behavior in Young Children with Autism
  ClinicalTrials.gov Identifier: NCT00090428 - Recruiting
  Autism
  
• Diet and Breast Cancer Prevention Trial
  ClinicalTrials.gov Identifier: NCT00148057 - Completed
  Breast Cancer
  
• Diet and Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00006419 - Completed
  Lung Diseases, Obstructive; Chronic Obstructive Pulmonary Disease
  
• Diet and Estrogen Metabolism in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00003098 - Active, not recruiting
  prevention of breast cancer; Breast Cancer
  
• Diet and Exercise for Elevated Risk (DEER)
  ClinicalTrials.gov Identifier: NCT00000598 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypercholesterolemia; Postmenopause
  
• Diet and Exercise in Overweight Children Postburn
  ClinicalTrials.gov Identifier: NCT00537160 - Not yet recruiting
  Obesity; Burns
  
• Diet and Exercise-Based Counseling Program Compared With a Standard Counseling Program in Patients With Early-Stage Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00044980 - Active, not recruiting
  Nutrition; Quality of Life; stage I prostate cancer; stage II prostate cancer
  
• Diet and Genetic Damage
  ClinicalTrials.gov Identifier: NCT00340743 - Active, not recruiting
  Colon Cancer; Diet
  
• Diet and Physical Activity Interactions in Obesity
  ClinicalTrials.gov Identifier: NCT00067964 - Completed
  Obesity
  
• Diet and Plasma Cholesterol - Secular Trend Analysis
  ClinicalTrials.gov Identifier: NCT00005257 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Hypercholesterolemia
  
• Diet and PSA Levels in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003367 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Diet and the Aging Brain
  ClinicalTrials.gov Identifier: NCT00463255 - Recruiting
  Healthy
  
• Diet Modification and Blood Pressure in Young People
  ClinicalTrials.gov Identifier: NCT00005167 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Diet, Exercise and Breastfeeding Intervention Program for Women With Gestational Diabetes (DEBI Trial)
  ClinicalTrials.gov Identifier: NCT00460018 - Recruiting
  Gestational Diabetes Mellitus
  
• Diet, Exercise and Cardiovascular Health Among Ethnic Children
  ClinicalTrials.gov Identifier: NCT00005179 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00264251 - Completed
  HIV Infections; Insulin Resistance; Obesity
  
• Diet, Exercise, and Cardiovascular Health Among Ethnic Children
  ClinicalTrials.gov Identifier: NCT00005416 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
  ClinicalTrials.gov Identifier: NCT00246376 - Recruiting
  Cardiovascular Diseases; Heart Diseases; HIV Infections; Hyperlipidemia; Hypertriglyceridemia; Insulin Resistance; Atherosclerosis
  
• Diet, Genetics, and CVD Risk Factor Response in Blacks
  ClinicalTrials.gov Identifier: NCT00079703 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases
  
• Diet, Insulin Resistance, and Cardiovascular Risk
  ClinicalTrials.gov Identifier: NCT00005530 - Completed
  Cardiovascular Diseases; Heart Diseases; Insulin Resistance; Hyperinsulinism; Diabetes Mellitus, non-insulin dependent; Diabetes Mellitus
  
• Diet, Obesity and Genes (DiOGenes)
  ClinicalTrials.gov Identifier: NCT00390637 - Active, not recruiting
  Obesity; Metabolic Syndrome; Type 2 Diabetes; Cardiovascular Disease
  
• Diet/Activity of Mexican American and Anglo Children
  ClinicalTrials.gov Identifier: NCT00005384 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Diet/Growth Factor Mechanisms of Gut Adaptation
  ClinicalTrials.gov Identifier: NCT00067860 - Recruiting
  Short Bowel Syndrome
  
• Dietary Adherence Enhancement in Peritoneal Dialysis: BalanceWise-PD
  ClinicalTrials.gov Identifier: NCT00447317 - Recruiting
  End-Stage Renal Disease; Peritoneal Dialysis
  
• Dietary Advanced Glycation End-Products and Insulin Resistance in Overweight and Obese Humans
  ClinicalTrials.gov Identifier: NCT00422253 - Recruiting
  Type 2 Diabetes; Insulin Resistance; Obesity
  
• Dietary and Genetic Factors in Asthma & Chronic Bronchitis in a Cohort of Chinese Singaporeans
  ClinicalTrials.gov Identifier: NCT00342030 - Active, not recruiting
  Chronic Bronchitis; Asthma
  
• Dietary Antioxidants and Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00005412 - Completed
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases; Carotid Stenosis
  
• Dietary Approaches to Stop Hypertension (DASH)
  ClinicalTrials.gov Identifier: NCT00000544 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases
  
• Dietary Calcium Supplementation to Reduce Blood Lead in Pregnancy
  ClinicalTrials.gov Identifier: NCT00558623 - Completed
  Lead, Blood; Pregnancy; Bone Resorption
  
• Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
  ClinicalTrials.gov Identifier: NCT00260299 - Recruiting
  Mevalonic Aciduria; Mevalonate Kinase Deficiency; Immune System Diseases; Periodic Fever Syndromes, Hereditary; Lipid Metabolism, Inborn Errors
  
• Dietary Effects of Sulfur Amino Acids
  ClinicalTrials.gov Identifier: NCT00228618 - Recruiting
  Healthy
  
• Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA)
  ClinicalTrials.gov Identifier: NCT00000538 - Completed
  Cardiovascular Diseases; Coronary Disease; Coronary Heart Disease Risk Reduction; Heart Diseases; Hyperlipoproteinemia; Myocardial Ischemia; ...
  
• Dietary Energy Restriction and Metabolic Aging in Humans
  ClinicalTrials.gov Identifier: NCT00183027 - Completed
  Obesity
  
• Dietary Fat, Plasma Lipids, and Other CHD Risk Factors
  ClinicalTrials.gov Identifier: NCT00005532 - Completed
  Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Heart Diseases
  
• Dietary Fatty Acids, PPAR Activated Genes, and CHD
  ClinicalTrials.gov Identifier: NCT00071019 - Active, not recruiting
  Coronary Disease; Cardiovascular Diseases; Heart Diseases; Myocardial Infarction
  
• Dietary Fiber and Cardiovascular Inflammatory Markers
  ClinicalTrials.gov Identifier: NCT00085800 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Diabetes Mellitus, non-insulin dependent; Hypertension; Obesity; Inflammation
  
• Dietary Fish Protein in Subjects With Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00400036 - Completed
  Insulin Resistance; Type 2 Diabetes
  
• Dietary Intake and Nutrient Status of Children With ADHD
  ClinicalTrials.gov Identifier: NCT00434928 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Dietary Intervention and Exercise Training (DIET) in Moderate to Severe Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00581269 - Active, not recruiting
  Chronic Kidney Disease
  
• Dietary Intervention in Follicular Lymphoma
  ClinicalTrials.gov Identifier: NCT00455416 - Recruiting
  Follicular Lymphoma
  
• Dietary Intervention in Women Who Have Been Treated For Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003787 - Active, not recruiting
  Breast Neoplasms
  
• Dietary Intervention Methods for Clinical Trials
  ClinicalTrials.gov Identifier: NCT00005686 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Dietary Intervention Study for Hypertension (DISH)
  ClinicalTrials.gov Identifier: NCT00000497 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases
  
• Dietary Intervention Study in Children (DISC)
  ClinicalTrials.gov Identifier: NCT00000459 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypercholesterolemia
  
• Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer Patients
  ClinicalTrials.gov Identifier: NCT00433797 - Not yet recruiting
  Prostate Cancer
  
• Dietary Interventions Evaluating Transport of Uric Acid Across the Tubules
  ClinicalTrials.gov Identifier: NCT00474396 - Completed
  Healthy
  
• Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre?
  ClinicalTrials.gov Identifier: NCT00189033 - Completed
  Colonic Diseases, Functional
  
• Dietary Interventions in Type 2 Obese Diabetic Patients in the Community
  ClinicalTrials.gov Identifier: NCT00520182 - Active, not recruiting
  Diabetes Type 2
  
• Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
  ClinicalTrials.gov Identifier: NCT00508456 - Active, not recruiting
  Glioblastoma Multiforme
  
• Dietary Modulation of Gene Expression and Metabolic Pathways in Glucose Metabolism
  ClinicalTrials.gov Identifier: NCT00573781 - Recruiting
  Metabolic Syndrome; Obesity; Impaired Glucose Tolerance; Impaired Fasting Glucose
  
• Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients with Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00069654 - Recruiting
  Coronary Arteriosclerosis
  
• Dietary Patterns and Risk of Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00005514 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Cerebrovascular Disorders; Heart Diseases; Cerebrovascular Accident
  
• Dietary Patterns, Sodium Intake and Blood Pressure (DASH - Sodium)
  ClinicalTrials.gov Identifier: NCT00000608 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases
  
• Dietary Phytoestrogens and Bone Metabolism
  ClinicalTrials.gov Identifier: NCT00010686 - Completed
  Osteoporosis
  
• Dietary Protein and Insulin Sensitivity Study
  ClinicalTrials.gov Identifier: NCT00508937 - Recruiting
  Insulin Resistance; Type 2 Diabetes; Metabolic Syndrome; Cardiovascular Disease; Dyslipidemia
  
• Dietary Quality and Subsequent Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00005423 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Dietary Soy Isoflavones for the Prevention of Cancer
  ClinicalTrials.gov Identifier: NCT00003100 - Active, not recruiting
  general prevention of cancer
  
• Dietary Strategies to Promote Muscle Protein Anabolism in the Elderly
  ClinicalTrials.gov Identifier: NCT00557388 - Not yet recruiting
  Sarcopenia
  
• Dietary Supplementation With Soy Isoflavones in Asthma
  ClinicalTrials.gov Identifier: NCT00277446 - Completed
  Asthma
  
• Dietary Supplements and Personal Energy Tracking Device to Promote and Maintain Healthy Weight
  ClinicalTrials.gov Identifier: NCT00502658 - Recruiting
  Overweight; Obesity
  
• Dietary Supplements for the Treatment of Angelman Syndrome
  ClinicalTrials.gov Identifier: NCT00348933 - Recruiting
  Angelman Syndrome; Nervous System Diseases
  
• Dietary Treatment of Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00343642 - Recruiting
  Crohn's Disease; Inflammatory Bowel Disease
  
• Dietary Treatment of Hyperlipidemia in Women vs. Men
  ClinicalTrials.gov Identifier: NCT00005336 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypercholesterolemia
  
• Dietary Variety Versus Dietary Fat Effects in Energy Intake
  ClinicalTrials.gov Identifier: NCT00285571 - Completed
  Healthy
  
• Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea
  ClinicalTrials.gov Identifier: NCT00002121 - Completed
  Diarrhea; HIV Infections
  
• Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00006397 - Active, not recruiting
  HIV Infections
  
• Differences in 30-Year Trends in Incidence and Survival for Malignant Germ Cell Tumors in Males and Females: A SEER Population-Based Study
  ClinicalTrials.gov Identifier: NCT00322790 - Recruiting
  Cancer
  
• Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity
  ClinicalTrials.gov Identifier: NCT00199745 - Recruiting
  Statin Therapy; Atorvastatin Therapy
  
• Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
  ClinicalTrials.gov Identifier: NCT00102986 - Active, not recruiting
  HIV Infections
  
• Differences in Blood Levels of Nevirapine in HIV-infected Patients in Uganda and the United States
  ClinicalTrials.gov Identifier: NCT00054743 - Active, not recruiting
  HIV Infection
  
• Differences in Brain Processing of First and Second Languages (Korean and English)
  ClinicalTrials.gov Identifier: NCT00016510 - Completed
  Brain Disorder; Healthy
  
• Differences in Genes and Proteins in Active and Controlled Uveitis
  ClinicalTrials.gov Identifier: NCT00357266 - Completed
  Ocular Inflammatory Disease; Uveitis
  
• Differences in Human Germinal Center B Cell Selection Revealed by Analysis of IgVH Gene Hypermutation and Lineage Trees in Inflammatory Bowel Disease
  ClinicalTrials.gov Identifier: NCT00291681 - Active, not recruiting
  Inflammatory Bowel Disease
  
• Differences in the Presentation Outcome and Response to Treatment Between Never- Smokers and Smokers With NSCLC
  ClinicalTrials.gov Identifier: NCT00483015 - Completed
  Smokers
  
• Different Approaches for Delivery of IPT in Pregnancy in Burkina Faso
  ClinicalTrials.gov Identifier: NCT00494416 - Not yet recruiting
  Malaria Parasitaemia; Birth Weight; Anaemia
  
• Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis
  ClinicalTrials.gov Identifier: NCT00362947 - Recruiting
  Thrombophlebitis
  
• Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid with Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen
  ClinicalTrials.gov Identifier: NCT00133159 - Completed
  Type I Hypersensitivity
  
• Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid with Monophosphoryl Lipid a (MPL) in Patients Sensitized to Tree Pollen
  ClinicalTrials.gov Identifier: NCT00118612 - Completed
  Type I Hypersensitivity
  
• Different Doses of Vitamin A and Childhood Morbidity and Mortality
  ClinicalTrials.gov Identifier: NCT00168584 - Completed
  Mortality; Morbidity
  
• Different Doses of Vitamin A Supplementation and Male and Female Morbidity and Mortality
  ClinicalTrials.gov Identifier: NCT00168636 - Active, not recruiting
  Mortality; Morbidity
  
• Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer
  ClinicalTrials.gov Identifier: NCT00301457 - Recruiting
  Breast Cancer
  
• Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00553124 - Recruiting
  Bladder Cancer
  
• Different Protocol of Transarterial Chemoembolization for Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00493402 - Recruiting
  Hepatocellular Carcinoma
  
• Different Regimen of Aprotinine(Trasylol) Administration in Patients Receiving Antiplatelet Therapy With Clopidogrel (Plavix)
  ClinicalTrials.gov Identifier: NCT00257751 - Recruiting
  Coronary Artery Disease
  
• Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients
  ClinicalTrials.gov Identifier: NCT00226447 - Active, not recruiting
  Chronic Hepatitis B
  
• Different Techniques for Insertion of the ProSeal Laryngeal Mask Airway in Patients With Difficult Airway
  ClinicalTrials.gov Identifier: NCT00500916 - Completed
  Difficult Airway; Ventilation
  
• Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00550992 - Recruiting
  Leukemia
  
• Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
  ClinicalTrials.gov Identifier: NCT00000255 - Completed
  Opioid-Related Disorders; Substance-Related Disorders
  
• Differential Adrenoreceptor Mediated Tachyphylaxis and Upregulation
  ClinicalTrials.gov Identifier: NCT00487032 - Not yet recruiting
  Allergic Rhinitis; Tachyphylaxis; Rhinitis Medicamentosa
  
• Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment
  ClinicalTrials.gov Identifier: NCT00451243 - Completed
  Psoriatic Arthritis
  
• Differential Effects of Eszopiclone Versus Ramelteon in Burned Children
  ClinicalTrials.gov Identifier: NCT00539110 - Not yet recruiting
  Sleep; Burns
  
• Differential Gene Expression of Liver Tissue and Blood from Individuals with Chronic Viral Hepatitis
  ClinicalTrials.gov Identifier: NCT00160940 - Recruiting
  Hepatitis C; Hepatitis B; Autoimmune Hepatitis; Liver Cirrhosis, Biliary; Cholangitis, Sclerosing
  
• Differential Metabolic Effects of Statins
  ClinicalTrials.gov Identifier: NCT00546559 - Recruiting
  Hypercholesterolemia
  
• Differential Metabolism of Dietary Fatty Acids
  ClinicalTrials.gov Identifier: NCT00059254 - Completed
  Obesity; Diabetes; Hyperlipidemia
  
• Differentiation Induction in Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00175812 - Recruiting
  Acute Myelogenous Leukemia
  
• Differentiation of Malig. & Ben. Solitary Pulm. Nodules & Prediction of Clin. Outcome Using Perfus. Analysis of DCEMRI
  ClinicalTrials.gov Identifier: NCT00172575 - Recruiting
  Lung Neoplasms
  
• Diffuse Fibrotic Lung Disease
  ClinicalTrials.gov Identifier: NCT00000596 - Completed
  Lung Diseases; Pulmonary Fibrosis; Sarcoidosis
  
• Diffuse Large B Cell Lymphoma of the Adult: Randomisation Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab
  ClinicalTrials.gov Identifier: NCT00561379 - Recruiting
  Lymphoma, Large-Cell, Diffuse
  
• Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
  ClinicalTrials.gov Identifier: NCT00485030 - Recruiting
  In-Stent Restenosis
  
• Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services
  ClinicalTrials.gov Identifier: NCT00203970 - Recruiting
  Thrombosis
  
• Diffusion Tensor Imaging in Autism
  ClinicalTrials.gov Identifier: NCT00382382 - Not yet recruiting
  Autistic Disorder; Human Volunteers
  
• Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis
  ClinicalTrials.gov Identifier: NCT00285324 - Recruiting
  Glioma Tumor Recurrence; Radiation Necrosis; Primary Brain Tumor
  
• Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)
  ClinicalTrials.gov Identifier: NCT00523666 - Recruiting
  Alzheimer's Disease
  
• Diffusion-Tensor MRI and the Evaluation of Perinatal Brain Injury
  ClinicalTrials.gov Identifier: NCT00131859 - Recruiting
  Perinatal brain injury
  
• Diffusionweighted MRI for Lymphnodes in the Axilla
  ClinicalTrials.gov Identifier: NCT00276211 - Recruiting
  Breast Cancer
  
• Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients with Sensitive Small Cell Lung Cancer (SCLC)
  ClinicalTrials.gov Identifier: NCT00080015 - Active, not recruiting
  Small Cell Lung Cancer
  
• Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00204789 - Completed
  Post-Solid Organ Transplant; Skin Neoplasms
  
• Digestive and Nutritional Effects of Probiotics Supplementation in Premature Newborns
  ClinicalTrials.gov Identifier: NCT00290576 - Recruiting
  Duration of Parenteral Nutrition ; Feeding Tolerance, Safety and Growth.
  
• Digital Imaging Aid for Assessment of Cervical Dysplasia
  ClinicalTrials.gov Identifier: NCT00511758 - Recruiting
  Cervical Dysplasia
  
• Digital Mammography, Ultrasound, MRI, and PET Scans in Women With Newly Diagnosed Breast Cancer
  ClinicalTrials.gov Identifier: NCT00194337 - Completed
  Breast Cancer
  
• Digital Photography to Evaluate Dry Eye
  ClinicalTrials.gov Identifier: NCT00073099 - Completed
  Eye Disease
  
• Digital Voice Analysis in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00524979 - Not yet recruiting
  Schizophrenia
  
• Digitalis Investigation Group (DIG)
  ClinicalTrials.gov Identifier: NCT00000476 - Completed
  Arrhythmia; Cardiovascular Diseases; Heart Diseases; Heart Failure, Congestive; Sinus Arrhythmia; Heart Failure
  
• Diindolylmethane in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00392652 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00450229 - Recruiting
  Prostate Cancer
  
• Diindolylmethane in Treating Patients With Abnormal Cervical Cells
  ClinicalTrials.gov Identifier: NCT00462813 - Recruiting
  Cervical Cancer; Precancerous/Nonmalignant Condition
  
• Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00305747 - Recruiting
  Prostate Cancer
  
• Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study
  ClinicalTrials.gov Identifier: NCT00219479 - Recruiting
  Seizures
  
• DILIN's Prospective Study
  ClinicalTrials.gov Identifier: NCT00345930 - Recruiting
  Liver Diseases
  
• DILIPO (DILutIonal HyPOnatremia)
  ClinicalTrials.gov Identifier: NCT00274326 - Completed
  Congestive Heart Failure
  
• Dilute Versus Concentrated Epidural Bupivacaine in Labor
  ClinicalTrials.gov Identifier: NCT00197327 - Completed
  Pain; Labor Complications
  
• Dilutional Coagulopathy in Patients Undergoing Elective Surgery
  ClinicalTrials.gov Identifier: NCT00493272 - Recruiting
  Blood Coagulation Disorder
  
• Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel
  ClinicalTrials.gov Identifier: NCT00003569 - Completed
  female reproductive cancer; Head and Neck Cancer; neurotoxicity; thorax and respiratory cancer
  
• Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003697 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy in Young Patients With Newly Diagnosed Cancer
  ClinicalTrials.gov Identifier: NCT00429702 - Recruiting
  Nausea and Vomiting; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Dipyridamole/Magnesium To Improve Sickle Cell Hydration
  ClinicalTrials.gov Identifier: NCT00276146 - Recruiting
  Anemia, Sickle Cell
  
• Direct Current Brain Polarization in Frontotemporal Dementia
  ClinicalTrials.gov Identifier: NCT00077896 - Completed
  Pick Disease of the Brain
  
• Direct Current Brain Polarization of the Frontal Lobes
  ClinicalTrials.gov Identifier: NCT00424216 - Recruiting
  Healthy
  
• Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00448214 - Recruiting
  Atrial Fibrillation
  
• Direct Injection of Alcohol for the Treatment of Spinal Tumors
  ClinicalTrials.gov Identifier: NCT00001417 - Completed
  Hemangioma; Neoplasm Metastasis; Spinal Neoplasm
  
• Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy
  ClinicalTrials.gov Identifier: NCT00239330 - Completed
  Hypercholesteremia
  
• Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With De Novo Coronary Artery Lesions
  ClinicalTrials.gov Identifier: NCT00371423 - Completed
  Coronary Artery Disease
  
• Direct, Noninvasive Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients
  ClinicalTrials.gov Identifier: NCT00501163 - Not yet recruiting
  Schizophrenia; Cardiovascular Disease
  
• Directly Administered HIV Therapy in Methadone Clinics
  ClinicalTrials.gov Identifier: NCT00279110 - Recruiting
  HIV Infections; Heroin Dependence
  
• Directly Observed Antiretroviral Therapy Among Active Drug Users
  ClinicalTrials.gov Identifier: NCT00367172 - Completed
  HIV/AIDS; Substance Abuse
  
• Directly Observed Therapy for HIV Infected Adolescents
  ClinicalTrials.gov Identifier: NCT00259389 - Active, not recruiting
  HIV Infections
  
• Directly Observed Therapy in High Risk Populations in Newark, NJ
  ClinicalTrials.gov Identifier: NCT00285883 - Completed
  Directly Observed Therapy; HIV Infections
  
• Directly Observed Therapy in HIV Infected Adolescent Focus Groups
  ClinicalTrials.gov Identifier: NCT00079729 - Active, not recruiting
  HIV Infections
  
• Disability Among Adults with Asthma
  ClinicalTrials.gov Identifier: NCT00005440 - Completed
  Asthma; Lung Diseases
  
• Disability and Health Outcomes in COPD
  ClinicalTrials.gov Identifier: NCT00087906 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease; Lung Diseases
  
• Disability of Musculoskeletal Origin in Community-Dwelling Elderly
  ClinicalTrials.gov Identifier: NCT00311103 - Recruiting
  Musculoskeletal Diseases
  
• Disc Prosthesis Versus Multidisciplinary Rehabilitation
  ClinicalTrials.gov Identifier: NCT00394732 - Recruiting
  Chronic Low Back Pain; Degenerative Disc Disease
  
• Disclosing a Cystic Fibrosis Diagnosis to a Dating Partner
  ClinicalTrials.gov Identifier: NCT00485082 - Recruiting
  Cystic Fibrosis
  
• DISCO - Influence of a Simple Information Booklet on the Evolution of Acute Low Back Pain (LBP)
  ClinicalTrials.gov Identifier: NCT00343057 - Completed
  Acute Low Back Pain
  
• Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva
  ClinicalTrials.gov Identifier: NCT00308204 - Terminated
  Discoid Lupus Erthematosus of the Scalp.
  
• Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
  ClinicalTrials.gov Identifier: NCT00433121 - Completed
  Dementia
  
• Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection
  ClinicalTrials.gov Identifier: NCT00050284 - Active, not recruiting
  HIV Infections
  
• Discontinuation Study of BAY 43-9006 in Patients with Advanced Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00079612 - Completed
  Colorectal Neoplasm; Carcinoma, Renal Cell
  
• DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia
  ClinicalTrials.gov Identifier: NCT00241488 - Recruiting
  Hypercholesterolemia
  
• Discovery Elbow Multi-Center Prospective Study
  ClinicalTrials.gov Identifier: NCT00515515 - Recruiting
  Elbow Replacement
  
• Discovery of New Circulating Biomarkers of Coronary Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00430820 - Not yet recruiting
  Coronary Artery Disease; Acute Coronary Syndromes; Myocardial Infarction; Atherosclerosis
  
• DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients.
  ClinicalTrials.gov Identifier: NCT00478933 - Recruiting
  Death, Sudden, Cardiac; Ventricular Fibrillation; Tachycardia; Atrial Fibrillation; Sick Sinus Syndrome
  
• Disease Management and Educational Intervention Outcomes in High-Risk Diabetics
  ClinicalTrials.gov Identifier: NCT00012662 - Completed
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Disease Management for Smoking Cessation
  ClinicalTrials.gov Identifier: NCT00440115 - Active, not recruiting
  Smoking Cessation
  
• Disease Modification in Toxaemia of Pregnancy.
  ClinicalTrials.gov Identifier: NCT00175695 - Recruiting
  Pre-Eclampsia
  
• Disease Modifying Genes in Severe Asthma
  ClinicalTrials.gov Identifier: NCT00212537 - Recruiting
  Asthma
  
• Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00339261 - Completed
  Lupus
  
• Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00454376 - Recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Metastatic Cancer; Neoplastic Syndrome
  
• DISH Data Analysis Study
  ClinicalTrials.gov Identifier: NCT00005464 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Dislocated Stable Distal Both-Bone Forearm Fractures in Children
  ClinicalTrials.gov Identifier: NCT00397852 - Recruiting
  Fracture; Forearm; Distal; Child; Treatment
  
• Dislocated Unstable Distal Both-Bone Forearm Fractures in Children
  ClinicalTrials.gov Identifier: NCT00398268 - Recruiting
  Fracture; Forearm; Distal; Child; Treatment
  
• Disorders of Systemic Glucose Balance
  ClinicalTrials.gov Identifier: NCT00006508 - Completed
  Hypoglycemia
  
• Dispatcher-Assisted Resuscitation Trial (DART)
  ClinicalTrials.gov Identifier: NCT00219687 - Recruiting
  Heart Arrest
  
• Dispensing Overnight Study in Lenses
  ClinicalTrials.gov Identifier: NCT00349856 - Active, not recruiting
  Myopia
  
• Dissection of Differentially Expressed Genes and Pathways in Patients With OSAS Before and After CPAP Treatment
  ClinicalTrials.gov Identifier: NCT00498732 - Recruiting
  Sleep Apnea, Obstructive
  
• Disseminated Endometrial Cancer Cells During Sonohysterography
  ClinicalTrials.gov Identifier: NCT00205023 - Completed
  Endometrial Cancer
  
• Dissemination of Colorectal Cancer Screening to Primary Care Physicians
  ClinicalTrials.gov Identifier: NCT00441311 - Completed
  Colorectal Cancer
  
• Distance Healing in Wound Healing
  ClinicalTrials.gov Identifier: NCT00067717 - Active, not recruiting
  Breast Reconstruction Surgery
  
• Distant Healing for HIV/AIDS
  ClinicalTrials.gov Identifier: NCT00079534 - Completed
  HIV Infections; AIDS
  
• Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada
  ClinicalTrials.gov Identifier: NCT00334750 - Recruiting
  Ocular Hypertension; Glaucoma, Open-Angle
  
• Distribution of Tacrolimus in Skin, Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00534508 - Completed
  Dermatitis, Atopic
  
• Disturbances of Kynurenine Pathway of Trytophan Metabolism in Schizophrenia: A Quantitative RT-PCR Study
  ClinicalTrials.gov Identifier: NCT00573300 - Completed
  Schizophrenia
  
• Disturbed Sleep Model Study.
  ClinicalTrials.gov Identifier: NCT00440323 - Completed
  Insomnia
  
• Disulfiram and Cognitive Behavioral Therapy
  ClinicalTrials.gov Identifier: NCT00350870 - Recruiting
  Cocaine Abuse
  
• Disulfiram for Cocaine Abuse
  ClinicalTrials.gov Identifier: NCT00395850 - Recruiting
  Cocaine Dependence
  
• Disulfiram for Cocaine-Alcohol Abuse - 3
  ClinicalTrials.gov Identifier: NCT00000278 - Completed
  Alcohol-Related Disorders; Cocaine-Related Disorders
  
• Disulfiram for Treating Cocaine Dependence in Individuals Maintained on Methadone
  ClinicalTrials.gov Identifier: NCT00218608 - Completed
  Cocaine-Related Disorders; Opioid-Related Disorders
  
• Disulfiram in Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00256230 - Completed
  Stage IV Melanoma
  
• DITPA, a Thyroid Hormone Analog to Treat Heart Failure
  ClinicalTrials.gov Identifier: NCT00032643 - Recruiting
  Congestive Heart Failure
  
• Diuretic Efficacy of Dexamethasone in Heart Failure
  ClinicalTrials.gov Identifier: NCT00263302 - Suspended
  Heart Failure, Congestive
  
• Diuretic Optimal Strategy Evaluation in Acute Heart Failure
  ClinicalTrials.gov Identifier: NCT00577135 - Not yet recruiting
  Acute Heart Failure
  
• Diuretics In the Management of Essential Hypertension (DIME) Study
  ClinicalTrials.gov Identifier: NCT00131846 - Recruiting
  Thiazide diuretics; Essential Hypertension; Type 2 Diabetes; Randomized clinical trial; Cost-effectiveness
  
• Diuretics, Hypertension, and Arrhythmias Clinical Trial
  ClinicalTrials.gov Identifier: NCT00000525 - Completed
  Cardiovascular Diseases; Death, Sudden, Cardiac; Heart Arrest; Heart Diseases; Hypertension
  
• Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
  ClinicalTrials.gov Identifier: NCT00347802 - Completed
  Glaucoma
  
• Diurnal Intraocular Pressure and Peripapillary Retinal Blood Flow in Medically Controlled Open-Angle Glaucoma
  ClinicalTrials.gov Identifier: NCT00481208 - Completed
  Open-Angle Glaucoma
  
• Diurnal Variation of Plasminogen Activator Inhibitor-1
  ClinicalTrials.gov Identifier: NCT00515021 - Recruiting
  Metabolic Syndrome X
  
• Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00241150 - Completed
  Hypertension; Metabolic Syndrome
  
• Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder
  ClinicalTrials.gov Identifier: NCT00203528 - Completed
  Substance Abuse; Bipolar Depression
  
• Divalproex Sodium ER in Adult Autism
  ClinicalTrials.gov Identifier: NCT00211796 - Recruiting
  Autism
  
• Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)
  ClinicalTrials.gov Identifier: NCT00108576 - Completed
  PTSD
  
• Divalproex Sodium Vs. Placebo in Childhood/Adolescent Autism
  ClinicalTrials.gov Identifier: NCT00211757 - Completed
  Autism
  
• Divalproex vs. Lamotrigine for Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00451542 - Active, not recruiting
  Bipolar Disorder
  
• Divergence of Blood Pressure By Race in Adolescent Girls
  ClinicalTrials.gov Identifier: NCT00005470 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Obesity
  
• DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00077077 - Completed
  unspecified adult solid tumor, protocol specific
  
• DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00080834 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up
  ClinicalTrials.gov Identifier: NCT00444353 - Completed
  Nasolabial Fold Wrinkles
  
• DL6049 vs CosmoPlast in the Treatment of Nasolabial Fold Wrinkles
  ClinicalTrials.gov Identifier: NCT00444210 - Completed
  Nasolabial Fold Wrinkles
  
• DLI for Relapsed (Post Transplant) Leukemia
  ClinicalTrials.gov Identifier: NCT00167167 - Recruiting
  Leukemia, Myeloid, Chronic; AML; MDS; Leukemia, Lymphocytic, Acute
  
• DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function
  ClinicalTrials.gov Identifier: NCT00401687 - Active, not recruiting
  Ventricular Ejection Fraction
  
• DMSO-PDT of BCC - A 6 Year Follow Up
  ClinicalTrials.gov Identifier: NCT00218829 - Completed
  Carcinoma, Basal Cell
  
• DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (ASCENT-2)
  ClinicalTrials.gov Identifier: NCT00273338 - Terminated
  Prostate Cancer
  
• DNA Analysis in Predicting Lung Cancer Risk
  ClinicalTrials.gov Identifier: NCT00559325 - Recruiting
  Lung Cancer
  
• DNA Analysis of Blood and Tissue From Patients With Lung Cancer
  ClinicalTrials.gov Identifier: NCT00471978 - Recruiting
  Lung Cancer
  
• DNA Array Analysis of Patients With Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00512551 - Recruiting
  Cervical Cancer
  
• DNA Changes as a Risk Factor for Barrett's Esophagus in Patients With Barrett's Esophagus, Gastroesophageal Reflux, or Gastrointestinal Bleeding
  ClinicalTrials.gov Identifier: NCT00445653 - Active, not recruiting
  Precancerous/Nonmalignant Condition
  
• DNA Changes That Affect Vitamin D Metabolism in Patients With Colorectal Cancer Receiving Vitamin D Supplements
  ClinicalTrials.gov Identifier: NCT00550563 - Recruiting
  Colorectal Cancer
  
• DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease
  ClinicalTrials.gov Identifier: NCT00264524 - Completed
  Rheumatic Heart Disease
  
• DNA Vaccine for Ragweed Allergic Adults
  ClinicalTrials.gov Identifier: NCT00346086 - Completed
  Seasonal Allergic Rhinitis
  
• dnaJ Peptide for Relieving Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00000435 - Completed
  Rheumatoid Arthritis
  
• DNP-Modified Autologous Tumor Cell Vaccine for Resectable Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00298298 - Recruiting
  Non-Small Cell Lung Cancer - Completely Resectable
  
• Do Antidepressants Induce Metabolic Syndromes METADAP Study
  ClinicalTrials.gov Identifier: NCT00526383 - Recruiting
  Major Depressive Disorder
  
• Do Benzodiazepines Improve the Outcome of Mechanical Physiotherapy for Lumbar Disk Prolapse
  ClinicalTrials.gov Identifier: NCT00533286 - Completed
  Pain; Disability; Paresis
  
• Do Blue-Blocking Lenses Block Blue Colour From Our Lives?
  ClinicalTrials.gov Identifier: NCT00403143 - Recruiting
  Blindness
  
• Do Community Cancer Support Groups Reduce Physiological Stress in Women With Primary Breast Cancer?
  ClinicalTrials.gov Identifier: NCT00186524 - Completed
  Breast Cancer
  
• Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?
  ClinicalTrials.gov Identifier: NCT00492973 - Recruiting
  Osteoarthritis; Post-Traumatic Arthritis
  
• Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?
  ClinicalTrials.gov Identifier: NCT00000473 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia
  
• Do HMG CoA Reductase Inhibitors Affect Abeta Levels?
  ClinicalTrials.gov Identifier: NCT00303277 - Completed
  Alzheimer's Disease; Aging
  
• Do Hostility and Stress Predict Cardiovascular Mortality in MRFIT?
  ClinicalTrials.gov Identifier: NCT00005498 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Depression
  
• Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?
  ClinicalTrials.gov Identifier: NCT00444145 - Recruiting
  Larynx Disease; Gastroesophageal Reflux
  
• Do Nasogastric Tubes After Cardiac Surgery Reduce Nausea and Vomiting
  ClinicalTrials.gov Identifier: NCT00193999 - Recruiting
  Heart Disease
  
• Do Patients with Colorectal Cancer Understand That Their Family is at Risk?
  ClinicalTrials.gov Identifier: NCT00145860 - Terminated
  Colorectal Cancer
  
• Do People With Insomnia Sleep Better After Psychological Treatment?
  ClinicalTrials.gov Identifier: NCT00170391 - Active, not recruiting
  Insomnia
  
• Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?
  ClinicalTrials.gov Identifier: NCT00223522 - Completed
  Schizophrenia; Schizoaffective
  
• Do Skin Markings Reflect the Location of the Surgical Cavity During Daily Radiotherapy Treatment?
  ClinicalTrials.gov Identifier: NCT00578747 - Not yet recruiting
  Breast Cancer
  
• Do Sulphonylureas Preserve Cortical Function During Hypoglycaemia?
  ClinicalTrials.gov Identifier: NCT00472875 - Recruiting
  Type 1 Diabetes Mellitus
  
• Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 2: Do Varenicline (Chantix) and Bupropion (Zyban) Change Alcohol Drinking?
  ClinicalTrials.gov Identifier: NCT00580645 - Recruiting
  Alcohol Drinking
  
• Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00461344 - Terminated
  Carcinoma, Ductal, Breast
  
• Docetaxel , Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00155259 - Completed
  Breast Cancer
  
• Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00362882 - Recruiting
  Lung Cancer
  
• Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck
  ClinicalTrials.gov Identifier: NCT00216138 - Terminated
  Head and Neck Cancer
  
• Docetaxel and Capecitabine in Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00142038 - Completed
  Stomach Neoplasm; Neoplasm Metastasis
  
• Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00054457 - Active, not recruiting
  adenocarcinoma of the stomach; Adenocarcinoma of the Esophagus; stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; ...
  
• Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00354601 - Active, not recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer.
  ClinicalTrials.gov Identifier: NCT00153881 - Recruiting
  Esophageal Neoplasm; Gastro-esophageal Neoplasm; Carcinoma of the Esophagus; Esophageal Cancer
  
• Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix
  ClinicalTrials.gov Identifier: NCT00084890 - Active, not recruiting
  stage IVB cervical cancer; recurrent cervical cancer; cervical squamous cell carcinoma
  
• Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00217568 - Active, not recruiting
  Ovarian Cancer; Peritoneal Cavity Cancer
  
• Docetaxel and Carboplatin in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00138242 - Completed
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005963 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With NSCLC.
  ClinicalTrials.gov Identifier: NCT00430651 - Recruiting
  Non-Small Cell Lung Cancer
  
• Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00068341 - Recruiting
  stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage II breast cancer
  
• Docetaxel and Carboplatin With or Without Zoledronate in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00093717 - Active, not recruiting
  Adenocarcinoma of the Lung; large cell lung cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; ...
  
• Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00281970 - Active, not recruiting
  Lung Cancer
  
• Docetaxel and Cisplatin in Treating Patients with Stage III Or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00118131 - Recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005868 - Active, not recruiting
  stage IIIA non-small cell lung cancer
  
• Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00077311 - Active, not recruiting
  Anemia; Drug Toxicity; Neutropenia; Non-small cell lung cancer
  
• Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer: A Phase II Study
  ClinicalTrials.gov Identifier: NCT00136526 - Completed
  Prostate Cancer
  
• Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
  ClinicalTrials.gov Identifier: NCT00075465 - Active, not recruiting
  adenocarcinoma of the stomach; stage III gastric cancer; stage IV gastric cancer
  
• Docetaxel and Epirubicin in Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00375999 - Recruiting
  Stomach Neoplasms
  
• Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002866 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Neutropenia
  
• Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00087035 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00390429 - Recruiting
  Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00020332 - Completed
  Breast Cancer
  
• Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00331682 - Completed
  Pancreatic Cancer
  
• Docetaxel and Flavopiridol to Treat Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006277 - Completed
  Breast Cancer
  
• Docetaxel and GEM 231 in Treating Patients with Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004864 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00004884 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Docetaxel and Gemcitabine I Hormonal Refractory Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00115635 - Completed
  Prostate Cancer
  
• Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00004223 - Active, not recruiting
  stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; transitional cell carcinoma of the bladder; ...
  
• Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003762 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; Quality of Life
  
• Docetaxel and Gemcitabine with Filgrastim-SD/01 Support in Patients with Advanced Non-Small Cell Lung Carcinoma
  ClinicalTrials.gov Identifier: NCT00050674 - Recruiting
  Non-small cell lung cancer
  
• Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00026078 - Recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008
  ClinicalTrials.gov Identifier: NCT00084825 - Completed
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00080665 - Active, not recruiting
  Male Breast Cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00577356 - Not yet recruiting
  Prostate Cancer
  
• Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach
  ClinicalTrials.gov Identifier: NCT00004235 - Completed
  stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
  
• Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004923 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Docetaxel and Lapatinib With or Without Combination Chemotherapy or Docetaxel and Trastuzumab With Combination Chemotherapy in Treating Women With Locally Advanced, Inflammatory, or Resectable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00450892 - Recruiting
  Breast Cancer
  
• Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00426127 - Recruiting
  Pancreatic Cancer
  
• Docetaxel and Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00356122 - Recruiting
  Non-Small Cell Lung Cancer
  
• Docetaxel and Oxaliplatin in Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00382720 - Recruiting
  Stomach Neoplasms
  
• Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor
  ClinicalTrials.gov Identifier: NCT00004243 - Completed
  unspecified adult solid tumor, protocol specific
  
• Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00075543 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00554918 - Recruiting
  Metastatic Cancer; Prostate Cancer
  
• Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00255606 - Recruiting
  Prostate Cancer
  
• Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00134056 - Recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer; bone metastases
  
• Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00110214 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00527124 - Recruiting
  Prostate Cancer
  
• Docetaxel and Prednisone With or Without OGX-011 in Treating Patients With Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00258388 - Active, not recruiting
  Prostate Cancer
  
• Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
  ClinicalTrials.gov Identifier: NCT00268918 - Active, not recruiting
  Ovarian Cancer; Endometrial Cancer; Cervical Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Breast Cancer
  
• Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx
  ClinicalTrials.gov Identifier: NCT00243113 - Recruiting
  Head and Neck Cancer
  
• Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00452920 - Suspended
  Cervical Cancer
  
• Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00041171 - Suspended
  adult solid tumor; Breast Cancer; Head and Neck Cancer; kidney and urinary cancer; male reproductive cancer; thorax and respiratory cancer
  
• Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00401180 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00114192 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00047255 - Active, not recruiting
  stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006215 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Docetaxel and Vinorelbine Plus Sargramostim in Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00256282 - Recruiting
  Metastatic Melanoma
  
• Docetaxel Based Chemotherapy Plus Or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
  ClinicalTrials.gov Identifier: NCT00117572 - Recruiting
  Cancer of the Pharynx; Cancer of the Larynx; Cancer of the Nasal Cavity; Paranasal Sinus Neoplasms; Cancer of the Oral Cavity
  
• Docetaxel Combined With Estramustine in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003066 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer
  ClinicalTrials.gov Identifier: NCT00212095 - Recruiting
  Metastatic Breast Cancer
  
• Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00376792 - Recruiting
  Prostate Cancer
  
• Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00415285 - Recruiting
  Breast Neoplasms
  
• Docetaxel Followed by CEF (cyclophosphamide, epirubicin and 5-fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (cyclophosphamide, epirubicin and capecitabine) as Adjuvant Treatment for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00114816 - Completed
  Breast Cancer
  
• Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193115 - Active, not recruiting
  Breast Cancer
  
• Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00343512 - Active, not recruiting
  Breast Cancer
  
• Docetaxel in Breast Cancer
  ClinicalTrials.gov Identifier: NCT00312208 - Active, not recruiting
  Breast Cancer
  
• Docetaxel in Combination With Cisplatin-5-Fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00565448 - Recruiting
  Nasopharyngeal Neoplasms; Carcinoma
  
• Docetaxel in Combination with Doxorubicin and Cyclophosphamide (TAC) Versus 5-Fluorouracil in Combination with Doxorubicin and Cyclophosphamide (5 FAC) as Adjuvant Treatment of Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00121992 - Completed
  Breast Neoplasms
  
• Docetaxel in Combination with GVAX ® Vaccine for Prostate Cancer Vs Docetaxel and Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer With Pain
  ClinicalTrials.gov Identifier: NCT00133224 - Recruiting
  Prostate Cancer
  
• Docetaxel in Combination with Iressa in Previously Treated Patients with Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00137761 - Active, not recruiting
  Metastatic pancreatic carcinoma
  
• Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck
  ClinicalTrials.gov Identifier: NCT00459043 - Recruiting
  Squamous Cell Carcinoma of Head and Neck
  
• Docetaxel in Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00261703 - Recruiting
  Head and Neck Neoplasms
  
• Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]
  ClinicalTrials.gov Identifier: NCT00268710 - Completed
  Prostatic Neoplasms
  
• Docetaxel in Locally Advanced Gastric Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00343239 - Recruiting
  Stomach Neoplasms
  
• Docetaxel in Non Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00258739 - Active, not recruiting
  Lung Neoplasms
  
• Docetaxel in Non Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00263016 - Terminated
  Carcinoma, Non-Small-Cell Lung
  
• Docetaxel in Non Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00432315 - Active, not recruiting
  Carcinoma, Squamous Cell
  
• Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)
  ClinicalTrials.gov Identifier: NCT00268671 - Completed
  Head and Neck Neoplasms
  
• Docetaxel in the Treatment of Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00280098 - Active, not recruiting
  Prostatic Neoplasms
  
• Docetaxel in Treating Children With Recurrent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00002825 - Active, not recruiting
  recurrent childhood brain stem glioma; recurrent childhood rhabdomyosarcoma; recurrent neuroblastoma; recurrent childhood ependymoma; ...
  
• Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00021242 - Completed
  recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; childhood acute promyelocytic leukemia (M3)
  
• Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00227708 - Active, not recruiting
  Lung Cancer; Quality of Life
  
• Docetaxel in Treating Older Patients With Metastatic Breast or Lung Cancer
  ClinicalTrials.gov Identifier: NCT00059943 - Completed
  stage IV breast cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer; recurrent breast cancer
  
• Docetaxel in Treating Older Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00025493 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Docetaxel in Treating Older Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00104624 - Active, not recruiting
  Quality of Life; stage IV breast cancer; recurrent breast cancer
  
• Docetaxel in Treating Patients Who Have Undergone Surgery for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00054509 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate
  
• Docetaxel in Treating Patients With Advanced Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00003445 - Completed
  cervical squamous cell carcinoma; stage IIB cervical cancer; stage III cervical cancer; stage IVA cervical cancer
  
• Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer
  ClinicalTrials.gov Identifier: NCT00058448 - Completed
  stage II penile cancer; stage III penile cancer; stage IV penile cancer
  
• Docetaxel in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00008411 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00022022 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Quality of Life
  
• Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00041093 - Active, not recruiting
  recurrent cervical cancer; cervical squamous cell carcinoma
  
• Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
  ClinicalTrials.gov Identifier: NCT00085332 - Completed
  recurrent endometrial cancer; stage III endometrial cancer; stage IV endometrial cancer
  
• Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer
  ClinicalTrials.gov Identifier: NCT00002903 - Active, not recruiting
  recurrent testicular cancer; recurrent ovarian germ cell tumor; testicular seminoma; extragonadal germ cell tumor
  
• Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00004037 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage IV ovarian epithelial cancer
  
• Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
  ClinicalTrials.gov Identifier: NCT00287885 - Active, not recruiting
  Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer; Sarcoma; Vaginal Cancer; Vulvar Cancer
  
• Docetaxel in Treating Patients With Relapsed Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00482274 - Recruiting
  Prostate Cancer
  
• Docetaxel in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003565 - Active, not recruiting
  adult solid tumor; Breast Cancer; Head and Neck Cancer; kidney and urinary cancer; thorax and respiratory cancer
  
• Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function
  ClinicalTrials.gov Identifier: NCT00002901 - Completed
  Lung Cancer; lip and oral cavity cancer; Head and Neck Cancer; ovarian sarcoma; ovarian epithelial cancer; Oropharyngeal Cancer; Breast Cancer
  
• Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005096 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate
  
• Docetaxel in Treating Patients With Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003781 - Active, not recruiting
  Pain; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00004081 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006120 - Active, not recruiting
  stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer
  
• Docetaxel or Pemetrexed with or without Cetuximab in Patients with Recurrent or Progressive Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00095199 - Recruiting
  Non-Small-Cell Lung Cancer
  
• Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00151047 - Active, not recruiting
  Prostate Cancer
  
• Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00003864 - Completed
  stage III esophageal cancer; stage IV esophageal cancer; squamous cell carcinoma of the esophagus
  
• Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003908 - Completed
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; metastatic squamous neck cancer with occult primary squamous cell carcinoma; ...
  
• Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003560 - Active, not recruiting
  Endometrial Cancer; Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003562 - Active, not recruiting
  stage IV non-small cell lung cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; Adenocarcinoma of the Lung; ...
  
• Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Docetaxel for NSCLC
  ClinicalTrials.gov Identifier: NCT00173888 - Recruiting
  Non-Small Cell Lung Cancer
  
• Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002775 - Active, not recruiting
  adenocarcinoma of the prostate; Quality of Life; stage IV prostate cancer; recurrent prostate cancer
  
• Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00079170 - Completed
  Breast Cancer
  
• Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193180 - Recruiting
  Breast Cancer
  
• Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer
  ClinicalTrials.gov Identifier: NCT00191243 - Active, not recruiting
  Breast Cancer
  
• Docetaxel with Either Cetuximab Or Bortezomib As First-Line Therapy in Treating Patients with Stage III Or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00118183 - Active, not recruiting
  Non-small cell lung cancer
  
• Docetaxel With or Without Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00217672 - Active, not recruiting
  Breast Cancer
  
• Docetaxel With or Without Bevacizumab Followed by Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00027885 - Active, not recruiting
  stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
  
• Docetaxel with Or Without Dimethylxanthenone Acetic Acid (AS1404) in Treating Patients with Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00119275 - Recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Docetaxel With or Without Exisulind in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00036322 - No longer recruiting
  Non-small cell lung cancer
  
• Docetaxel With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00088907 - Recruiting
  Head and Neck Cancer
  
• Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00080678 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients with Unresectable Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00040885 - Active, not recruiting
  Anorexia; Cachexia; Fatigue; Non-small cell lung cancer
  
• Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate
  ClinicalTrials.gov Identifier: NCT00085228 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00030641 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00303888 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00103389 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00020046 - Completed
  Stage IV Prostate Cancer; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer
  
• Docetaxel With or Without Vaccine Therapy and GM-CSF in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00217750 - Recruiting
  Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
  
• Docetaxel With or Without Vandetanib in Treating Patients With Previously Treated Stage IV Transitional Cell Cancer
  ClinicalTrials.gov Identifier: NCT00378794 - Recruiting
  Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter
  
• Docetaxel+Oxali+Cetux Met Gastric/GEJ
  ClinicalTrials.gov Identifier: NCT00517829 - Recruiting
  Metastatic Gastric or GEJ Cancer
  
• Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients
  ClinicalTrials.gov Identifier: NCT00526110 - Recruiting
  Gastrointestinal Diseases
  
• Docetaxel, Androgen Ablation Therapy, and External-Beam Radiation Therapy in Treating Patients With High-Risk Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00225420 - Recruiting
  Prostate Cancer
  
• Docetaxel, Bevacizumab, Thalidomide, and Prednisone in Treating Patients With Metastatic Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00091364 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00088998 - Active, not recruiting
  Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
  
• Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084734 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00293332 - Active, not recruiting
  Lung Cancer
  
• Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery
  ClinicalTrials.gov Identifier: NCT00251329 - Active, not recruiting
  Breast Cancer
  
• Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00107510 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
  
• Docetaxel, Carboplatin, Radiotherapy, Surgical Resection in Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00238615 - Recruiting
  Non-Small Cell Lung Cancer
  
• Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00226239 - Active, not recruiting
  Cancer
  
• Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00288054 - Recruiting
  Lung Cancer
  
• Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004264 - Active, not recruiting
  Drug Toxicity; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00238407 - Recruiting
  Esophageal Cancer
  
• Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00394433 - Recruiting
  Esophageal Cancer; Stomach Cancer
  
• Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer
  ClinicalTrials.gov Identifier: NCT00544765 - Active, not recruiting
  Breast Cancer
  
• Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00074139 - Active, not recruiting
  stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
  
• Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004175 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer
  
• Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00416533 - Completed
  Prostate Cancer
  
• Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00398489 - Recruiting
  Breast Cancer
  
• Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment
  ClinicalTrials.gov Identifier: NCT00165399 - Active, not recruiting
  Adenocarcinoma of the Prostate; Prostate Cancer
  
• Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00052845 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate
  ClinicalTrials.gov Identifier: NCT00083005 - Active, not recruiting
  Prostate Cancer
  
• Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00046826 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
  ClinicalTrials.gov Identifier: NCT00101127 - Active, not recruiting
  recurrent uterine sarcoma; stage III uterine sarcoma; stage IV uterine sarcoma; uterine leiomyosarcoma
  
• Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00264134 - Terminated
  Non-Small Cell Lung Cancer; Extensive Stage Unresectable
  
• Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00525005 - Recruiting
  Stomach Neoplasms
  
• Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00293371 - Active, not recruiting
  Prostate Cancer
  
• Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00099086 - Recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00348816 - Recruiting
  Prostate Cancer
  
• Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00089609 - Recruiting
  Prostatic Neoplasms
  
• Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00569673 - Not yet recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193089 - Active, not recruiting
  Breast Cancer
  
• Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00015938 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• DOCICAR: Cardiac Dysfunction in Cirrhosis
  ClinicalTrials.gov Identifier: NCT00250315 - Completed
  Cirrhosis; Cirrhotic Cardiomyopathy
  
• Docosahexaenoic Acid in the Treatment of Autism
  ClinicalTrials.gov Identifier: NCT00577447 - Completed
  Autistic Disorder
  
• Doctor-Patient Communication in Spanish
  ClinicalTrials.gov Identifier: NCT00187785 - Terminated
  Upper Respiratory Infection; Hypertension; Diabetes
  
• Doctoral CRP On Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients
  ClinicalTrials.gov Identifier: NCT00122746 - Recruiting
  Cancer of the Cervix
  
• Documented Candida or Aspergillus Infections in Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00082524 - Active, not recruiting
  Aspergillosis; Candidiasis
  
• Documenting a Learning Curve and Test-Retest Reliability of a Virtual Reality Training Simulator in Laparoscopic Surgery
  ClinicalTrials.gov Identifier: NCT00435630 - Completed
  Education
  
• Does a Low Volume Ultrasound-Guided Technique Reduce Common Complications of Interscalene Brachial Plexus Block?
  ClinicalTrials.gov Identifier: NCT00497354 - Not yet recruiting
  Pain After Shoulder Surgery
  
• Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?
  ClinicalTrials.gov Identifier: NCT00360282 - Recruiting
  Migraine
  
• Does a Nitrofurazone Coated Bladder Catheter Reduce the Number of Urinary Tract Infections in Trauma
  ClinicalTrials.gov Identifier: NCT00192985 - Active, not recruiting
  Trauma; Urinary Tract Infections
  
• Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer?
  ClinicalTrials.gov Identifier: NCT00186602 - Active, not recruiting
  Breast Cancer
  
• Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?
  ClinicalTrials.gov Identifier: NCT00457405 - Active, not recruiting
  Ischemia-Reperfusion Injury; Atherosclerosis
  
• Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?
  ClinicalTrials.gov Identifier: NCT00486902 - Recruiting
  Cesarean Section; Ketamine; Spinal Anesthesia
  
• Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma
  ClinicalTrials.gov Identifier: NCT00307606 - Recruiting
  Breast Neoplasms; Mastectomy
  
• Does a Web-Based Personalized Health Care Program Improve Diabetes Control?
  ClinicalTrials.gov Identifier: NCT00542204 - Not yet recruiting
  Diabetes Mellitus
  
• Does Access to an EHR Patient Portal Influence Chronic Disease Outcomes?
  ClinicalTrials.gov Identifier: NCT00147706 - Recruiting
  Congestive Heart Failure; Diabetes; Cardiovascular Disease
  
• Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients?
  ClinicalTrials.gov Identifier: NCT00220688 - Completed
  Cancer
  
• Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? Formal Study
  ClinicalTrials.gov Identifier: NCT00550251 - Not yet recruiting
  Nausea; Vomiting
  
• Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?
  ClinicalTrials.gov Identifier: NCT00553722 - Not yet recruiting
  Hypertension; Dialysis; Hyperaldosteronism
  
• Does An Abnormal PFA 100 Predict Bleeding After Renal Biopsy?
  ClinicalTrials.gov Identifier: NCT00334204 - Recruiting
  Kidney Failure, Acute; Kidney Failure, Chronic; Blood Platelet Disorders; Hemorrhage
  
• Does Antenatal Fetal Head Circumference Predict Anal Sphincter Injury, a Prospective Study
  ClinicalTrials.gov Identifier: NCT00580879 - Recruiting
  Anorectal Sphincter Laceration; Pelvic Floor Dysfunction
  
• Does Ascorbic Acid Reduce Sympathoexcitation in CHF?
  ClinicalTrials.gov Identifier: NCT00550121 - Recruiting
  Heart Failure
  
• Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?
  ClinicalTrials.gov Identifier: NCT00578760 - Not yet recruiting
  Hearing Loss; Ototoxicity
  
• Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?
  ClinicalTrials.gov Identifier: NCT00441597 - Completed
  Ischemia Reperfusion Injury; Cardiovascular Disease
  
• Does Bipolar Disease Program (BDP) intervention improve long term manic and depressive symptoms.
  ClinicalTrials.gov Identifier: NCT00007761 - Completed
  Bipolar Disorder
  
• Does Block Play Improve Language Acquisition: A Randomized Trial
  ClinicalTrials.gov Identifier: NCT00428376 - Active, not recruiting
  Healthy
  
• Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?
  ClinicalTrials.gov Identifier: NCT00205166 - Recruiting
  Coronary Artery Disease
  
• Does Caffeine Help Children With Obstructive Sleep Apnea Recover Faster From Anesthesia and With Less Complication After Tonsillectomy and Adenoidectomy?
  ClinicalTrials.gov Identifier: NCT00273754 - Recruiting
  Sleep Apnea, Obstructive; Tonsillectomy and Adenoidectomy; Postoperative Complications
  
• Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?
  ClinicalTrials.gov Identifier: NCT00430170 - Completed
  Cardiovascular Disease; Ischemia-Reperfusion Injury
  
• Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?
  ClinicalTrials.gov Identifier: NCT00457652 - Recruiting
  Ischemia Reperfusion Injury
  
• Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?
  ClinicalTrials.gov Identifier: NCT00166348 - Recruiting
  Brain Injuries
  
• Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?
  ClinicalTrials.gov Identifier: NCT00186264 - Active, not recruiting
  Depressive Disorder, Major
  
• Does DHEA Enhance the Effects of Exercise in Postmenopausal Women?
  ClinicalTrials.gov Identifier: NCT00434915 - Completed
  Aging
  
• Does Doing Pelvic Floor Exercise Ease Symptoms for Women Living with Prolapse?
  ClinicalTrials.gov Identifier: NCT00158626 - Completed
  Uterine Prolapse
  
• Does Early Ambulation After Hip Fracture Surgery Accelerate Recovery?
  ClinicalTrials.gov Identifier: NCT00224367 - Completed
  Fractured Hip
  
• Does Erythropoietin Improve Outcome in Very Preterm Infants?
  ClinicalTrials.gov Identifier: NCT00413946 - Recruiting
  Intracranial Hemorrhage; Periventricular Leukomalacia; Postnatal Development; Cerebral Palsy
  
• Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic Protoporphyria
  ClinicalTrials.gov Identifier: NCT00206869 - Recruiting
  Erythropoietic Protoporphyria
  
• Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?
  ClinicalTrials.gov Identifier: NCT00125775 - Recruiting
  Peritoneal Dialysis
  
• Does Fetal Fibronectin and Ultrasound Cervical Length Help in the Evaluation of Women With Suspected Preterm Labor?
  ClinicalTrials.gov Identifier: NCT00371046 - Completed
  Preterm Birth
  
• Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?
  ClinicalTrials.gov Identifier: NCT00208897 - Active, not recruiting
  Major Depressive Disorder
  
• Does Gloved Medical Personnel Scratch Less Often?
  ClinicalTrials.gov Identifier: NCT00425048 - Completed
  Hygiene; Equipment Contamination; Health Education
  
• Does Glyceryl Nitrate Prevent Post-Endoscopic Retrograde Cholangiopancreaticography (ERCP) Pancreatitis?
  ClinicalTrials.gov Identifier: NCT00121901 - Completed
  Pancreatitis
  
• Does Heme Oxygenase-1 Induction Ameliorate Cardiac Injury After Myocardial Infarction?
  ClinicalTrials.gov Identifier: NCT00483587 - Recruiting
  Acute Myocardial Infarction
  
• Does Immobilization of the Shoulder in External Rotation Reduce the Recurrence Rate of Shoulder Dislocation?
  ClinicalTrials.gov Identifier: NCT00202735 - Recruiting
  Shoulder Dislocation
  
• Does Implant Design Improve Postoperative Flexion?
  ClinicalTrials.gov Identifier: NCT00380861 - Recruiting
  Arthritis
  
• Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department?
  ClinicalTrials.gov Identifier: NCT00583648 - Not yet recruiting
  Urinary Tract Infections
  
• Does Improving Insulation and Heating Improve Health?
  ClinicalTrials.gov Identifier: NCT00489762 - Completed
  Asthma
  
• Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00207363 - Active, not recruiting
  Hepatitis C
  
• Does Inhaled Busedonide or Fluticasone Impair Adrenal Function?
  ClinicalTrials.gov Identifier: NCT00560625 - Recruiting
  Adrenal Insufficency
  
• Does Intensive Task Specific Training Improve Balance After Acute Stroke?
  ClinicalTrials.gov Identifier: NCT00184431 - Recruiting
  Cerebrovascular Accident
  
• Does Intravitreal Injection of Triamcinolone Acetonide Impairs the Adrenal Function
  ClinicalTrials.gov Identifier: NCT00561236 - Recruiting
  Secondary Adrenal Insuffisency
  
• Does Islet Transplantation Eliminate Hypoglycemia?
  ClinicalTrials.gov Identifier: NCT00006068 - Not yet recruiting
  Diabetes Mellitus
  
• Does it Make Sense to Give Postoperative Antibiotics to Patients With an Uncomplicated Acute Cholecystitis
  ClinicalTrials.gov Identifier: NCT00323648 - Recruiting
  Uncomplicated Acute Cholecystitis
  
• Does Lead Burden alter Neuropsychological Development?
  ClinicalTrials.gov Identifier: NCT00000104 - Completed
  Lead Poisoning
  
• Does Lung Impedance Correlate With Changes in BNP in Stable and Acutely Decompensated Heart Failure Patients?
  ClinicalTrials.gov Identifier: NCT00560339 - Recruiting
  Congestive Heart Failure
  
• Does Menopause Matter?
  ClinicalTrials.gov Identifier: NCT00097994 - Active, not recruiting
  Menopause; Quality of Life
  
• Does Metabolic Syndrome Exist in Anorexia Nervosa?
  ClinicalTrials.gov Identifier: NCT00271921 - Recruiting
  Anorexia Nervosa; Metabolic Syndrome
  
• Does Mid-Gestation Placental Function Assessment Reduce Psychological Distress in Women With High-Risk Pregnancies?
  ClinicalTrials.gov Identifier: NCT00546026 - Not yet recruiting
  High-Risk Pregnancy
  
• Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?
  ClinicalTrials.gov Identifier: NCT00420160 - Not yet recruiting
  Lung Cancer; Heart Disease; COPD
  
• Does Montelukast Have an Affect on the Function of the Artery in Patients With Heart Disease
  ClinicalTrials.gov Identifier: NCT00351364 - Recruiting
  Coronary Artery Disease; Acute Coronary Syndrome
  
• Does Omeprazole Decrease Intestinal Calcium Absorption?
  ClinicalTrials.gov Identifier: NCT00582972 - Not yet recruiting
  Osteoporosis; Achlorhydria; GERD; Hip Fracture
  
• Does Optimal Control of Pre-Operative Chronic and Acute Pain Predict Improved Function After Orthopedic Surgery?
  ClinicalTrials.gov Identifier: NCT00581685 - Not yet recruiting
  Osteoarthritis
  
• Does Oral Magnesium Substitution Relieve Pregnancy Induced Leg Cramps ?
  ClinicalTrials.gov Identifier: NCT00525317 - Completed
  Leg Cramps
  
• Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery?
  ClinicalTrials.gov Identifier: NCT00334490 - Recruiting
  Pulmonary Hypertension
  
• Does PEP Compensate the Reduction of Tidal Volume During One Lung Ventilation?
  ClinicalTrials.gov Identifier: NCT00534690 - Recruiting
  Lung Neoplasms; Pulmonary Disease
  
• Does Progesterone Prevent Very Preterm Delivery in Twin Pregnancies?
  ClinicalTrials.gov Identifier: NCT00329914 - Recruiting
  Preterm Delivery
  
• Does prophylactic coronary artery revascularization for high risk patients reduce long-term risk of mortality
  ClinicalTrials.gov Identifier: NCT00032370 - Completed
  Cardiovascular Disease
  
• Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?
  ClinicalTrials.gov Identifier: NCT00534261 - Completed
  Relapsing Remitting Multiple Sclerosis
  
• Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in Endogenous Subclinical Hyperthyroidism?
  ClinicalTrials.gov Identifier: NCT00151723 - Recruiting
  endogenous subclinical hyperthyroidism
  
• Does Reducing Spasticity Permit an Increase in Strength?
  ClinicalTrials.gov Identifier: NCT00255073 - Completed
  Spastic Diplegic Cerebral Palsy
  
• Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?
  ClinicalTrials.gov Identifier: NCT00571688 - Recruiting
  Bipolar Disorder
  
• Does Routine Screening for Intimate Partner Violence Against Women in Health Care Settings do More Good Than Harm?
  ClinicalTrials.gov Identifier: NCT00182468 - Active, not recruiting
  Wife Abuse
  
• Does Scar Massage Improve Postoperative Pain and Function in Women With Breast Cancer?
  ClinicalTrials.gov Identifier: NCT00175344 - Active, not recruiting
  Breast Cancer
  
• Does Shared Decision-Making Improve Adherence in Asthma
  ClinicalTrials.gov Identifier: NCT00217945 - Active, not recruiting
  Lung Diseases; Asthma
  
• Does Shared Decision-Making Improve Asthma Outcomes?
  ClinicalTrials.gov Identifier: NCT00149526 - Active, not recruiting
  Asthma
  
• Does Sildenafil Protect Against Pulmonary Related Complications Following Cardiopulmonary Bypass?
  ClinicalTrials.gov Identifier: NCT00350441 - Recruiting
  Cardiopulmonary Bypass
  
• Does Spiritual/Religious Commitment Mediate the Relationship Between Mood Variability and Suicidal Ideation.
  ClinicalTrials.gov Identifier: NCT00225459 - Active, not recruiting
  Anxiety Disorder; Mood Disorder
  
• Does Splinting Prevent Contractures Following Stroke?
  ClinicalTrials.gov Identifier: NCT00286702 - Completed
  Cerebrovascular Accident
  
• Does Static Ultrasound-Preview Reduce the Incidence of Difficult Lumbar Puncture?
  ClinicalTrials.gov Identifier: NCT00317382 - Recruiting
  Headache; Meningitis; Subarachnoid Hemorrhage
  
• Does Statin Initiation Undermine Dietary Behavior?
  ClinicalTrials.gov Identifier: NCT00224159 - Completed
  All English Speaking Adults From the Manhattan VA Clinic Who Have Recently Received Their First Prescription for a Statin
  
• Does Statin Therapy Reduce Sympathoexcitation in Hypertension?
  ClinicalTrials.gov Identifier: NCT00497016 - Recruiting
  Hypertension
  
• Does Sunbed Radiation With Mainly UVA Provoke Cutaneous Vitamin D Synthesis in Humans?
  ClinicalTrials.gov Identifier: NCT00516867 - Completed
  Healthy
  
• Does Telephone Follow-up Improve Patients Satisfaction
  ClinicalTrials.gov Identifier: NCT00192738 - Completed
  Congestive Heart Failure; Angina Pectoris; Pneumonia; Urinary Tract Infection
  
• Does Tension-Free Herniorrhaphy or Laparoscopic Herniorrhaphy Achieve Equal or Better Recurrence Rates and Lower Costs While Achieving Equivalent Outcomes for Hernia Patients?
  ClinicalTrials.gov Identifier: NCT00032448 - Completed
  Hernia
  
• Does Testosterone Improve Function in Hypogonadal Older Men
  ClinicalTrials.gov Identifier: NCT00304213 - Recruiting
  Hypogonadism
  
• Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?
  ClinicalTrials.gov Identifier: NCT00306475 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Does the Message Matter? Enhancing Adherence in Healthcare Through Persuasive Messages
  ClinicalTrials.gov Identifier: NCT00178737 - Completed
  Diabetes Mellitus
  
• Does the Optic Disc Grading Done Visually by Your Doctor Agree With Optic Nerve Testing Which is Done by Machines?
  ClinicalTrials.gov Identifier: NCT00430287 - Recruiting
  Open Angle Glaucoma
  
• Does the Order in Which Vaccines Are Administered Affect Pain Response?
  ClinicalTrials.gov Identifier: NCT00390130 - Active, not recruiting
  Pain
  
• Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section?
  ClinicalTrials.gov Identifier: NCT00257803 - Recruiting
  Postpartum Hemorrhage
  
• Does the reduction of Total Body Iron Storage (TBIS) alter mortality in a population of patients with advanced PVD.
  ClinicalTrials.gov Identifier: NCT00032357 - Active, not recruiting
  Reduction of Total Body Iron Storage(TBIS); Atherosclerosis; Intermittent Claudication
  
• Does the Relaxation Response Inhibit Acute Stress?
  ClinicalTrials.gov Identifier: NCT00179595 - Recruiting
  Healthy
  
• Does the Threat of an Aversive Reaction Affect Craving of Alcohol During Cue Exposure in Alcohol Dependent Patients?
  ClinicalTrials.gov Identifier: NCT00372749 - Recruiting
  Alcohol Dependence
  
• Does the Use of a Moisture Chamber Decrease the Incidence of Corneal Abrasions in Critically Ill Pediatric Patients?
  ClinicalTrials.gov Identifier: NCT00129077 - Completed
  Corneal abrasions
  
• Does Thinning the Blood During Surgery Prevent Blood Clots Following Total Knee Replacement Surgery
  ClinicalTrials.gov Identifier: NCT00253851 - Recruiting
  DVT; Osteoarthritis
  
• Does Topical Steroid Treatment Impair the Adrenal Function?
  ClinicalTrials.gov Identifier: NCT00476489 - Recruiting
  Hypothalamus-Pituitary-Adrenal Axis Assessement; Topical Steroid Therapy in Chronic Skin Diseases
  
• Does Topiramate Adjust the Excitability of the Brain in Migraine Sufferers?
  ClinicalTrials.gov Identifier: NCT00286923 - Not yet recruiting
  Migraine; Chronic Headache
  
• Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery?
  ClinicalTrials.gov Identifier: NCT00147862 - Completed
  Head and Neck Neoplasms
  
• Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
  ClinicalTrials.gov Identifier: NCT00581828 - Active, not recruiting
  Osteoporosis; Osteopenia; Vitamin D Deficiency; Hypoparathyroidism; Hypercalciuria; Hypercalcemia
  
• Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy
  ClinicalTrials.gov Identifier: NCT00409227 - Recruiting
  Urolithiasis; Nephrolithiasis; Ureterolithiasis
  
• Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children?
  ClinicalTrials.gov Identifier: NCT00348166 - Recruiting
  Refractive Error - Myopia
  
• Does Using LMA Instead of an ET Tube Affect the Incidence of Postoperative Vomiting in Children Undergoing Strabismus Correction?
  ClinicalTrials.gov Identifier: NCT00338559 - Recruiting
  Strabismus
  
• Dolastatin 10 in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003914 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00005579 - Completed
  adult non-Hodgkin's lymphoma
  
• Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00003557 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; cholangiocarcinoma of the gallbladder; ...
  
• Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003677 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00003626 - Completed
  stage IV prostate cancer; recurrent prostate cancer
  
• Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00003778 - Completed
  stage IVB adult soft tissue sarcoma; recurrent uterine sarcoma; recurrent adult soft tissue sarcoma; stage IV uterine sarcoma; ...
  
• Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003693 - Active, not recruiting
  Previously Treated Myelodysplastic Syndrome; recurrent adult acute myeloid leukemia; refractory anemia with excess blasts in transformation; ...
  
• Domestic Violence Enhanced Home Visitation Program (DOVE)
  ClinicalTrials.gov Identifier: NCT00465556 - Recruiting
  Intimate Partner Violence
  
• DOMME Dose Optimization Multicentric Mexican Evaluation
  ClinicalTrials.gov Identifier: NCT00488527 - Recruiting
  Diabetes Mellitus, Type 2
  
• Domperidone as a Treatment for Dopamine Agonist-Induced Peripheral Edema in Patients With Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00305331 - Recruiting
  Parkinson's Disease; Peripheral Edema
  
• Domperidone for Gastroparesis in Solid Organ Transplantation
  ClinicalTrials.gov Identifier: NCT00552422 - Recruiting
  Gastroparesis; Gastroesophageal Reflux
  
• Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00408525 - Recruiting
  Alzheimer's Disease
  
• Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006349 - Completed
  extensive stage small cell lung cancer; limited stage small cell lung cancer; Depression; Delirium; Recurrent Small Cell Lung Cancer; ...
  
• Donepezil Double Blind Trial for ECT Memory Disfunction
  ClinicalTrials.gov Identifier: NCT00465283 - Not yet recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
  
• Donepezil HCl in the Treatment of Subjects with Cognitive Impairment Associated Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
  ClinicalTrials.gov Identifier: NCT00103948 - Completed
  CADASIL
  
• Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease
  ClinicalTrials.gov Identifier: NCT00165737 - Completed
  Dementia, Vascular
  
• Donepezil in Chronic Poststroke Aphasia: a Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00196690 - Completed
  Stroke; Aphasia
  
• Donepezil in Preventing Delirium in Hospitalized Elderly
  ClinicalTrials.gov Identifier: NCT00182884 - Completed
  Postoperative Complications; Delirium
  
• Donepezil in the Prevention of Post-Operative Cognitive Decline
  ClinicalTrials.gov Identifier: NCT00182845 - Completed
  Postoperative Complications; Delirium
  
• Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
  ClinicalTrials.gov Identifier: NCT00369785 - Recruiting
  Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Fatigue; Psychosocial Effects/Treatment; Radiation Toxicity
  
• Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain
  ClinicalTrials.gov Identifier: NCT00452868 - Recruiting
  Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Long-Term Effects Secondary to Cancer Therapy in Children; Neurotoxicity; Psychosocial Effects/Treatment; Radiation Toxicity
  
• Donepezil or EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases
  ClinicalTrials.gov Identifier: NCT00070161 - Completed
  adult brain tumor; brain metastases; radiation toxicity
  
• Donepezil to Treat Dementia in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00030979 - Completed
  Parkinson Disease
  
• Donepezil Treatment of Psychotic Symptoms in Dementia Patients
  ClinicalTrials.gov Identifier: NCT00190021 - Not yet recruiting
  Dementia of Alzheimer type
  
• Donor Bone Marrow Transplant in Treating Young Patients with Cancer Or a Non-Cancerous Disease
  ClinicalTrials.gov Identifier: NCT00118326 - Active, not recruiting
  Wilms'' tumor and other childhood kidney tumors; childhood Hodgkin''s lymphoma; childhood non-Hodgkin''s lymphoma; childhood rhabdomyosarcoma; Leukemia; ...
  
• Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases
  ClinicalTrials.gov Identifier: NCT00450450 - Not yet recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003960 - Active, not recruiting
  untreated adult acute myeloid leukemia; chronic phase chronic myelogenous leukemia; Previously Treated Myelodysplastic Syndrome; ...
  
• Donor Bone Marrow Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
  ClinicalTrials.gov Identifier: NCT00005622 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ...
  
• Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant
  ClinicalTrials.gov Identifier: NCT00476177 - Active, not recruiting
  Hematologic Malignancy
  
• Donor Dopamine and Initial Graft Function
  ClinicalTrials.gov Identifier: NCT00115115 - Recruiting
  Kidney Transplantation; ESRD
  
• Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Allogeneic Transplantation
  ClinicalTrials.gov Identifier: NCT00068718 - Recruiting
  Cancer; Graft Versus Host Disease
  
• Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00534118 - Recruiting
  Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00004878 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Graft Versus Host Disease; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00361049 - Recruiting
  Cancer
  
• Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00569283 - Recruiting
  Cancer
  
• Donor Natural Killer Cell Infusion in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00303667 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
  ClinicalTrials.gov Identifier: NCT00398346 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Secondary Myelofibrosis; Small Intestine Cancer
  
• Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00262886 - Recruiting
  Kidney Cancer
  
• Donor Peripheral Stem Cell Transplant After Fludarabine and Cyclophosphamide in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00376805 - Recruiting
  Breast Cancer
  
• Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
  ClinicalTrials.gov Identifier: NCT00450983 - Recruiting
  Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes
  
• Donor Peripheral Stem Cell Transplant in Treating Older Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00025662 - Active, not recruiting
  Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
  ClinicalTrials.gov Identifier: NCT00544115 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Precancerous/Nonmalignant Condition
  
• Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00281775 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00274846 - Recruiting
  Leukemia
  
• Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00031655 - Active, not recruiting
  adult acute lymphoblastic leukemia in remission; childhood acute lymphoblastic leukemia in remission
  
• Donor Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
  ClinicalTrials.gov Identifier: NCT00049634 - Recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ...
  
• Donor Recipient Kidney Function following Open Surgical vs. Laparoscopic Kidney Donation
  ClinicalTrials.gov Identifier: NCT00100516 - Active, not recruiting
  Kidney Transplantation
  
• Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease
  ClinicalTrials.gov Identifier: NCT00521430 - Recruiting
  Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Precancerous/Nonmalignant Condition; Unspecified Adult Solid Tumor, Protocol Specific
  
• Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00301860 - Recruiting
  Leukemia; Lymphoma
  
• Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00296023 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
  ClinicalTrials.gov Identifier: NCT00101140 - Not yet recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
  
• Donor Stem Cell Transplant in Treating Patients With Fanconi's Anemia
  ClinicalTrials.gov Identifier: NCT00453388 - Recruiting
  Fanconi Anemia; Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes
  
• Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
  ClinicalTrials.gov Identifier: NCT00453206 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00295997 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
  ClinicalTrials.gov Identifier: NCT00392782 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
  ClinicalTrials.gov Identifier: NCT00295971 - Recruiting
  Congenital Amegakaryocytic Thrombocytopenia; Leukemia; Myelodysplastic Syndromes; Severe Congenital Neutropenia
  
• Donor Stem Cell Transplant in Treating Young Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00553202 - Not yet recruiting
  Leukemia
  
• Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00112645 - Recruiting
  unspecified childhood solid tumor, protocol specific
  
• Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00281879 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Unusual Cancers of Childhood
  
• Donor Stem Cell Transplantation for Congenital Immunodeficiencies
  ClinicalTrials.gov Identifier: NCT00426517 - Recruiting
  MUD Transplant; AlloPBSC; Congenital Immunodeficiencies; HLA Matched Transplant; BMT
  
• Donor Stem Cell Transplantation for the Treatment of Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00497952 - Recruiting
  Multiple Sclerosis
  
• Donor Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00054327 - Recruiting
  childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases
  
• Donor Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome and Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00052546 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ...
  
• Donor Stem Cell Transplantation in Treating Patients With Relapsed Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00053196 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ...
  
• Donor Stem Cell Transplantation With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00047268 - Active, not recruiting
  atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; juvenile myelomonocytic leukemia; myelodysplastic and myeloproliferative disease; ...
  
• Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00521261 - Recruiting
  Lymphoma
  
• Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants
  ClinicalTrials.gov Identifier: NCT00001830 - No longer recruiting
  Chronic Lymphocytic Leukemia; Graft vs Host Disease; Hodgkin's Disease; Multiple Myeloma; Non Hodgkin's Lymphoma
  
• Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00295880 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes
  
• Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00304018 - Recruiting
  Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00290628 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Diamond-Blackfan Anemia; Fanconi Anemia; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
  ClinicalTrials.gov Identifier: NCT00055653 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; myelodysplastic and myeloproliferative diseases
  
• Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer
  ClinicalTrials.gov Identifier: NCT00248430 - Active, not recruiting
  Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm
  
• Donors After Cardiac Death: Validating Identification Criteria
  ClinicalTrials.gov Identifier: NCT00177606 - Active, not recruiting
  Withdrawing Treatment
  
• Dopamine and Norepinephrine in Shock Patients
  ClinicalTrials.gov Identifier: NCT00314704 - Recruiting
  Shock
  
• Dopamine Function in Developmental Stuttering
  ClinicalTrials.gov Identifier: NCT00024960 - Active, not recruiting
  Developmental Stuttering
  
• Dopamine Receptor Imaging in Mood Disorders
  ClinicalTrials.gov Identifier: NCT00116077 - Recruiting
  
  
• Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
  ClinicalTrials.gov Identifier: NCT00000276 - Active, not recruiting
  Cocaine-Related Disorders
  
• Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
  ClinicalTrials.gov Identifier: NCT00209456 - Completed
  Lewy Body Dementia; Non-DLB Dementia; Alzheimer’s; Vascular Dementia
  
• Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson''s Disease
  ClinicalTrials.gov Identifier: NCT00153972 - Recruiting
  Parkinson''s Disease
  
• Dopaminergic Enhancement of Learning and Memory in Aphasia
  ClinicalTrials.gov Identifier: NCT00102869 - Recruiting
  Cerebrovascular Accident; Aphasia
  
• Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment
  ClinicalTrials.gov Identifier: NCT00306124 - Recruiting
  Alzheimer's Disease; Mild Cognitive Impairment; Healthy
  
• Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients with Dyslexia
  ClinicalTrials.gov Identifier: NCT00111371 - Recruiting
  Dyslexia
  
• Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions
  ClinicalTrials.gov Identifier: NCT00280501 - Recruiting
  Regional Blood Flow; Ocular Physiology
  
• Dopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00166322 - Recruiting
  Schizophrenia
  
• Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00206960 - Active, not recruiting
  Schizophrenia
  
• Dopexamine and Norepinephrine Compared with Epinephrine Alone in Septic Shock
  ClinicalTrials.gov Identifier: NCT00134212 - Completed
  Septic Shock
  
• Doppler and Biological Second Trimester Placental Insufficiency Screening
  ClinicalTrials.gov Identifier: NCT00465634 - Active, not recruiting
  Pre-Eclampsia; Fetal Growth Retardation; Placental Insufficiency
  
• Doppler or Amniocentesis to Predict Fetal Anemia
  ClinicalTrials.gov Identifier: NCT00295516 - Completed
  Rh Isoimmunization
  
• Doppler Ultrasonography Evaluation of Tibial Fracture Site Vascularity
  ClinicalTrials.gov Identifier: NCT00365573 - Recruiting
  Tibial Fracture
  
• DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
  ClinicalTrials.gov Identifier: NCT00330369 - Recruiting
  Hypertension
  
• DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
  ClinicalTrials.gov Identifier: NCT00389779 - Recruiting
  Hypertension
  
• DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
  ClinicalTrials.gov Identifier: NCT00389675 - Recruiting
  Hypertension
  
• DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension
  ClinicalTrials.gov Identifier: NCT00353574 - Recruiting
  Hypertension
  
• Doripenem in the Treatment of Complicated Intra-Abdominal Infections
  ClinicalTrials.gov Identifier: NCT00210938 - Completed
  Peritonitis; Appendicitis; Cholecystitis; Pancreatitis; Bacterial Infections and Mycoses
  
• Doripenem in the Treatment of Complicated Intra-Abdominal Infections
  ClinicalTrials.gov Identifier: NCT00229060 - Completed
  Cholecystitis; Peritonitis; Appendicitis; Pancreatitis; Bacterial Infections and Mycoses
  
• Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis
  ClinicalTrials.gov Identifier: NCT00210990 - Completed
  Urinary Tract Infections; Pyelonephritis
  
• Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis
  ClinicalTrials.gov Identifier: NCT00229021 - Completed
  Urinary Tract Infections; Pyelonephritis
  
• Doripenem in the Treatment of Hospital-Acquired Pneumonia
  ClinicalTrials.gov Identifier: NCT00211003 - Active, not recruiting
  Pneumonia
  
• Doripenem in the Treatment of Ventilator-Associated Pneumonia
  ClinicalTrials.gov Identifier: NCT00211016 - Active, not recruiting
  Pneumonia; Ventilators, Mechanical
  
• Dornase Alfa and Urokinase for Kids With Pleural Empyema
  ClinicalTrials.gov Identifier: NCT00502632 - Recruiting
  Pleural Empyema
  
• Dornase Alfa Inhalation Solution or a Placebo in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Radiation Therapy and Chemotherapy
  ClinicalTrials.gov Identifier: NCT00536952 - Not yet recruiting
  Head and Neck Cancer
  
• Dorsal Splint or Circular Cast for Colles’ Fracture?
  ClinicalTrials.gov Identifier: NCT00470691 - Completed
  Colles' Fracture
  
• Dosage Effects of Folic Acid on Blood Folates of Honduran Women
  ClinicalTrials.gov Identifier: NCT00207532 - Completed
  Spina Bifida and Anencephaly
  
• Dosage of Metal Ions in the Blood of Different Metal-on-Metal Prostheses, in Correlation With Physical Activity
  ClinicalTrials.gov Identifier: NCT00285974 - Active, not recruiting
  Hip Osteoarthritis
  
• Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic NSCLC
  ClinicalTrials.gov Identifier: NCT00370292 - Recruiting
  Non Small Cell Lung Cancer
  
• Dose and Dose Interval Study of Myozyme
  ClinicalTrials.gov Identifier: NCT00483379 - Recruiting
  Pompe Disease; Glycogen Storage Disease Type II (GSD-II); Glucogenesis 2; Acid Maltase Deficiency
  
• Dose Comparison of Amino Acids On Growth in Premature Neonates
  ClinicalTrials.gov Identifier: NCT00120926 - Completed
  Malnutrition
  
• Dose Comparison Study of Topiramate in Pediatric Subjects with Basilar/Hemiplegic Migraine
  ClinicalTrials.gov Identifier: NCT00131443 - Completed
  Basilar Migraine
  
• Dose Confirmation Efficacy Study
  ClinicalTrials.gov Identifier: NCT00092443 - Completed
  Rotavirus Infections
  
• Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00308178 - Active, not recruiting
  Breast Cancer
  
• Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer
  ClinicalTrials.gov Identifier: NCT00232479 - Recruiting
  Breast Cancer
  
• Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00499018 - Recruiting
  Diffuse Large B-Cell Lymphoma; IPI≥2
  
• Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer
  ClinicalTrials.gov Identifier: NCT00286819 - Completed
  Breast Cancer
  
• Dose Determination of 5-Fluorouracil in Combination with Leucovorin and the Experimental Drug UCN-01 to Treat Cancer
  ClinicalTrials.gov Identifier: NCT00039637 - Completed
  Neoplasms
  
• Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers
  ClinicalTrials.gov Identifier: NCT00236301 - Terminated
  Healthy Symptomatic Menopausal Women
  
• Dose Escalating Study of the Safety and Efficacy of Patupilone in Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00171834 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine
  ClinicalTrials.gov Identifier: NCT00140348 - Completed
  Prostate Cancer
  
• Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00458237 - Recruiting
  Breast Cancer
  
• Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
  ClinicalTrials.gov Identifier: NCT00461149 - Completed
  Acromegaly
  
• Dose Escalation of Sorafenib in Patients With Advanced HCC
  ClinicalTrials.gov Identifier: NCT00490685 - Recruiting
  Carcinoma, Hepatocellular
  
• Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
  ClinicalTrials.gov Identifier: NCT00583102 - Recruiting
  Acute Myeloid Leukemia
  
• Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00543972 - Recruiting
  Myeloid Leukemia
  
• Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma
  ClinicalTrials.gov Identifier: NCT00216437 - Terminated
  Cancer of Liver
  
• Dose Escalation Study for Primary Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00243841 - Recruiting
  Carcinoma, Hepatocellular
  
• Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00338494 - Recruiting
  B-Cell Lymphoma
  
• Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00259818 - Recruiting
  Cancer
  
• Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients
  ClinicalTrials.gov Identifier: NCT00558961 - Recruiting
  Chronic Lymphocytic Leukemia
  
• Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00474825 - Recruiting
  Carcinoma, Squamous Cell; Cancer of the Head and Neck
  
• Dose Escalation Study of KW-3902 on Diuresis in Subjects with Congestive Heart Failure (CHF).
  ClinicalTrials.gov Identifier: NCT00159627 - Completed
  Heart Failure, Congestive
  
• Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL
  ClinicalTrials.gov Identifier: NCT00543114 - Recruiting
  Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia
  
• Dose Escalation Study of SH U04722 in Solid Tumors
  ClinicalTrials.gov Identifier: NCT00375453 - Recruiting
  Tumors
  
• Dose Escalation Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults with Mild-to-Moderate Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00129831 - Completed
  COPD
  
• Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
  ClinicalTrials.gov Identifier: NCT00031083 - Suspended
  Glioblastoma Multiforme; Anaplastic Astrocytoma; Oligoastrocytoma, Mixed; Gliosarcoma
  
• Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old
  ClinicalTrials.gov Identifier: NCT00439660 - Active, not recruiting
  Diarrhea
  
• Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00227435 - Completed
  Chronic Hepatitis C
  
• Dose Escalation Study with QLT0074 for Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00077012 - Completed
  Benign Prostatic Hyperplasia
  
• Dose Escalation Trial of 2-deoxy-D-glucose (2DG) in Subjects with Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00096707 - Recruiting
  Lung Cancer; Breast Cancer; Pancreatic Cancer; Head and Neck Cancer; Gastric Cancer
  
• Dose Escalation, Double-Blind Treatment with Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression
  ClinicalTrials.gov Identifier: NCT00042575 - Completed
  Major Depressive Disorder
  
• Dose Estimation for Studies of Acute Respiratory Effects
  ClinicalTrials.gov Identifier: NCT00005362 - Completed
  Lung Diseases
  
• Dose Evaluation Study Of Oral Eltrombopag In Patients With Sarcoma Receiving The ADRIAMYCIN And Ifosfamide Regimen
  ClinicalTrials.gov Identifier: NCT00358540 - Recruiting
  Sarcoma; Thrombocytopenia; Thrombopoiesis
  
• Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00357188 - Completed
  HIV Infections; Protease Inhibitor
  
• Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis
  ClinicalTrials.gov Identifier: NCT00449397 - Completed
  Psychosis
  
• Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis
  ClinicalTrials.gov Identifier: NCT00259558 - Completed
  Ulcerative Colitis
  
• Dose Finding Study of Danggui Buxue Tang (Herbal Formula)on the Treatment of Menopausal Symptoms
  ClinicalTrials.gov Identifier: NCT00420576 - Recruiting
  Postmenopausal
  
• Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients
  ClinicalTrials.gov Identifier: NCT00364468 - Recruiting
  Neutropenia
  
• Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS).
  ClinicalTrials.gov Identifier: NCT00239486 - Completed
  Restless Legs Syndrome
  
• Dose Finding Study to Assess the Efficacy & Safety of Dysport in Upper Back Myofascial Pain Syndrome
  ClinicalTrials.gov Identifier: NCT00134810 - Completed
  Myofascial Pain Syndrome
  
• Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C
  ClinicalTrials.gov Identifier: NCT00446940 - Recruiting
  Hepatitis C
  
• Dose of Norepinephrine and the Concentration of L-Lactate in the Rectum and Stomach in Patients With Septic Shock.
  ClinicalTrials.gov Identifier: NCT00197886 - Completed
  Septic Shock
  
• Dose of Spinal Manipulation for Chronic Low Back Pain
  ClinicalTrials.gov Identifier: NCT00376350 - Recruiting
  Low Back Pain
  
• Dose On Safety, Tolerability, and Immunogenicity of ACAM2000 Smallpox Vaccine in Adults With Previous Smallpox Vaccination
  ClinicalTrials.gov Identifier: NCT00053482 - Active, not recruiting
  Smallpox
  
• Dose Ranging Study - Macroflux PTH in Postmenopausal Women With Osteoporosis
  ClinicalTrials.gov Identifier: NCT00489918 - Active, not recruiting
  Osteoporosis
  
• Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Moderately to Severely Active Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00562887 - Not yet recruiting
  Crohn's Disease
  
• Dose Ranging Study for Indacaterol in Japanese Asthma Patients
  ClinicalTrials.gov Identifier: NCT00403754 - Completed
  Asthma
  
• Dose Ranging Study in Elective Total Hip Replacement Surgery (DRIVE)
  ClinicalTrials.gov Identifier: NCT00338897 - Completed
  Venous Thromboembolism
  
• Dose Ranging Study in Healthy Methadone Maintenance Subjects
  ClinicalTrials.gov Identifier: NCT00387491 - Completed
  Adult
  
• Dose Ranging Study of 3 Formulations of Hib-MenCY-TT Vaccine and 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2, 3, and 4 Months of Age.
  ClinicalTrials.gov Identifier: NCT00129116 - Completed
  Invasive bacterial disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y.
  
• Dose Ranging Study of 3 Formulations of Hib-MenCY-TT Vaccine Compared to Licensed Hib and Meningococcal Serogroup C Vaccines, Each Administered at 2, 4, and 6 Months of Age.
  ClinicalTrials.gov Identifier: NCT00127855 - Completed
  Invasive bacterial disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y.
  
• Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00409357 - Completed
  Benign Prostatic Hyperplasia
  
• Dose Ranging Study of Alpharen in Haemodialysis Subjects With Hyperphosphataemia
  ClinicalTrials.gov Identifier: NCT00436683 - Active, not recruiting
  Chronic Kidney Failure
  
• Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease Receiving Chronic Hemodialysis
  ClinicalTrials.gov Identifier: NCT00548249 - Recruiting
  End-Stage Renal Disease
  
• Dose Ranging Study of Indacaterol in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00403845 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children with Hyperinsulinism
  ClinicalTrials.gov Identifier: NCT00004699 - Active, not recruiting
  Hyperinsulinism
  
• Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms
  ClinicalTrials.gov Identifier: NCT00343486 - Recruiting
  Overactive Bladder
  
• Dose Ranging Study of TBC3711 in Resistant Hypertension
  ClinicalTrials.gov Identifier: NCT00272961 - Recruiting
  Hypertension
  
• Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
  ClinicalTrials.gov Identifier: NCT00534560 - Recruiting
  Migraine Without Aura; Migraine With Aura
  
• Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00299871 - Completed
  Type 2 Diabetes
  
• Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects
  ClinicalTrials.gov Identifier: NCT00498654 - Active, not recruiting
  Typhoid Fever
  
• Dose Ranging Study With LT, Monotherapy, PPAR
  ClinicalTrials.gov Identifier: NCT00240383 - Completed
  Diabetes Melitus II
  
• Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS
  ClinicalTrials.gov Identifier: NCT00179582 - Recruiting
  IBS
  
• Dose ranging trial for pixantrone in the FND-R variant regimen in indolent non-Hodgkin's lymphoma
  ClinicalTrials.gov Identifier: NCT00060684 - Completed
  Lymphoma, Low-Grade; Lymphoma, Small Lymphocytic; Lymphoma, Mixed-Cell, Follicular; Lymphoma, Small Cleaved-Cell, Follicular
  
• Dose ranging trial of tipranavir/ritonavir in treatment-experienced HIV infected individuals
  ClinicalTrials.gov Identifier: NCT00034866 - Completed
  HIV Infections
  
• Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects
  ClinicalTrials.gov Identifier: NCT00255528 - Completed
  Hypertension
  
• Dose Reduction in Thoracic CT
  ClinicalTrials.gov Identifier: NCT00188461 - Completed
  Lymphoma
  
• Dose Response and Efficacy of GW842166 in Pain
  ClinicalTrials.gov Identifier: NCT00554762 - Not yet recruiting
  Healthy Volunteers
  
• Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00189787 - Completed
  Asthma, Bronchial; Bronchial Asthma
  
• Dose Response of Valsartan on Sitting Systolic Blood Pressure in 1-5 Year Old Children With High Blood Pressure
  ClinicalTrials.gov Identifier: NCT00435162 - Recruiting
  Hypertension
  
• Dose Response Relations for Health Effects Caused by Office Dust.
  ClinicalTrials.gov Identifier: NCT00143637 - Active, not recruiting
  Lung function, discomfort.
  
• Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients with Adrenal Insufficiency
  ClinicalTrials.gov Identifier: NCT00001180 - Completed
  Adrenal Gland Hyperfunction; Adrenal Gland Hypofunction; Cushing's Syndrome; Healthy
  
• Dose Response Study
  ClinicalTrials.gov Identifier: NCT00139750 - Completed
  Smoking cessation
  
• Dose Response Study in Japanese Patients
  ClinicalTrials.gov Identifier: NCT00261417 - Completed
  Type 2 Diabetes
  
• Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon
  ClinicalTrials.gov Identifier: NCT00480753 - Completed
  Raynaud's Disease
  
• Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon
  ClinicalTrials.gov Identifier: NCT00378521 - Completed
  Raynaud's Disease; Raynaud's Disease Secondary to Scleroderma; Raynaud's Disease Secondary to Autoimmune Disease
  
• Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00465621 - Completed
  Open-Angle Glaucoma; Ocular Hypertension
  
• Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00174746 - Completed
  Asthma
  
• Dose Response Study of Lasofoxifene in Postmenopausal Women with Osteoporosis (Japanese Asian Dose Evaluation:JADE)
  ClinicalTrials.gov Identifier: NCT00143273 - Completed
  Osteoporosis
  
• Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy
  ClinicalTrials.gov Identifier: NCT00056576 - Active, not recruiting
  Epilepsy, Complex Partial
  
• Dose Response to Exercise and Cardiovascular Health
  ClinicalTrials.gov Identifier: NCT00005555 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Dose Response to Recombinant Factor VIIa when administered for Bleed
  ClinicalTrials.gov Identifier: NCT00104455 - Completed
  Healthy
  
• Dose Response Trial of Pergolide for Cocaine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00000248 - Completed
  Cocaine-Related Disorders
  
• Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults without Previous Smallpox Vaccination
  ClinicalTrials.gov Identifier: NCT00053508 - Active, not recruiting
  Smallpox
  
• Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00001337 - Recruiting
  Non Hodgkin's Lymphoma
  
• Dose-Comparison Study.
  ClinicalTrials.gov Identifier: NCT00185380 - Active, not recruiting
  Contraception
  
• Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study
  ClinicalTrials.gov Identifier: NCT00378638 - Recruiting
  Breast Cancer
  
• Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00201708 - Active, not recruiting
  Breast Cancer
  
• Dose-Determining Study of R115777 for Childhood Leukemia
  ClinicalTrials.gov Identifier: NCT00017888 - Completed
  Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Acute Nonlymphocytic Leukemia; Acute Myelomonocytic Leukemia; ...
  
• Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00284908 - Active, not recruiting
  Esophagitis; Gastroesophageal Reflux; Stomach Ulcer; Duodenal Ulcer
  
• Dose-Effect of SSR180575 in Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00502515 - Recruiting
  Diabetic Neuropathies
  
• Dose-Escalating and Safety Study of CP-461 in Patients with Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00036257 - Completed
  Chronic Lymphocytic Leukemia
  
• Dose-Escalating Multiple Dose Study of PD 0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00550355 - Recruiting
  Arthritis, Rheumatoid
  
• Dose-Escalating Safety Study in Subjects on Stable Statin Therapy
  ClinicalTrials.gov Identifier: NCT00231569 - Active, not recruiting
  Hypercholesterolemia
  
• Dose-Escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy
  ClinicalTrials.gov Identifier: NCT00280995 - Active, not recruiting
  Hypercholesterolemia, Familial
  
• Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00292422 - Completed
  Rheumatoid Arthritis
  
• Dose-Escalating Study of SB-485232 Administered Intravenously Every 28 Days to Adults with Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00085904 - Active, not recruiting
  Cancer; Lymphoma
  
• Dose-Escalating Trial Using Vero Cell-Culture Derived H5N1 +/- Aluminum in Adults
  ClinicalTrials.gov Identifier: NCT00382980 - Active, not recruiting
  Influenza
  
• Dose-Escalation Safety Study of Glyceryl Tri (4-Phenylbutyrate)(GT4P)to Treat Urea Cycle Disorders
  ClinicalTrials.gov Identifier: NCT00551200 - Recruiting
  Urea Cycle Disorders
  
• Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure
  ClinicalTrials.gov Identifier: NCT00109655 - Recruiting
  Carcinoma, Transitional Cell; Bladder Neoplasms
  
• Dose-Escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00420485 - Recruiting
  Solid Tumors
  
• Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00085878 - Active, not recruiting
  Solid Tumors
  
• Dose-Exposure-Response in Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00368394 - Completed
  Diabetes Mellitus, Type I
  
• Dose-Finding Pediatric Trial With Sugammadex
  ClinicalTrials.gov Identifier: NCT00421148 - Completed
  Anesthesia, General
  
• Dose-Finding Safety and Efficacy Trial in the Treatment of Vasomotor Symptoms
  ClinicalTrials.gov Identifier: NCT00560833 - Completed
  Menopause; Vasomotor Symptoms
  
• Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00438607 - Recruiting
  Parkinson's Disease
  
• Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00442780 - Recruiting
  Parkinson's Disease
  
• Dose-Finding Study for Vitamin K2 in Human Volunteers
  ClinicalTrials.gov Identifier: NCT00483431 - Recruiting
  Vitamin K-Status
  
• Dose-Finding Study of ASP2151 in Subjects With Herpes Zoster
  ClinicalTrials.gov Identifier: NCT00487682 - Recruiting
  Herpes Zoster
  
• Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell Carcinoma Not Previously Treated
  ClinicalTrials.gov Identifier: NCT00372853 - Recruiting
  Carcinoma, Renal Cell
  
• Dose-Finding Study of CS19 Expressing ETEC Challenge Strains
  ClinicalTrials.gov Identifier: NCT00564863 - Recruiting
  Travelers' Diarrhea
  
• Dose-Finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy
  ClinicalTrials.gov Identifier: NCT00540384 - Completed
  Anemia; Solid Tumors
  
• Dose-Finding Study of REN-1654 in Patients with Post-Herpetic Neuralgia
  ClinicalTrials.gov Identifier: NCT00099528 - Active, not recruiting
  Neuralgia; Shingles; Peripheral Nervous System Disease
  
• Dose-Finding Study of WS6788A and LSN03-016011/A Enterotoxigenic E. Coli ETEC Challenge Strains That Express CS17
  ClinicalTrials.gov Identifier: NCT00564577 - Completed
  Travelers' Diarrhea
  
• Dose-Finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.
  ClinicalTrials.gov Identifier: NCT00189956 - Completed
  Smallpox
  
• Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD
  ClinicalTrials.gov Identifier: NCT00315276 - Completed
  Attention Deficit Hyperactivity Disorder; ADHD
  
• Dose-Finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations with FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.
  ClinicalTrials.gov Identifier: NCT00161772 - Completed
  Tick-Borne Encephalitis
  
• Dose-Finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations with FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.
  ClinicalTrials.gov Identifier: NCT00161798 - Completed
  Tick-Borne Encephalitis
  
• Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD
  ClinicalTrials.gov Identifier: NCT00032773 - Terminated
  Acute Graft Versus Host Disease
  
• Dose-finding Trial of CHIR-12.12 in Patients with Chronic Lymphocytic Leukemia (CLL) that is Relapsed or Non-responsive to Prior Therapy
  ClinicalTrials.gov Identifier: NCT00108108 - Recruiting
  Chronic Lymphocytic Leukemia
  
• Dose-Finding Trial With Sugammadex at 3 and 15 Minutes After 1.0 and 1.2 mg/kg Rocuronium Bromide in Subjects of ASA Class 1-3
  ClinicalTrials.gov Identifier: NCT00535743 - Completed
  Anesthesia, General
  
• Dose-finding, open-label study in patients with Acute Myelogenous Leukemia after they receive a transplantation
  ClinicalTrials.gov Identifier: NCT00044733 - Completed
  Acute Myelogenous Leukemia
  
• Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD
  ClinicalTrials.gov Identifier: NCT00500071 - Active, not recruiting
  ADHD
  
• Dose-Range Finding Study for MK0893
  ClinicalTrials.gov Identifier: NCT00479466 - Recruiting
  Diabetes Mellitus, Type 2
  
• Dose-Range-Finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
  ClinicalTrials.gov Identifier: NCT00402337 - Active, not recruiting
  Chronic Constipation
  
• Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
  ClinicalTrials.gov Identifier: NCT00471510 - Recruiting
  Androgenetic Alopecia
  
• Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia
  ClinicalTrials.gov Identifier: NCT00345410 - Completed
  Obesity; Dyslipidemia
  
• Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment
  ClinicalTrials.gov Identifier: NCT00361738 - Recruiting
  Type 2 Diabetes Mellitus
  
• Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty
  ClinicalTrials.gov Identifier: NCT00485693 - Recruiting
  Postoperative Pain
  
• Dose-Ranging Study for Prolonged Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair
  ClinicalTrials.gov Identifier: NCT00485433 - Recruiting
  Postoperative Pain
  
• Dose-Ranging Study in Patients with Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00098228 - Completed
  COPD
  
• Dose-Ranging Study in Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive
  ClinicalTrials.gov Identifier: NCT00495469 - Recruiting
  Type 2 Diabetes Mellitus
  
• Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
  ClinicalTrials.gov Identifier: NCT00500331 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement- ODIXa-HIP2 Study
  ClinicalTrials.gov Identifier: NCT00398905 - Completed
  Prevention of Venous Thromboembolism
  
• Dose-Ranging Study of Once-Daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement- ODIXaHIP-OD
  ClinicalTrials.gov Identifier: NCT00396786 - Completed
  Prevention of Venous Thromboembolism
  
• Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B
  ClinicalTrials.gov Identifier: NCT00230503 - Active, not recruiting
  Hepatitis B, Chronic
  
• Dose-Ranging Study of Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine
  ClinicalTrials.gov Identifier: NCT00365716 - Completed
  Papillomavirus Infections; Genital Diseases, Female
  
• Dose-Ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers
  ClinicalTrials.gov Identifier: NCT00434512 - Active, not recruiting
  Acquired Immunodeficiency Syndrome
  
• Dose-Ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis
  ClinicalTrials.gov Identifier: NCT00504426 - Recruiting
  Pain Due to Osteoporosis
  
• Dose-Response of Adenosine for Perioperative Pain
  ClinicalTrials.gov Identifier: NCT00298636 - Completed
  Perioperative Pain
  
• Dose-Response of Exercise on Long-Term Weight Loss
  ClinicalTrials.gov Identifier: NCT00177762 - Completed
  Obesity; Weight Loss
  
• Dose-Response of Gonadal Steroids and Bone Turnover in Men
  ClinicalTrials.gov Identifier: NCT00114114 - Recruiting
  Healthy volunteers
  
• Dose-Response Study of OPC-12759 Ophthalmic Suspension
  ClinicalTrials.gov Identifier: NCT00234078 - Completed
  Dry Eye Syndromes
  
• Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A
  ClinicalTrials.gov Identifier: NCT00289536 - Active, not recruiting
  Hemophilia A
  
• Dose-Response Study of Sodium Nitroprusside in Children Requiring Controlled Hypotension in the Operating Room
  ClinicalTrials.gov Identifier: NCT00135668 - Recruiting
  Controlled Hypotension
  
• Dose-Response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00580125 - Recruiting
  Schizophrenia
  
• Dose-Response to Exercise in Women Aged 45-75 Years
  ClinicalTrials.gov Identifier: NCT00011193 - Active, not recruiting
  Cardiovascular Diseases; Hypertension; Postmenopause
  
• Dose-Response, Safety and Efficacy Study of Oral Febuxostat in Subjects With Gout
  ClinicalTrials.gov Identifier: NCT00174967 - Completed
  Gout
  
• Dose/Response of Exercise on Long Term Weight Loss
  ClinicalTrials.gov Identifier: NCT00006315 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma
  ClinicalTrials.gov Identifier: NCT00165126 - Active, not recruiting
  Endometrial Carcinoma; Cervix Cancer; Carcinoma of the Uterus
  
• Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00392821 - Recruiting
  Kidney Cancer
  
• Dosing and Safety Study of E7820 in Patients with a Malignant Solid Tumor or Lymphoma
  ClinicalTrials.gov Identifier: NCT00078637 - Completed
  Neoplasms; Lymphoma, Malignant
  
• Dosing Chart for Calculating the First Dose of Doxapram in Premature Infants
  ClinicalTrials.gov Identifier: NCT00389909 - Recruiting
  Premature Infants; Apnea
  
• Dosing Flexibility Study in Patients With RA EXTEND TRIAL
  ClinicalTrials.gov Identifier: NCT00580840 - Not yet recruiting
  Rheumatoid Arthritis
  
• Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML
  ClinicalTrials.gov Identifier: NCT00074737 - Completed
  Acute Myelogenous Leukemia
  
• Dosing Study of Replagal in Patients with Fabry Disease
  ClinicalTrials.gov Identifier: NCT00068107 - Active, not recruiting
  Fabry Disease
  
• Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients with Mild to Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00145236 - Completed
  Hypertension
  
• Double Bedtime Dosing During Immediate-Release Morphine Administration to Cancer Patients
  ClinicalTrials.gov Identifier: NCT00201539 - Completed
  Cancer
  
• Double Blind Atorvastatin Amlodipine Study (DUAAL Study)
  ClinicalTrials.gov Identifier: NCT00159718 - Completed
  Angina
  
• Double Blind Crossover Comparison of Diuretics in the Young
  ClinicalTrials.gov Identifier: NCT00429897 - Recruiting
  Low-Renin Hypertension
  
• Double Blind Placebo Controlled Bellis Perenis and Arnica Montana as a Drug for PPH
  ClinicalTrials.gov Identifier: NCT00405626 - Not yet recruiting
  Hemorrhage
  
• Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of ssr149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-Triggered Icd interventiOnS (ICARIOS)
  ClinicalTrials.gov Identifier: NCT00232297 - Completed
  Arrhythmia; Tachycardia, Ventricular; Ventricular Fibrillation
  
• Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of ssr149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr (CORYFEE)
  ClinicalTrials.gov Identifier: NCT00232310 - Completed
  Atrial Fibrillation; Atrial Flutter
  
• Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS
  ClinicalTrials.gov Identifier: NCT00579085 - Recruiting
  Complex Regional Pain Syndrome
  
• Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EF
  ClinicalTrials.gov Identifier: NCT00505791 - Not yet recruiting
  Heart Failure, Congestive; Dyspnea; Pulmonary Edema
  
• Double Blind Randomized Study Comparing Endeavor With Cypher Stents
  ClinicalTrials.gov Identifier: NCT00476957 - Not yet recruiting
  Ischemic Hearth Disease
  
• Double Blind Randomized Study Into the Efficacy of Codeine Phosphate Analgesia After Cleft Palate Repair in Infants
  ClinicalTrials.gov Identifier: NCT00386269 - Completed
  Cleft Palate Repair
  
• Double Blind Randomized Trial of Saline vs Pentaspan for Resuscitation After Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00337805 - Recruiting
  Cardiac Surgery
  
• Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00396851 - Not yet recruiting
  Type 2 Diabetes Mellitus
  
• Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes
  ClinicalTrials.gov Identifier: NCT00553592 - Recruiting
  Diabetic Peripheral Neuropathy
  
• Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00002049 - Completed
  HIV Infections
  
• Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00002051 - Completed
  HIV Infections
  
• Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00002066 - Completed
  HIV Infections
  
• Double Blind Study of Trp01 in Patients With Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00202124 - Completed
  Alzheimer's Disease
  
• Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence
  ClinicalTrials.gov Identifier: NCT00527683 - Active, not recruiting
  Cocaine Dependence
  
• Double Blind Trial of DC Polarization in FTD
  ClinicalTrials.gov Identifier: NCT00117858 - Completed
  
  
• Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome
  ClinicalTrials.gov Identifier: NCT00375973 - Recruiting
  Fatigue Syndrome, Chronic
  
• Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00581607 - Not yet recruiting
  Sarcoidosis; Pulmonary Arterial Hypertension
  
• Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo
  ClinicalTrials.gov Identifier: NCT00570063 - Recruiting
  Schizophrenia
  
• Double Blinded Randomised Trial Comparing Metformin Versus Placebo in NASH Patients Receiving Bariatric Surgery for Obesity
  ClinicalTrials.gov Identifier: NCT00134303 - Recruiting
  Obesity
  
• Double Cord Blood Transplant Study
  ClinicalTrials.gov Identifier: NCT00067002 - Recruiting
  Leukemia, Lymphocytic, Acute; Leukemia, Myelocytic, Acute; Leukemia, Myeloid, Chronic; Lymphoma, Non-Hodgkin; Multiple Myeloma
  
• Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation in Treating Patients With Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00083135 - Active, not recruiting
  recurrent neuroblastoma
  
• Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions
  ClinicalTrials.gov Identifier: NCT00233714 - Active, not recruiting
  Coronary Artery Disease
  
• Double Protease Inhibitor to Darunavir Switch Study
  ClinicalTrials.gov Identifier: NCT00531557 - Recruiting
  HIV Infections
  
• Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00461617 - Active, not recruiting
  Diabetes
  
• Double-Blind Comparison of Combined General-Spinal Anesthesia to General Anesthesia for Coronary Artery Surgery
  ClinicalTrials.gov Identifier: NCT00242697 - Completed
  Coronary Artery Disease; Coronary Artery Bypass Surgery
  
• Double-Blind Comparison of the Efficacy of Continued Zidovudine versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment with Zidovudine
  ClinicalTrials.gov Identifier: NCT00002035 - Completed
  HIV Infections
  
• Double-Blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis)
  ClinicalTrials.gov Identifier: NCT00145327 - Active, not recruiting
  Osteoporosis
  
• Double-Blind Lamictal in Neurotic Excoriation
  ClinicalTrials.gov Identifier: NCT00513019 - Recruiting
  Neurotic Excoriation; Pathologic Skin Picking; Psychogenic Excoriation
  
• Double-Blind Naltrexone in Compulsive Sexual Behavior
  ClinicalTrials.gov Identifier: NCT00467558 - Recruiting
  Compulsive Sexual Behavior
  
• Double-Blind Naltrexone in Kleptomania
  ClinicalTrials.gov Identifier: NCT00332579 - Recruiting
  Kleptomania
  
• Double-Blind Placebo Study on Magnetic Field Therapy in Chronic Lumbar Pain
  ClinicalTrials.gov Identifier: NCT00407615 - Recruiting
  Chronic Low Back Pain
  
• Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel with Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects with Acquired Immunodeficiency Syndrome (AIDS)
  ClinicalTrials.gov Identifier: NCT00002186 - Completed
  Herpes Simplex; HIV Infections
  
• Double-Blind Placebo-Controlled Trial of Quetiapine in Anorexia Nervosa
  ClinicalTrials.gov Identifier: NCT00518973 - Recruiting
  Anorexia Nervosa
  
• Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo
  ClinicalTrials.gov Identifier: NCT00282178 - Active, not recruiting
  Hypertension; Obesity
  
• Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal Polyposis
  ClinicalTrials.gov Identifier: NCT00480298 - Completed
  Nasal Polyposis
  
• Double-Blind Study Assessing the Efficacy, Safety and Tolerability of Brivaracetam (200 Mg/Day or 400 Mg/Day), Compared to Placebo, in Subjects (18 Years or Older) with Persistent Pain After Shingles (Post-Herpetic Neuralgia).
  ClinicalTrials.gov Identifier: NCT00160667 - Completed
  Nerve Pain
  
• Double-Blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Men With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00321620 - Recruiting
  Bone Metastases in Men With Hormone-Refractory Prostate Cancer
  
• Double-Blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Subjects With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00330759 - Recruiting
  Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
  
• Double-Blind Study of E2020 in Patients With Dementia With Lewy Bodies - Phase II
  ClinicalTrials.gov Identifier: NCT00543855 - Not yet recruiting
  Dementia
  
• Double-Blind Study of Miglitol in Japanese With type2 Diabetes
  ClinicalTrials.gov Identifier: NCT00380822 - Completed
  Type 2 Diabetes Mellitus
  
• Double-Blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children
  ClinicalTrials.gov Identifier: NCT00307021 - Active, not recruiting
  Plasmodium Falciparum Malaria
  
• Double-Blind Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
  ClinicalTrials.gov Identifier: NCT00289185 - Active, not recruiting
  Plasmodium Falciparum Malaria
  
• Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy
  ClinicalTrials.gov Identifier: NCT00002109 - Completed
  HIV Infections
  
• Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
  ClinicalTrials.gov Identifier: NCT00334399 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment
  ClinicalTrials.gov Identifier: NCT00213070 - Completed
  Type 2 Diabetes Mellitus
  
• Double-Blind Trial of Olanzapine in Patients with Manic or Mixed Episode of Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00129220 - Recruiting
  Manic or mixed episode associated with bipolar I disorder
  
• Double-Blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20mg in Sore Throat
  ClinicalTrials.gov Identifier: NCT00525044 - Recruiting
  Pharyngitis
  
• Double-Blind, Double-Dummy, 2-Period Crossover of a 20-Minute Versus a 4-Hour IV of MOA-728 in Stable Methadone Subjects
  ClinicalTrials.gov Identifier: NCT00444158 - Completed
  Constipation
  
• Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.
  ClinicalTrials.gov Identifier: NCT00562055 - Terminated
  Attention Deficit Hyperactivity Disorder
  
• Double-Blind, Multicenter Study to Assess the Efficacy of Bilateral Pallidal Stimulation in Patients with Medically Refractory Primary Cervical Dystonia
  ClinicalTrials.gov Identifier: NCT00148889 - Recruiting
  Cervical dystonia
  
• Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 For Efficacy and Safety in Subjects With Idiopathic Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00400634 - Active, not recruiting
  Idiopathic Parkinson's Disease
  
• Double-Blind, Parallel Group, Placebo-Controlled Trial of the Efficacy and Tolerability of Memantine (20 Mg) in Frontotemporal Dementia (FTD) Patients.
  ClinicalTrials.gov Identifier: NCT00200538 - Recruiting
  Patients with frontotemporal dementia
  
• Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00224432 - Completed
  Atopic Dermatitis; Atopic Eczema; Infantile Eczema
  
• Double-Blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression
  ClinicalTrials.gov Identifier: NCT00194116 - Active, not recruiting
  Bipolar Disorder
  
• Double-Blind, Placebo-Controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00377715 - Active, not recruiting
  Alzheimer's Disease
  
• Double-blind, placebo-controlled trial of vitamin E as add-on therapy for children with epilepsy
  ClinicalTrials.gov Identifier: NCT00004637 - Completed
  Epilepsy
  
• Double-Blind, Randomised, Placebo-Controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis
  ClinicalTrials.gov Identifier: NCT00333411 - Suspended
  Psoriasis
  
• Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  ClinicalTrials.gov Identifier: NCT00464269 - Recruiting
  Epilepsy
  
• Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
  ClinicalTrials.gov Identifier: NCT00490035 - Recruiting
  Epilepsy
  
• Double-Blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine
  ClinicalTrials.gov Identifier: NCT00223990 - Completed
  Clinical Episodes of Plasmodium Falciparum Malaria
  
• Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects
  ClinicalTrials.gov Identifier: NCT00002018 - Completed
  HIV Infections
  
• Double-Blind, Randomized, Placebo-Controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis
  ClinicalTrials.gov Identifier: NCT00317499 - Completed
  Psoriatic Arthritis; Psoriasis
  
• Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients
  ClinicalTrials.gov Identifier: NCT00002012 - Completed
  HIV Infections
  
• Double-Blind,2 Dose Group Study of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients with MPS VI
  ClinicalTrials.gov Identifier: NCT00048620 - Completed
  Mucopolysaccharidosis VI
  
• Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMC
  ClinicalTrials.gov Identifier: NCT00423371 - Active, not recruiting
  Osteoarthritis
  
• Double-Blinded Randomized Trial of Terbutaline for the Treatment of Status Asthmaticus in Children
  ClinicalTrials.gov Identifier: NCT00124995 - Completed
  Status Asthmaticus
  
• Double-Masked Study of Efficacy and Safety of IVT VEGF Trap-Eye in Subjects With Wet AMD (VIEW 1)
  ClinicalTrials.gov Identifier: NCT00509795 - Recruiting
  Neovascular Age-Related Macular Degeneration
  
• Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00157976 - Recruiting
  Macular Degeneration
  
• Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters
  ClinicalTrials.gov Identifier: NCT00006445 - Active, not recruiting
  Down Syndrome; Chromosome Abnormalities
  
• Down Syndrome and Continuous Positive Pressure Therapy
  ClinicalTrials.gov Identifier: NCT00394290 - Recruiting
  Down Syndrome; Obstructive Sleep Apnea Syndrome
  
• Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00295555 - Completed
  Diabetes Mellitus; Essential Hypertension; Renal Failure
  
• Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00022412 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer
  
• Doxercalciferol in Recurrent Pediatric Solid Tumors
  ClinicalTrials.gov Identifier: NCT00511017 - Recruiting
  Solid Tumors
  
• Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00052832 - Active, not recruiting
  Chronic Myelomonocytic Leukemia; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes; de novo myelodysplastic syndromes; ...
  
• Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00303108 - Recruiting
  Metastatic Breast Cancer
  
• Doxil and Gemcitabine in Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00312650 - Terminated
  Ovarian Carcinoma
  
• DOXIL for Consolidation Therapy in Ovarian Cancer.
  ClinicalTrials.gov Identifier: NCT00248248 - Recruiting
  Ovarian Neoplasm
  
• DOXIL in Combination With Abraxane in Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00442260 - Not yet recruiting
  Metastatic Breast Cancer
  
• Doxil Topotecan Doublet Cancer Study
  ClinicalTrials.gov Identifier: NCT00252889 - Completed
  Small Cell Lung Cancer; Pancreatic Cancer; Head and Neck Cancer; Gastric Cancer; Esophageal Cancer
  
• Doxil, Gemcitabine and Velcade (PS341) in Advanced Cancer Patients
  ClinicalTrials.gov Identifier: NCT00500422 - Recruiting
  Advanced Cancer
  
• Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas
  ClinicalTrials.gov Identifier: NCT00184002 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00052390 - Completed
  recurrent adult soft tissue sarcoma; stage III adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage IVB adult soft tissue sarcoma
  
• Doxorubicin and Bortezomib in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00083226 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00562185 - Not yet recruiting
  Ovarian Cancer
  
• Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00052312 - Active, not recruiting
  recurrent endometrial cancer; stage III endometrial cancer; stage IV endometrial cancer; endometrial papillary carcinoma
  
• Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00129376 - Completed
  Breast Cancer
  
• Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer
  ClinicalTrials.gov Identifier: NCT00482391 - Recruiting
  Breast Cancer
  
• Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00436566 - Recruiting
  Breast Cancer; Cardiac Toxicity
  
• Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00424203 - Recruiting
  Breast Cancer; Cognitive/Functional Effects; Depression; Malnutrition; Psychosocial Effects/Treatment
  
• Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
  ClinicalTrials.gov Identifier: NCT00004067 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer
  
• Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005800 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer
  
• Doxorubicin and Flavopiridol in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00098579 - Recruiting
  gastrointestinal stromal tumor; recurrent adult soft tissue sarcoma; stage IV adult soft tissue sarcoma
  
• Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma (Kidney Cancer)
  ClinicalTrials.gov Identifier: NCT00068393 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00004248 - Active, not recruiting
  recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• Doxorubicin and Paclitaxel in Treating Women Who are Undergoing Surgery For Breast Cancer
  ClinicalTrials.gov Identifier: NCT00096291 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003035 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer
  
• Doxorubicin and Radiofrequency Ablation Therapy for Metastatic Liver Tumors
  ClinicalTrials.gov Identifier: NCT00090805 - Recruiting
  
  
• Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00080782 - Active, not recruiting
  recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
  Breast Cancer
  
• Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00237627 - Recruiting
  Breast Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Ovarian Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00470067 - Recruiting
  Endometrial Cancer
  
• Doxorubicin Hydrochloride Liposome and Cyclophosphamide in Treating Patients With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00331552 - Recruiting
  Breast Cancer
  
• Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma
  ClinicalTrials.gov Identifier: NCT00392990 - Recruiting
  Lymphoma
  
• Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00334932 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00002985 - Completed
  epidemic Kaposi's sarcoma; childhood skin cancer
  
• Doxorubicin in Treating Women With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003165 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00516425 - Recruiting
  Breast Cancer
  
• Doxorubicin PK Study
  ClinicalTrials.gov Identifier: NCT00124956 - Terminated
  Cancer
  
• Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002721 - Active, not recruiting
  recurrent prostate cancer
  
• Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00004109 - Active, not recruiting
  recurrent adult soft tissue sarcoma; stage III adult soft tissue sarcoma
  
• Doxorubicin With or Without Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00079027 - Active, not recruiting
  advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00061984 - Recruiting
  adult soft tissue sarcoma
  
• Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus
  ClinicalTrials.gov Identifier: NCT00165191 - Completed
  Adenocarcinoma of Stomach; Adenocarcinoma of GE Junction; Adenocarcinoma of Esophagus
  
• Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
  ClinicalTrials.gov Identifier: NCT00433511 - Recruiting
  Breast Cancer
  
• Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00016406 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
  
• Doxorubicin, Cyclophosphamide, and/or Paclitaxel in Treating Women With Nonmetastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00131963 - Recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00006377 - Active, not recruiting
  stage III endometrial cancer; stage IV endometrial cancer; recurrent endometrial cancer
  
• Doxycycline and OA Progression
  ClinicalTrials.gov Identifier: NCT00000403 - Completed
  Osteoarthritis
  
• Doxycycline Prophylaxis at Vacuum Aspiration Trial
  ClinicalTrials.gov Identifier: NCT00547170 - Not yet recruiting
  Endometritis
  
• Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic Filariasis
  ClinicalTrials.gov Identifier: NCT00340691 - Active, not recruiting
  Mansonella Perstans Infection; Mp Microfilaremia
  
• DPP Outcome Study
  ClinicalTrials.gov Identifier: NCT00038727 - Completed
  Diabetes Mellitus
  
• DPPE in Combination with Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer
  ClinicalTrials.gov Identifier: NCT00099281 - Terminated
  Breast Cancer; Metastases
  
• Drainage Amount for Removal of Thoracostomy Tube
  ClinicalTrials.gov Identifier: NCT00575198 - Not yet recruiting
  Pneumothorax; Pleural Effusion
  
• Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent
  ClinicalTrials.gov Identifier: NCT00166361 - Recruiting
  Ureteral Obstruction
  
• Drainage of Tuberculous Pleural Effusions
  ClinicalTrials.gov Identifier: NCT00524147 - Completed
  Tuberculous Pleurisy
  
• Dreaming and EEG Changes During Anaesthesia Maintained With Propofol or Desflurane
  ClinicalTrials.gov Identifier: NCT00446212 - Recruiting
  Anaesthesia; Dreaming
  
• Dreaming During Anaesthesia and Anaesthetic Depth
  ClinicalTrials.gov Identifier: NCT00226876 - Completed
  Dreaming Under Anaesthesia
  
• Dressing Preparation Comparison for Smallpox Vaccination Sites
  ClinicalTrials.gov Identifier: NCT00063856 - Completed
  Smallpox
  
• Dressing: Frequency of Change and Evaluation of an Antiseptic-Impregnated Catheter Dressing in ICU Patients
  ClinicalTrials.gov Identifier: NCT00417235 - Recruiting
  Systemic Inflammatory Response Syndrome; Bacteremia
  
• DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
  ClinicalTrials.gov Identifier: NCT00224081 - Completed
  Anemia, Iron-Deficiency; Kidney Failure, Chronic; Hemodialysis
  
• Drotaverine in Dysmenorrhoea Treatment
  ClinicalTrials.gov Identifier: NCT00292747 - Terminated
  Dysmenorrhea
  
• Droxidopa in Treating Patients With Neurogenic Hypotension
  ClinicalTrials.gov Identifier: NCT00004478 - Suspended
  Shy-Drager Syndrome; Orthostatic Hypotension
  
• Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-Daily or Twice-Daily Coreg
  ClinicalTrials.gov Identifier: NCT00272805 - Active, not recruiting
  Chronic Heart Failure
  
• Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia
  ClinicalTrials.gov Identifier: NCT00539123 - Recruiting
  Opiate Dependence
  
• Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC
  ClinicalTrials.gov Identifier: NCT00484016 - Completed
  Adjuvant; Chemotherapy; Lung; Cancers
  
• Drug Eluting Stents In The Critically Ischemic Lower Leg
  ClinicalTrials.gov Identifier: NCT00510393 - Not yet recruiting
  Peripheral Vascular Disease; Critical Limb Ischemia
  
• Drug Elution and Distal Protection During Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00192868 - Recruiting
  Coronary Artery Disease
  
• Drug Etiology of Aplastic Anemia and Related Dyscrasias
  ClinicalTrials.gov Identifier: NCT00005302 - Completed
  Blood Disease; Anemia, Aplastic; Agranulocytosis; Purpura, Thrombocytopenic
  
• Drug Facts Page or a Short Drug Summary in Helping Patients and Doctors Understand Medical Information
  ClinicalTrials.gov Identifier: NCT00450931 - Active, not recruiting
  Health Status Unknown
  
• Drug Interaction - Oral Contraceptive
  ClinicalTrials.gov Identifier: NCT00399685 - Completed
  HIV Infections
  
• Drug Interaction of SMC021 With Concomitant Antacid (Calcium Carbonate/Magnesium Hydroxide).
  ClinicalTrials.gov Identifier: NCT00421590 - Completed
  Health Postmenopausal Women
  
• Drug Interaction Study Between Antimalarial and Anti-HIV Medications
  ClinicalTrials.gov Identifier: NCT00266058 - Recruiting
  HIV Infections; Malaria
  
• Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients
  ClinicalTrials.gov Identifier: NCT00421473 - Recruiting
  HIV Infections; Malaria
  
• Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00384904 - Completed
  HIV Infections
  
• Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil
  ClinicalTrials.gov Identifier: NCT00474201 - Recruiting
  HIV Infections; Cholesterol
  
• Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00449280 - Suspended
  Advanced Solid Tumor
  
• Drug Interaction Study of Tegretol (Carbamazepine) and St. John's Wort in Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00006395 - Completed
  Healthy
  
• Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone
  ClinicalTrials.gov Identifier: NCT00362726 - Completed
  HIV Infections
  
• Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
  ClinicalTrials.gov Identifier: NCT00365339 - Completed
  HIV Infections
  
• Drug Interaction Study with NS2359 and Cocaine in Cocaine Experienced Volunteers - 1
  ClinicalTrials.gov Identifier: NCT00032916 - Active, not recruiting
  Cocaine-Related Disorders; Drug Administration Schedule; Infusions, Intravenous
  
• Drug Interaction Study With Proton Pump Inhibitor
  ClinicalTrials.gov Identifier: NCT00357240 - Completed
  HIV Infections; Protease Inhibitor
  
• Drug Interaction With Metformin
  ClinicalTrials.gov Identifier: NCT00546741 - Completed
  Diabetes
  
• Drug Interactions Among Anti-HIV Agents
  ClinicalTrials.gov Identifier: NCT00001766 - Completed
  HIV Infection
  
• Drug Interactions and Bioavailability of Cranberry
  ClinicalTrials.gov Identifier: NCT00200759 - Recruiting
  Healthy; Drug Interactions
  
• Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00376038 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Drug Interactions of Amprenavir and Efavirenz, in Combination with a Second Protease Inhibitor, in HIV-Negative Volunteers
  ClinicalTrials.gov Identifier: NCT00005762 - Completed
  HIV Infections
  
• Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken with Lopinavir/Ritonavir in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00103012 - Recruiting
  
  
• Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
  ClinicalTrials.gov Identifier: NCT00312091 - Recruiting
  HIV Infections
  
• Drug Resistance Inhibition in Treating Patients With Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002826 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• Drug Study of Albuterol to Treat Acute Lung Injury
  ClinicalTrials.gov Identifier: NCT00434993 - Recruiting
  Respiratory Distress Syndrome, Adult
  
• Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
  ClinicalTrials.gov Identifier: NCT00281619 - Recruiting
  Kidney Transplant
  
• Drug Study of Once Daily Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00273273 - Completed
  HIV
  
• Drug Therapy for Alcohol Dependence in Alaska Natives (naltrexone/sertraline)
  ClinicalTrials.gov Identifier: NCT00000451 - Completed
  Alcoholism
  
• Drug Therapy for Alcohol Detoxification
  ClinicalTrials.gov Identifier: NCT00000441 - Completed
  Alcoholism
  
• Drug Therapy for Generalized Anxiety Disorder Among the Elderly
  ClinicalTrials.gov Identifier: NCT00105586 - Active, not recruiting
  Anxiety Disorders
  
• Drug Therapy in Lupus Nephropathy
  ClinicalTrials.gov Identifier: NCT00001212 - Completed
  Nephrotic Syndrome; Systemic Lupus Erythematosus
  
• Drug Therapy to Treat Minor Depression
  ClinicalTrials.gov Identifier: NCT00048815 - Active, not recruiting
  Depression
  
• Drug Transport in Patients With Anorexia Nervosa
  ClinicalTrials.gov Identifier: NCT00176150 - Recruiting
  Anorexia Nervosa
  
• Drug Treatment Combined With Drug and Risk Reduction Counseling in the Prevention of HIV Infection Among Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00270257 - Not yet recruiting
  HIV Infections; Opioid-Related Disorders
  
• Drug Treatment for Alcoholics with Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00000439 - Completed
  Alcoholism; Bipolar Disorder
  
• Drug Treatment for Alcoholics with Post-Traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00000446 - Completed
  Alcoholism; Post-Traumatic Stress Disorder
  
• Drug Treatment for Alcoholism (ondansetron)
  ClinicalTrials.gov Identifier: NCT00006205 - Recruiting
  Alcoholism
  
• Drug Treatment for Autism
  ClinicalTrials.gov Identifier: NCT00047697 - Active, not recruiting
  Autistic Disorder
  
• Drug Treatment for Depressed Alcoholics (naltrexone/fluoxetine)
  ClinicalTrials.gov Identifier: NCT00006204 - Completed
  Alcoholism; Depression
  
• Drug Treatment for Pathologic Gambling Disorder
  ClinicalTrials.gov Identifier: NCT00053677 - Active, not recruiting
  Impulse Control Disorders
  
• Drug Treatment for Pathological Gambling
  ClinicalTrials.gov Identifier: NCT00055393 - Active, not recruiting
  Gambling
  
• Drug Treatment in Pregnancy - 1
  ClinicalTrials.gov Identifier: NCT00227903 - Not yet recruiting
  Alcohol Abuse; Behavior Therapy; Brief Advice; Cocaine Abuse; Marijuana Abuse
  
• Drug Use Investigation Of Gabapentin
  ClinicalTrials.gov Identifier: NCT00567268 - Active, not recruiting
  Epilepsies, Partial
  
• Drug Use Prevention Among Girls Through a Mother-Daughter Intervention
  ClinicalTrials.gov Identifier: NCT00310258 - Completed
  Adolescent Behavior
  
• Drug Utilization Prevalence in a Pediatric Care Medical Center
  ClinicalTrials.gov Identifier: NCT00550706 - Recruiting
  Infectious Diseases; Metabolic Diseases; Cancer
  
• Drug-Drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder
  ClinicalTrials.gov Identifier: NCT00321516 - Completed
  Bipolar Disorder
  
• Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil
  ClinicalTrials.gov Identifier: NCT00566865 - Recruiting
  Type 2 Diabetes Mellitus
  
• Drug-Drug Interaction Study of MRA in Patient with Rheumatoid Arthritis(RA)
  ClinicalTrials.gov Identifier: NCT00144560 - Completed
  Rheumatoid Arthritis
  
• Drug-Eluting-Stents for Unprotected Left Main Stem Disease
  ClinicalTrials.gov Identifier: NCT00133237 - Completed
  Coronary Disease
  
• Drug-Induced Liver Injury (DILN) Retrospective
  ClinicalTrials.gov Identifier: NCT00360646 - Recruiting
  Drug Induced Liver Injury
  
• Drug-Induced Sudden Death & Ventricular Arrhythmia
  ClinicalTrials.gov Identifier: NCT00102180 - Active, not recruiting
  Cardiovascular Diseases; Death, Sudden, Cardiac; Heart Diseases; Ventricular Arrhythmia
  
• Drugs to Reduce the Side Effects of Chemotherapy
  ClinicalTrials.gov Identifier: NCT00003213 - Active, not recruiting
  solid tumor; Nausea; Vomiting
  
• Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure
  ClinicalTrials.gov Identifier: NCT00471731 - Recruiting
  Turner Syndrome; Ovarian Failure, Premature; Sex Chromosome Aberrations; Menopause; Perimenopause
  
• Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00545064 - Recruiting
  Ocular Hypertension; Open Angle Glaucoma
  
• Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome
  ClinicalTrials.gov Identifier: NCT00378677 - Recruiting
  Lung Transplantation; Bronchiolitis Obliterans
  
• Dryvax vaccine immunogenicity in previously vaccinated
  ClinicalTrials.gov Identifier: NCT00050505 - Completed
  Smallpox
  
• DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Accelerated Phase or Blastic Phase Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00397579 - Recruiting
  Leukemia
  
• DTaP and Apnea/Bradycardia in Preterm Infants
  ClinicalTrials.gov Identifier: NCT00482781 - Completed
  Prolonged Apnea; Prolonged Bradycardia
  
• DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003840 - Completed
  recurrent adult acute myeloid leukemia
  
• DTPACE followed by Tandem Transplant with MEL 200 versus MEL/DTPACE Hybrid and DTPACE Consolidation
  ClinicalTrials.gov Identifier: NCT00083915 - Active, not recruiting
  Multiple Myeloma
  
• Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial
  ClinicalTrials.gov Identifier: NCT00056641 - Completed
  HIV Infections
  
• Dual Chamber versus Single Chamber Cardiac Pacing in People 80 Years of Age and Older
  ClinicalTrials.gov Identifier: NCT00116987 - Recruiting
  Atrial Fibrillation; Cardiac Pacing, Artificial
  
• Dual Diagnosis Self-Help Referral
  ClinicalTrials.gov Identifier: NCT00286728 - Recruiting
  Dual Diagnosis
  
• Dual Therapy in Depression
  ClinicalTrials.gov Identifier: NCT00519428 - Recruiting
  Major Depressive Disorder
  
• Dual Time Point PET Imaging in Lymphoma
  ClinicalTrials.gov Identifier: NCT00297557 - Not yet recruiting
  Hodgkin's or Non-Hodgkin's Lymphoma
  
• Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People
  ClinicalTrials.gov Identifier: NCT00028366 - Completed
  HIV Infections
  
• Dual-Plane Breast Augmentation: Axillary Approach With Assistant of Endoscope
  ClinicalTrials.gov Identifier: NCT00505557 - Completed
  Mammoplasty
  
• Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00082979 - Recruiting
  Breast Cancer
  
• Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy
  ClinicalTrials.gov Identifier: NCT00083044 - Completed
  Breast Cancer; breast cancer in situ; stage I breast cancer; lobular breast carcinoma in situ; intraductal breast carcinoma
  
• Duke Autoimmunity in Pregnancy Registry
  ClinicalTrials.gov Identifier: NCT00513591 - Not yet recruiting
  Pregnancy; Systemic Lupus Erythematosus; Cutaneous Lupus; Rheumatoid Arthritis; Sjogren's Syndrome; Scleroderma
  
• Duke Conte Center for the Neuroscience of Depression in Late Life
  ClinicalTrials.gov Identifier: NCT00576875 - Recruiting
  Major Depression
  
• Duke Lupus Registry
  ClinicalTrials.gov Identifier: NCT00512694 - Recruiting
  Systemic Lupus Erythematosus; Cutaneous Lupus
  
• Dulcolax vs Placebo in Functional Constipation
  ClinicalTrials.gov Identifier: NCT00526097 - Recruiting
  Constipation
  
• Duloxetine - Warfarin Pharmacodynamic Study
  ClinicalTrials.gov Identifier: NCT00533026 - Completed
  Anticoagulant Effect of Warfarin When Taken With Duloxetine.
  
• Duloxetine Compared with Placebo in Patients with Generalized Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00122824 - Completed
  Anxiety Disorders
  
• Duloxetine Compared with Placebo in the Prevention of Relapse in Generalized Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00122863 - Completed
  Anxiety Disorders
  
• Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
  ClinicalTrials.gov Identifier: NCT00071708 - Recruiting
  Major Depressive Disorder
  
• Duloxetine for Chronic Depression: a Double-Blind Study
  ClinicalTrials.gov Identifier: NCT00360724 - Recruiting
  Dysthymic Disorder; Depressive Disorder NOS
  
• Duloxetine for Perimenopausal Depression
  ClinicalTrials.gov Identifier: NCT00517985 - Recruiting
  Major Depressive Disorder
  
• Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome
  ClinicalTrials.gov Identifier: NCT00114127 - Recruiting
  Anxiety Disorder
  
• Duloxetine for the Treatment of Dysthymia
  ClinicalTrials.gov Identifier: NCT00185575 - Active, not recruiting
  Depressive Disorder
  
• Duloxetine for the Treatment of OCD
  ClinicalTrials.gov Identifier: NCT00464698 - Recruiting
  Obsessive Compulsive Disorder
  
• Duloxetine in Patients With Suspected Functional Pancreatic/Biliary Pain (Sphincter of Oddi Dysfunction)
  ClinicalTrials.gov Identifier: NCT00471315 - Recruiting
  Sphincter of Oddi
  
• Duloxetine in the Treatment of Melancholic Depression
  ClinicalTrials.gov Identifier: NCT00191685 - Completed
  Depressive Disorder, Major
  
• Duloxetine in the Treatment of Stress Urinary Incontinence.
  ClinicalTrials.gov Identifier: NCT00191087 - Completed
  Urinary Incontinence, Stress
  
• Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00489411 - Not yet recruiting
  Neurotoxicity; Pain; Unspecified Adult Solid Tumor, Protocol Specific
  
• Duloxetine Referenced Study Evaluating the Efficacy and Safety of 50 mg & 100 mg Doses of DVS SR in Outpatients With MDD
  ClinicalTrials.gov Identifier: NCT00384033 - Completed
  Depressive Disorder, Major
  
• Duloxetine Stress Urinary Incontinence Efficacy and Safety Study
  ClinicalTrials.gov Identifier: NCT00475397 - Completed
  Urinary Incontinence, Stress
  
• Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression
  ClinicalTrials.gov Identifier: NCT00494377 - Completed
  Depression
  
• Duloxetine Versus Paroxetine for Major Depression
  ClinicalTrials.gov Identifier: NCT00489775 - Completed
  Major Depressive Disorder
  
• Duloxetine Versus Placebo for Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00489073 - Completed
  Fibromyalgia
  
• Duloxetine Versus Placebo for Osteoarthritis Knee Pain
  ClinicalTrials.gov Identifier: NCT00408421 - Completed
  Osteoarthritis Knee Pain
  
• Duloxetine versus Placebo in the Prevention of Recurrence of Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00105989 - Active, not recruiting
  Depressive Disorder, Major
  
• Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00036309 - Completed
  Depressive Disorder
  
• Duloxetine Versus Placebo in the Treatment of FMS
  ClinicalTrials.gov Identifier: NCT00233025 - Completed
  Fibromyalgia
  
• Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China
  ClinicalTrials.gov Identifier: NCT00408993 - Active, not recruiting
  Diabetic Neuropathies
  
• Duloxetine vs Placebo in the Treatment of General Anxiety
  ClinicalTrials.gov Identifier: NCT00475969 - Completed
  Anxiety
  
• Duloxetine vs. Active Comparator for the Treatment of Depression
  ClinicalTrials.gov Identifier: NCT00067912 - Completed
  Depression
  
• Duloxetine vs. active comparator in the treatment of patients with depression
  ClinicalTrials.gov Identifier: NCT00071695 - Completed
  Depression
  
• Duloxetine vs. Placebo in Chronic Low Back Pain
  ClinicalTrials.gov Identifier: NCT00408876 - Active, not recruiting
  Back Pain Without Radiation
  
• Duloxetine vs. Placebo in Chronic Low Back Pain
  ClinicalTrials.gov Identifier: NCT00424593 - Active, not recruiting
  Back Pain Without Radiation
  
• Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain
  ClinicalTrials.gov Identifier: NCT00433290 - Recruiting
  Osteoarthritis Knee Pain
  
• Duodenal Exclusion for the Treatment of T2DM
  ClinicalTrials.gov Identifier: NCT00456352 - Recruiting
  Diabetes
  
• Duodenal Exclusion for the Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00534547 - Not yet recruiting
  Diabetes
  
• Duodenal Jejunal Bypass for Type 2 Diabetes (DJBD)
  ClinicalTrials.gov Identifier: NCT00487526 - Recruiting
  Diabetes Mellitus
  
• Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial
  ClinicalTrials.gov Identifier: NCT00362674 - Active, not recruiting
  Hepatitis B
  
• DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery
  ClinicalTrials.gov Identifier: NCT00387829 - Recruiting
  Spinal Injuries; Adhesions
  
• Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain
  ClinicalTrials.gov Identifier: NCT00237341 - Completed
  Low Back Pain
  
• Duration and Force Variations in Applied Kinesiology Manual Muscle Testing
  ClinicalTrials.gov Identifier: NCT00526955 - Completed
  Healthy
  
• Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers
  ClinicalTrials.gov Identifier: NCT00223171 - Recruiting
  Prostate Cancer
  
• Duration of GnRH-Analogue Downregulation and Pregnancy Rates
  ClinicalTrials.gov Identifier: NCT00436319 - Recruiting
  Infertility
  
• Duration of Skin Numbing Effect Created by the S-Caine™ Peel
  ClinicalTrials.gov Identifier: NCT00110253 - Completed
  Pain
  
• Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
  ClinicalTrials.gov Identifier: NCT00564018 - Enrolling by invitation
  Type 1 Diabetes
  
• Dust Mite Allergen Reduction Study
  ClinicalTrials.gov Identifier: NCT00339690 - Recruiting
  Dust Mite Allergen
  
• Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects
  ClinicalTrials.gov Identifier: NCT00368979 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)
  ClinicalTrials.gov Identifier: NCT00527605 - Not yet recruiting
  Benign Prostatic Hyperplasia
  
• Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)
  ClinicalTrials.gov Identifier: NCT00382356 - Recruiting
  Benign Prostatic Hypertrophy
  
• Dutasteride and Androgen-Ablation Therapy in Treating Patients With Localized Prostate Cancer Who Have Undergone Radiation Therapy and/or Surgery
  ClinicalTrials.gov Identifier: NCT00516815 - Recruiting
  Prostate Cancer
  
• Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00398281 - Recruiting
  Prostate Cancer
  
• Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)
  ClinicalTrials.gov Identifier: NCT00274417 - Active, not recruiting
  Benign Prostatic Hyperplasia; Lower Urinary Tract Symptoms
  
• Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
  ClinicalTrials.gov Identifier: NCT00403000 - Active, not recruiting
  Prostate Cancer
  
• Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)
  ClinicalTrials.gov Identifier: NCT00303446 - Active, not recruiting
  Kennedy's Disease; Spinal and Bulbar Muscular Atrophy
  
• Dutasteride to Treat Women with Menstrually Related Mood Disorders
  ClinicalTrials.gov Identifier: NCT00082043 - Recruiting
  Premenstrual Syndrome
  
• Dutch EASYcare Study
  ClinicalTrials.gov Identifier: NCT00105378 - Completed
  Cognition Disorders; Mood Disorder; Gait Disorder, Neurologic; Malnutrition
  
• Dutch National ITB Study in Children With Cerebral Palsy
  ClinicalTrials.gov Identifier: NCT00367068 - Completed
  Cerebral Palsy; Spasticity
  
• Dutch Prediction of Psychosis Study
  ClinicalTrials.gov Identifier: NCT00188981 - Active, not recruiting
  Psychotic Disorders
  
• Dutch Randomised Endovascular Aneurysm Management (DREAM-) Trial
  ClinicalTrials.gov Identifier: NCT00421330 - Active, not recruiting
  Abdominal Aortic Aneurysm
  
• Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study
  ClinicalTrials.gov Identifier: NCT00228514 - Completed
  Rosuvastatin; Heart Failure; Positron Emission Tomography (PET)
  
• DVS-233 SR For Prevention Of Depressive Relapse In Adult Outpatients With Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00075257 - Active, not recruiting
  Major Depressive Disorder
  
• DVT Prophylaxis in Orthopaedic Oncology Patients - A Safety Study
  ClinicalTrials.gov Identifier: NCT00525057 - Recruiting
  Bone Cancer
  
• DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00004212 - Completed
  childhood Hodgkin's lymphoma; childhood brain tumor; childhood non-Hodgkin's lymphoma; childhood solid tumor
  
• DX-8951f in Treating Patients With Biliary Cancer
  ClinicalTrials.gov Identifier: NCT00005938 - Active, not recruiting
  localized gallbladder cancer; cholangiocarcinoma of the gallbladder; localized extrahepatic bile duct cancer; recurrent gallbladder cancer; ...
  
• DX-8951f in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00004108 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
  
• DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003951 - Active, not recruiting
  recurrent pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage IV pancreatic cancer; adenocarcinoma of the pancreas
  
• DX-8951f in Treating Patients With Metastatic Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00017212 - Completed
  stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; ...
  
• DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005091 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
  
• DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00004866 - Completed
  stage III cervical cancer; stage IV cervical cancer; recurrent cervical cancer; cervical squamous cell carcinoma
  
• Dyadic Coping in Breast and Prostate Cancer Patients and Their Spouses
  ClinicalTrials.gov Identifier: NCT00536055 - Not yet recruiting
  Breast Cancer; Prostate Cancer; Dyadic Coping
  
• DynaCT Imaging in EVAR: Comparing Clinical Benefit of DynaCT to Multidetector CT as the Current Gold Standard.
  ClinicalTrials.gov Identifier: NCT00264862 - Completed
  Abdominal Aortic Aneurysm
  
• Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00165100 - Completed
  Malignant Tumors; Subcutaneous Tumors; Lymph Node Tumors
  
• Dynamic Aspects of Amino Acid Metabolism
  ClinicalTrials.gov Identifier: NCT00005767 - Recruiting
  Kidney Diseases
  
• Dynamic Breast MRI in Assessing Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00455273 - Recruiting
  Locally Advanced Breast Cancer
  
• Dynamic Cervical Change: Prediction of Preterm Labor in Symptomatic Patients
  ClinicalTrials.gov Identifier: NCT00298480 - Recruiting
  Dynamic Cervical Change in Preterm Labor Patients
  
• Dynamic Contrast Enhanced MRI (DCE-MRI) and Magnetic Resonance Spectroscopy (MRS) of Head and Neck Tumors
  ClinicalTrials.gov Identifier: NCT00581906 - Recruiting
  Head and Neck Cancer
  
• Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences
  ClinicalTrials.gov Identifier: NCT00540371 - Enrolling by invitation
  Port Wine Stain
  
• Dynamic Hyperinflation and Tiotropium
  ClinicalTrials.gov Identifier: NCT00569270 - Recruiting
  COPD
  
• Dynamic Laryngotracheal Separation for Aspiration
  ClinicalTrials.gov Identifier: NCT00580346 - Recruiting
  Neurological Insults Producing Aspiration Pneumonia
  
• Dynamic Light Scattering and Keratoscopy for Corneal Examination
  ClinicalTrials.gov Identifier: NCT00050466 - Completed
  Corneal Diseases
  
• Dynamic Light Scattering Device (DLS) Study of Age-Related Changes in the Lens and Cataracts
  ClinicalTrials.gov Identifier: NCT00007215 - Completed
  Cataract; Healthy
  
• Dynamic Light Scattering for Studying Lens Aging and Cataract Formation
  ClinicalTrials.gov Identifier: NCT00081991 - Completed
  Cataract
  
• Dynamic Light Scattering to Study Crystalline Proteins in Young Normal Lenses
  ClinicalTrials.gov Identifier: NCT00304967 - Completed
  Healthy
  
• Dynamic Magnetic Resonance (MR) Study in Evaluating the Vertebral Bone Marrow Perfusion and Its Related Research
  ClinicalTrials.gov Identifier: NCT00172224 - Recruiting
  Osteoporosis; Fractures, Compression
  
• Dynamic Measures of Neurochemistry in Mood Disorders
  ClinicalTrials.gov Identifier: NCT00178828 - Active, not recruiting
  Depression
  
• Dynamic PET Acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment
  ClinicalTrials.gov Identifier: NCT00294840 - Recruiting
  Pancreatic Cancer
  
• Dynamic Posturographic Testing and Motor Learning Predictability in Gymnasts
  ClinicalTrials.gov Identifier: NCT00374569 - Active, not recruiting
  Gymnastics Injury, Motor Learning, Balance
  
• Dynamic Profiles of Cytokine/Chemokine in Severe Acute Respiratory Syndrome
  ClinicalTrials.gov Identifier: NCT00173459 - Completed
  SARS
  
• Dynamic Stabilization for Lumbar Spinal Stenosis With Stabilimax NZ® Dynamic Spine Stabilization System
  ClinicalTrials.gov Identifier: NCT00529997 - Recruiting
  Lumbar Spinal Stenosis
  
• DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change)
  ClinicalTrials.gov Identifier: NCT00308386 - Recruiting
  Diabetes Mellitus; Hypertension; Hyperlipidemia
  
• Dynamic Substrate Mapping (DSM) for Ischemic VT
  ClinicalTrials.gov Identifier: NCT00558857 - Enrolling by invitation
  Ischemic Ventricular Tachycardia
  
• Dynamics of Leptin and Endocrine Function
  ClinicalTrials.gov Identifier: NCT00001543 - Completed
  Healthy; Involutional Depression
  
• Dynasplint Therapy for Trismus in Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00507208 - Recruiting
  Trismus
  
• Dynepo Infrequent Dosing Study
  ClinicalTrials.gov Identifier: NCT00450333 - Recruiting
  Anemia; Kidney Failure
  
• Dynepo Long-Term Safety Study
  ClinicalTrials.gov Identifier: NCT00514813 - Recruiting
  Anemia; Kidney Failure, Chronic
  
• DYSCAR: Characterization of Dystonia
  ClinicalTrials.gov Identifier: NCT00361465 - Recruiting
  Dystonia; Parkinson Disease
  
• Dysesthesia Study After Sternotomy
  ClinicalTrials.gov Identifier: NCT00408044 - Recruiting
  Ischemic Cardiopathy; Other Forms of Cardiopathy
  
• Dyskinesia in Parkinson's Disease (Study P04501AM2)
  ClinicalTrials.gov Identifier: NCT00406029 - Recruiting
  Parkinson Disease; Movement Disorders; Central Nervous System Diseases; Neurodegenerative Diseases; Brain Diseases
  
• Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women
  ClinicalTrials.gov Identifier: NCT00037258 - Active, not recruiting
  Cardiovascular Diseases; Diabetes Mellitus, non-insulin dependent; Heart Diseases; Atherosclerosis; Diabetes Mellitus
  
• Dyslipidemia in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00547274 - Completed
  Diabetes Mellitus, Type II; Dyslipidemia
  
• Dyslipidemia Study Investigating The Increase In "Good Cholesterol"
  ClinicalTrials.gov Identifier: NCT00169559 - Completed
  Dyslipidemia; Hypertriglyceridemia
  
• Dyspnea Self-Management: Internet or Face-to-Face
  ClinicalTrials.gov Identifier: NCT00461162 - Recruiting
  Chronic Obstructive Pulmonary Disease (COPD)
  
• Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study
  ClinicalTrials.gov Identifier: NCT00258609 - Completed
  Migraine Without Aura Prophylaxis
  
• Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis
  ClinicalTrials.gov Identifier: NCT00497913 - Recruiting
  Tennis Elbow
  
• Dysregulated Tyrosine Kinase Signaling in Leukemia
  ClinicalTrials.gov Identifier: NCT00277056 - Completed
  Leukemia - Chronic